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SUMMARY 
 
The vascularisation of the embryonic brain is a dynamic process governed by an 
intricate network of regulatory pathways.  The process of vascularisation has been 
studied in the spinal cord of avian embryos but very little work has been conducted in 
the rostral brain.  The present study therefore aimed to characterise the major events 
involved in the vascularisation of the Gallus gallus brain, with supporting work 
conducted in Xenopus laevis.  Endothelial cells migrated from the mesoderm towards 
the brain, leading to the formation of the perineural vascular plexus.  Endothelial 
sprouts invaded the brain, which then branched and fused to form the intraneural 
vascular plexus.  Cell replication was also detected throughout the process.  A similar 
sequence of events have previously been described in quail and mouse, providing 
support for an evolutionarily conserved process throughout vertebrate evolution. 
 
Matrix metalloproteinases play a major role in remodelling the extracellular matrix, 
which is an essential aspect in angiogenesis.  MMPs -1, -2 and -9 were expressed 
within the perineural vascular plexus, differentially within the invading sprouts and 
also in the intraneural vascular plexus.  Gelatinase activity was also detected in 
specific cells within the perineural vascular plexus and in the invading sprouts.  
Altering the level of MMP activity lead to the formation of endothelial cell clusters, 
which may have resulted from defective proliferation and migration.  The results 
provide a novel contribution to the role of MMPs in brain vascularisation. 
 
The brain plays an important role in organising its vasculature, therefore the influence 
of neural tube patterning on ingression was investigated.  The ectopic expression of 
the ventralising signal, sonic hedgehog, expanded the perineural vascular plexus and 
disrupted sprout formation.  Lowering Notch activity lead to a significant increase in 
the number of endothelial cells within the brain.  Endothelial cell clusters were 
formed, suggesting that Notch may also play a role in maintaining the structural 
integrity of vessel sprouts.  The arrangement of the sprout, with a leading tip cell and 
follower stalk cells, is reminiscent of invasion by certain cancers.  The process of 
endothelial ingression may therefore share similarities with tumour angiogenesis and 
could aid in developing novel strategies for reducing tumourigenesis and for stroke 
recovery. 
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1. INTRODUCTION 
 
The development of a properly patterned blood vessel network is crucial for supplying 
oxygen and nutrients to developing organ systems during embryogenesis.  A critical 
step in the development of the vertebrate nervous system is the vascularisation of the 
neural tube.  The brain in particular has a high demand for oxygen and nutrients, 
relying on an efficient and highly specialised network of blood vessels to meet its 
substantial metabolic demands.  In early embryogenesis, the neuroectoderm is absent 
of endothelial cells and is also unable to give rise to angioblastic cells.  The 
vascularisation of the neural tube therefore relies solely on an extraneuroectodermal 
origin of endothelial cells and angioblasts, which are recruited from the surrounding 
mesodermal tissue.  A primary capillary bed, referred to as the perineural vascular 
plexus (PNVP), begins to form as endothelial cells aggregate around the developing 
neural tube (reviewed in Kurz et al., 1996; James & Mukouyama, 2011), which then 
receives its first blood vessels by the dorsal immigration of isolated angioblasts and 
the ventral and medial invasion of endothelial sprouts.  The arrangement of the 
endothelial sprout, with a leading tip cell and follower stalk cells, is reminiscent of 
multicellular invasion by certain cancers, shown to be facilitated by matrix 
metalloproteinases (MMPs).  The mechanisms underlying the invasive behaviour of 
endothelial cells in central nervous system (CNS) vascularisation may therefore share 
similarities with cancer biology, particularly tumour invasiveness and angiogenesis 
(Kurz et al., 1996; Gerhardt et al., 2003; Wolf et al., 2007; James et al., 2009).  Once 
inside the neural tube, sprouts extend along radial glia and encounter the ependymal 
layer where they then branch and fuse to form the intraneural vascular plexus (INVP) 
(Gerhardt et al., 2003).  In the adult, PNVP-derived vessels form the blood-brain 
barrier (BBB), which has a neuroprotective role by regulating the transport of 
substances between the blood and the brain (Risau & Wolburg, 1990; Bauer et al., 
1993). 
 
1.1 Gallus gallus embryos as a model organism for developmental biology 
 
The embryos of G. gallus have been used extensively as a model organism in 
developmental biology and for studying the processes of disease.  Chicken eggs are 
relatively cheap and easy to maintain compared to many other research models and 
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are readily accessible throughout the year.  The semitransparent embryos are large 
enough to perform experimental manipulations inside the egg under a dissecting 
microscope and can also be removed from the shell for culture.  The nature of G. 
gallus as amniotes is a key advantage for research and so their development of these 
embryos, which is described as a series of Hamburger and Hamilton (HH) stages 
based on morphological characteristics (Hamburger & Hamilton, 1951), is close to 
that of humans.  The development of human embryos has been described in a 
morphological system of Carnegie stages based on features such as embryonic length 
and number of somites, covering the first 60 days of gestation (Streeter, 1942; 
O’Rahilly & Müller, 1987).  A comparison of the developing brain in early chick 
and human embryos is shown in Fig. 1i.  The majority of information obtained from 
chick embryos is also applicable to the quail and embryos of other avians, although a 
major limitation is that the information on genetic mutations is scarce compared to 
other models such as Drosophila melanogaster and Danio rerio.  Information 
obtained across a range of research models must therefore be integrated for a 
thorough understanding of how the brain develops in terms of anatomy and 
molecular control, which is essential for the applicability to understanding human 
embryology and the subsequent developmental origins of disorders. 
 
Figure 1i.  Comparison of brain development in early human and chick 
embryos.  A. The first sign of neural tube development in the human embryo is the 
emergence of neural ridges along the two sides of the neural plate on embryonic day 
(E)19, which fold over to begin the formation of the neural tube.  The neural tube 
begins to close in the central regions on E22, proceeding in both rostral and caudal 
directions.  The anterior and posterior neuropores are the last segments to close on 
E25 and E27, respectively.  The shape of the cylindrical centre of the neural tube 
changes as the brain grows larger and more complex, expanding to form the three 
primary brain vesicles that are distinguished by E28: the prosencephalon is the 
embryonic precursor of the forebrain, the mesencephalon is the precursor of 
midbrain structures and the most posterior is the rhombencephalon that will become 
the hindbrain. The embryo bends into a 'C' shape on E28-E30 and a prominent 
cephalic flexure appears at the level of the mesencephalon.  A cervical flexure 
appears at the boundary between the hindbrain and the spinal cord at the beginning 
of the fifth week and the primary brain vesicles further subdivide by E49 to form 
five secondary vesicles that establish the primary organisation of the central nervous 
system, which persist into adulthood.  The prosencephalon differentiates into the 
telencephalon that ultimately forms the cerebral hemispheres and the diencephalon 
with optic vesicles extending from the lateral walls.  The rhombencephalon 
differentiates into the metencephalon and a more caudal myelencephalon, whereas 
the mesencephalon does not further divide and remains tubular in structure.  Adapted 
from Stiles & Jernigan (2010) and iKnowledge (2015).  B. The chick embryo is a 
popular model organism and the development of the chick and human brains share 
various similarities, although specific regions develop at different rates.  Neural folds 
become visible in the head region towards the end of E1 (HH7) and the neural tube 
begins to close at the level of the future mesencephalon on E2 (HH8).  Closure of the 
anterior and posterior neuropores occurs between E2 and E3 (HH12-HH13).  The 
three primary brain vesicles are established by E2 (HH10) during which the cranial 
and cervical flexures are first indicated.  The subdivision of primary vesicles into the 
five secondary brain vesicles soon follows, which continue to grow in size and 
complexity.  Adapted from Hamburger & Hamilton (1951) and www.mun.ca.  The 
morphological similarities between a 5-week human embryo and E4 (HH22) chick 
embryo are shown in C and D, respectively.  
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1.2 The avian and mouse neural tube and the retina as models for CNS 
 vascularisation 
 
The earliest descriptions of the vascularisation of the neural tube were achieved 
primarily through the use of conventional histology and India ink injections in the 
spinal cord of avian embryos.  The formation of the PNVP was first described in the 
classic study by Feeney & Watterson (1946), which also documented the appearance 
of sixteen distinct intraneural capillaries in specific regions along the dorsoventral 
axis of the chick neural tube.  The spatial and temporal formation of early vessels 
was found to give rise to a scaffold, allowing for association with subsequent 
vessels.   
 
The avian embryo has been a popular model organism for developmental studies on 
angiogenesis, particularly since the use of anti-MB1 monoclonal antibodies (Peault 
et al., 1983) within the quail-chick chimera system.  The MB1 antigen (Labastie et 
al., 1986; Peault et al., 1987) is expressed on the surface of hemangioblasts and all 
endothelial and haematopoietic cells, excluding mature erythrocytes.  Throughout 
ontogenesis and in the adult, MB1 is used as a lineage-specific marker characteristic 
of endothelial cells specific to quail.  Other monoclonal antibodies have been 
produced that have similar specificities, such as the QH1 antibody (Pardanaud et al., 
1987).  A systematic approach to investigating the origin of cephalic blood vessel 
endothelial cells was conducted by Couly et al. (1995) in early avian embryos by 
performing grafts of defined mesodermal territories from the 3-somite stage quail 
embryo into stage-matched chick embryos in a strictly isotopic manner.  The 
tyrosine-kinase receptor Quek1 (Eichmann et al., 1993), which is the avian 
homologue of the mammalian vascular endothelial growth factor receptor 2 
(VEGFR2), was used as a molecular marker to label endothelial precursors from the 
time of gastrulation.  Quek1 positive cells later form endothelial cells of blood 
vessels and express the antigen MB1/QH1, specifically in quail.  The monoclonal 
antibody, MB1/QH1, was therefore used as a second molecular marker in order to 
identify endothelial cells as they assemble to constitute the lining of the newly 
formed blood vessels.  The use of two markers to label vascular endothelial cells and 
their precursors showed that the cephalic mesoderm has considerable angiogenic 
potentials, vascularising specific regions of the face and brain in a restricted and well 
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defined pattern.  The anterior region of the cephalic paraxial mesoderm was shown 
to be largely recruited by the forebrain to provide its vasculature, while angiogenic 
cells from the more posterior mesodermal territories vascularised the corresponding 
levels of the brain.  
   
The major blood vessel patterning events in the quail neural tube were observed by 
Kurz et al. (1996) and James et al. (2009), utilising the monoclonal antibody QH1 
directed against quail endothelial cells and angioblasts.  Kurz et al. (1996) found that 
the first blood vessels in the quail spinal cord at cervical level develop by a 
combination of two processes, the dorsal immigration of isolated migrating 
angioblastic cells at stage HH19 and the ventral sprouting of endothelial cells on 
either side of the floor plate at HH21, both of which contribute to the developing 
INVP.  The exclusive extraectodermal origin of angioblastic cells was also 
demonstrated through the study of chick-quail chimeras.  Replacing the quail neural 
tube with a chick neural tube graft resulted in the same distribution of angioblasts 
and sprouts observed in controls.  Starting caudal to the rhombencephalic neural 
tube, the same pattern of vascularisation was observed in a craniocaudal sequence 
with sprouting cells displaying extremely long filopodia.  James et al. (2009) 
characterised blood vessel ingression into the quail neural tube at the thoracic level, 
visualising patent vessels and non-patent sprouts with QH1 immunostaining.  Neural 
development was also followed by staining with a TuJ1 antibody against β-tubulin 
III to label differentiated neurons.  PNVP formation was found to initiate at stages 
HH16-18 along the mid-levels of the lateral surface of the neural tube and continued 
to develop until stages HH22-24.  The dorsal migration of single QH1-positive 
angioblasts and ventral sprouting were first observed at stages HH22-24 followed by 
medial angiogenic sprouting at stages HH24-25, occurring slightly later than that of 
the cervical neural tube identified by Kurz et al. (1996).  Obvious stereotypical blood 
vessel ingression points were exhibited by stage HH26.  The number of TuJ1-
positive cells were found to increase over time forming a TuJ1-positive area into 
which angiogenic sprouts invaded at specific ventral and medial regions.  Once 
inside the neural tube, the angiogenic sprouts avoided the TuJ1-negative medial area 
containing proliferative progenitor cells, suggesting that blood vessel ingression may 
be influenced by the developing neural tube (Fig. 1ii).   
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Figure 1ii.  Vascularisation of the avian neural tube.  A. Schematic summary of 
the major blood vessel patterning events in the spinal cord from the initial migration 
of endothelial cells towards the neural tube leading to the formation of the PNVP, 
dorsal migration of isolated angioblasts and ventral sprouting, followed by medial 
sprouting and formation of the INVP.  Vascularisation of the quail neural tube by 
QH1 immunostaining reveals the beginning of sprouting at stage HH21 at cervical 
level (B) and stages HH22-24 at thoracic level (C) as endothelial cells invade the 
ventral spinal cord.  Obvious stereotypical blood vessel ingression points were 
exhibited by stage HH26 (Kurz et al., 1996; James et al., 2009). 
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The mouse embryo hindbrain and forebrain are popular mammalian models used to 
study the cellular mechanisms of CNS vascularisation.  In the mouse hindbrain, 
vascularisation initiates around embryonic (E) day 9.5 when blood vessels begin to 
sprout from the PNVP and grow radially towards the ventricular zone where 
vascular growth factors are released by neural progenitors.  The radial vessels begin 
sprouting at near right angles from around E10.25 and extend parallel to the surface 
of the hindbrain.  The subventricular vascular plexus (SVP) is formed by E12.5 
through the anastomosis of neighbouring vessel sprouts (Ruhrberg et al., 2002; 
Fantin et al., 2010; Fantin et al., 2013), which is promoted by tissue macrophages 
derived from the yolk sac.  The macrophages interact with endothelial tip cells and 
bridge neighbouring vessel sprouts during the fusion process (Fantin et al., 2010; 
Schmidt & Carmeliet, 2010).  Pericytes also interact with endothelial cells as they 
assemble into sprouts, providing them with structural support and instructive cues 
(Gerhardt & Betsholtz, 2003).  In the mouse forebrain, blood vessels begin to sprout 
from the PNVP into the ventrolateral brain at E9.5, progressing in an orderly 
ventrolateral to dorsomedial direction across the rostrocaudal axis.  The SVP is 
formed in the ventral forebrain by E10, while the dorsal part remains largely 
avascular.  Interestingly, the vasculature in the dorsal forebrain derives from the SVP 
of the ventral compartment rather than sprouting from the dorsal PNVP.  The SVP 
forms in both the ventral and dorsal areas and by E11, reaching the dorsal medial 
wall of the forebrain (Vasudevan et al., 2008). 
 
The retina is another popular model for studying CNS angiogenesis as it originates 
from the developing forebrain and is easily accessible due to the position outside the 
brain.  Vascularisation of the mouse retina begins around birth and studies in 
additional species including rat, cat, human, rabbit and possum, have revealed that 
development of the retinal vasculature is regulated by interactions between 
astrocytes, retinal neurons and vessel sprouts.  Astrocytes make up the largest cell 
population of the CNS and their organisation, differentiation and migration are 
crucial for retinal angiogenesis.  Astrocyte progenitor cells (APCs) are derived from 
neuroepithelial cells of the optic nerve, therefore morphogenesis of the optic stalk, 
which is the precursor of the optic nerve, is important for astrocyte development.  
Studies in zebrafish have demonstrated the importance of Nodal, a member of the 
transforming growth factor beta (TGFβ) family, for early proximal-distal patterning 
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of the eye that occurs in part through modulating the Sonic hedgehog (Shh) pathway 
(Take-uchi et al., 2003; Müller et al., 2000).  In chick embryos, the chemical 
inhibition of Shh and Nodal pathways have been shown to result in optic vesicles 
that were lost or defective (Mercier et al., 2013).  Optic vesicle formation was also 
lost in Nodal deficient mice (Lowe et al., 2001).  The differentiation of optic stalk 
neuroepithelial cells into APCs at E12 to E14 is coincident with the onset of Shh 
expression from differentiating retinal ganglion cells (RGCs), which promotes the 
proliferation of astrocytes and may also induce the expression of the receptor 
tyrosine kinase (RTK), platelet-derived growth factor receptor alpha (PDGFR alpha), 
in APCs (Kuwabara, 1975; Xie et al., 2001; Dakubo et al., 2003; Dakubo et al., 
2008).  In rodents, fibronectin-expressing astrocytes emerge from the optic nerve 
head and invade the inner surface of the retina over the axons of RGCs.  Genetic 
studies have demonstrated that the neuroretina provides the permissive extracellular 
matrix (ECM) for the migration of astrocytes as deletions of laminin α1, β2 and γ3 
chains in the retina disrupts astrocyte migration and spatial distribution (Edwards et 
al., 2010; Gnanaguru et al., 2013).  RGCs express platelet-derived growth factor 
alpha (PDGF-A), which is critical to the patterning of the retinal astrocyte network 
as PDGF-A stimulates the proliferation of the invading astrocytes by binding to 
PDGFR alpha present on the cell surface (Stone & Dreher, 1987; Watanabe & Raff, 
1988; Ling et al., 1989; Fruttiger et al., 1996; Sandercoe et al., 1999; West et al., 
2005).  The network of retinal astrocytes transiently secretes vascular endothelial 
growth factor A (VEGFA) that promotes angiogenesis by stimulating the invasion, 
proliferation and migration of endothelial cells, thus guiding the radial expansion of 
vessel sprouts, also emerging from the optic nerve head, over the retina.  The arrival 
of endothelial cells relieves the oxygen tension in the retina and the arrangement of 
blood vessels depends on the pattern of retinal astrocytes, which is determined by the 
factors influencing astrocyte development.  Oxygen-enriched atmospheres have been 
shown to prevent the development of retinal blood vessels, leading to retinal 
hypoxia, which is associated with inhibited astrocyte differentiation and 
downregulated VEGFA expression.  The formation of vessels therefore depends on 
oxygen demand and the hyperoxia-induced obliteration of newly-formed retinal 
vessels in premature newborn results in retinopathy of prematurity (Stone et al., 
1995; Jiang et al., 1995; Alon et al., 1995; Pierce et al., 1996; Zhang & Stone, 1997; 
Provis et al., 1997; Fruttiger, 2002; West et al., 2005). 
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1.3 CNS angiogenesis is regulated by neural-tube derived signals 
 
The stereotypical pattern of vessel ingression and the existence of a hierarchical 
system of intraneural blood vessel development has lead to the investigation into the 
regulation of neural tube angiogenesis by neural tube-derived signals (James & 
Mukouyama, 2011).  Hogan et al. (2004) used mouse-quail chimeras to identify the 
neural tube as a midline signalling centre for vascular patterning that directs the 
formation of the PNVP.  Mouse neural tubes, derived from ROSA26 heterozygous 
embryos that ubiquitously express the lacZ transgene, were transplanted between the 
intermediate mesoderm and lateral plate in quail hosts.  β-galactosidase staining and 
whole-mount visualisation showed the grafts to be well incorporated.  QH1 staining 
on sections identified the recruitment of host-derived blood vessels immediately 
adjacent to the grafted neural tube in a structure resembling the PNVP.  The grafting 
of acrylic beads and avian notochords did not elicit a vascular plexus, indicating that 
the vascular plexus surrounding the neural tube did not result from the encapsulation 
of a foreign body.  The neural tube-derived vascular patterning signal was also 
demonstrated to induce target cells at a distance by grafting mouse presomitic 
mesoderm into a cavity made from the removal of lateral presomitic mesoderm in 
the quail host, thus setting up a buffer of several cell layers of quail mesoderm 
between the host neural tube and the graft.  Graft-derived vascular cells were found 
to contribute to the PNVP, indicating that the signal does not require direct cell 
contact.  VEGFA expression was then analysed in mouse embryos and correlated 
with PNVP formation, suggesting it as a component of the neural tube signal.  A 
collagen gel explant model was developed in which explants of mouse presomitic 
mesoderm formed a robust vascular plexus when incubated with added VEGFA.  
Co-cultures between presomitic mesoderm and neural tube also resulted in vascular 
plexus formation, indicating that the neural tube was able to replace the requirement 
for VEGFA.  Furthermore, VEGFA signalling through the VEGFR2 receptor was 
found to be a required component of the neural tube vascular patterning signal, 
identified through a combination of pharmacological and genetic perturbations.  
VEGFA was therefore identified to be a necessary component of the neural tube 
vascular patterning signal.   
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The VEGF family of growth factors comprises VEGFA, VEGFB, VEGFC, VEGFD 
and placental growth factor (PlGF), which bind to the RTKs VEGFR1 (Flt-1), 
VEGFR2 (Flk-1) and VEGFR3 (Flt-4), together with co-receptors neuropilin-1 
(NRP1) and neuropilin-2 (NRP2), to stimulate cellular responses including 
vasculogenesis and angiogenesis (Fig. 1iii).  VEGFA as an endothelial growth factor 
with unique target cell specificity for vascular endothelial cells was first isolated 
from the AtT-20 pituitary cell line (Plouët et al., 1989) and was characterised as a 
homodimer composed of two subunits with molecular weights of 23 kd.  The potent 
mitogen for vascular endothelial cells in vitro was also found to induce angiogenesis 
in vivo, the process by which new blood vessels are formed from the remodelling of 
existing ones, without stimulating the growth of other cell types of the vascular 
system.  VEGFA can also have direct effects on neuroectoderm-derived cells and has 
been demonstrated to promote neurogenesis and neuronal patterning.  The treatment 
of cultured primary cortical neurons with VEGFA was shown to enhance neurite 
growth and maturation independently of blood vessels (reviewed by Rosenstein et 
al., 2010).  VEGFs are now known to be synthesised by many different cell types 
including macrophages (Sunderkotter et al., 1994), keratinocytes (Frank et al., 
1995), platelets (Verheul et al., (1997) and tumour cells (Boocock et al., 1995; 
Itakura et al., 2000), playing a number of roles in normal physiological functions, 
development and pathology.     
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Figure 1iii.  VEGFs and VEGFRs.  The binding of VEGF isoforms, VEGFA, 
VEGFB, VEGFC, VEGFD and PlGF, to RTKs VEGFR1, VEGFR2 and VEGFR3 
and co-receptors, NRP1 and NRP2, stimulates cellular responses in the vasculature 
and CNS.  NRP1 can also act independent of VEGFA to control brain angiogenesis.  
The biological actions of VEGFA, VEGFB and PlGF can be reduced by binding to 
soluble VEGFR1 (sFlt-1) (adapted from Lange et al., 2016).     
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The alternative splicing of the VEGFA primary transcript results in multiple 
transcript variants that encode distinct isoforms (Fig. 1iv) that differ in receptor 
binding properties and have different affinities for the ECM.  The three major 
isoforms in human are termed VEGF121, VEGF165 and VEGF189, which reflect 
the number of total amino acid residues present in the mature protein.  The 
corresponding isoforms in mouse are one amino acid shorter in length and are named 
VEGF188, VEGF165, VEGF120 and VEGF112, respectively.  VEGFA isoforms 
differ in biochemical properties such as the capacity to interact with the ECM, which 
is dependent upon the ability to bind heparin most likely through binding to heparin 
sulfate proteoglycans (HSPGs; Esko & Lindahl, 2001).  VEGFA isoforms are 
differentially sequestered by HSPGs and are subject to inhibitors that are involved in 
establishing vascular quiescence (Ambati et al., 2006).  The release of VEGFA from 
sequestration is typically proangiogenic and occurs as extracellular proteases cleave 
HSPG core proteins and associated ECM molecules (Flaumenhaft et al., 1990; 
Purushothaman et al., 2006).  Proteases can also cleave VEGFA to generate new 
isoforms (Lee et al., 2005).  
 
The presence of heparin-binding domains encoded within exons 6 and 7 allow each 
isoform to interact with the ECM to a different extent, resulting in the distribution of 
the various isoforms across the matrix that regulate sprout guidance and vessel 
growth.  Isoforms VEGF189 and VEGF165 have the strongest matrix interactions 
and exhibit steep spatial gradients, whereas VEGF121 is more diffusible due to the 
absence of heparin-binding properties (Park et al., 1993; Bautch, 2012).  A diffuse 
immunostaining pattern has been shown in the hindbrain of mice engineered to 
secrete only VEGF120, whereas wild-type mice that predominantly secrete 
VEGF164 possess a steeper gradient with a higher level of VEGFA at the midline  
that falls off more rapidly (Ruhrberg et al., 2002).  The gradient does not only reflect 
restricted diffusion rates of VEGFA from secreting cells and the heterogeneities in 
the concentration of VEGFA binding partners, but also results from combined 
sequestration and degradation.  Soluble VEGFA inhibitors including the splice form 
of VEGFR1, sFlt-1, play a major role in VEGFA patterning (Kappas et al., 2008; 
Chappell et al., 2009; Vempati et al., 2011; Hashambhoy et al., 2011).  Furthermore, 
the VEGFA gradient in endothelial cells is shaped by the degradation of VEGFA 
through internalisation of the VEGFA-VEGFR complex (Greenaway et al., 2007). 
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Figure 1iv.  VEGFA isoforms in human.  The primary transcript of VEGFA is 
alternatively spliced to form multiple transcript variants that encode distinct 
isoforms.  The major isoforms in human are VEGF189, VEGF165 and VEGF121, 
which differ in biochemical properties including their affinity for VEGFRs and 
HSPGs, resulting in varied effects on the growth of blood vessels.  Heparin-binding 
domains encoded within exons 6 and 7 confer the ability of each isoform to interact 
with the ECM and the extent to which they bind, resulting in the distribution of the 
various isoforms across the matrix.  VEGF189 and VEGF165 have the strongest 
matrix interactions and steepest gradients.  The diffusion of these isoforms is 
therefore more restricted compared with VEGF121, which is more diffusible due to 
the absence of heparin-binding properties. 
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1.4 The recruitment of angioblasts and endothelial cells  
 
Ambler et al. (2003) analysed mouse-avian chimeras and found mammalian 
angioblasts could  recognise, migrate and pattern in response to avian vascular 
patterning cues.  Murine embryonic stem (ES) cell-derived embryoid bodies (EBs) 
labelled with Nile Blue were grafted into the host in a cavity made by the removal of 
presomitic mesoderm from one side of the quail neural tube.  The murine endothelial 
cells and progenitors derived from the ES cells migrated extensively, colonised the 
appropriate vascular beds of the host and also formed mosaic vessels with avian 
endothelial cells.  The requirement of the VEGFA signalling pathway for proper 
vascular patterning of the embryo was also demonstrated by grafting EBs either 
mutant for VEGFR2 (Flk-1
-/-
) or VEGFA (VEGFA
-/-
) into quail hosts.  The Flk-1
-/-
 
EB grafts produced rare endothelial cells that neither migrated nor assembled into 
vessels.  However, VEGFA
-/- 
EB grafts produced endothelial cells that resembled 
wild-type and colonised vascular beds of the host.  The VEGFA
-/- 
graft endothelial 
cells also crossed the midline but at a much lower frequency compared with wild-
type EB grafts, suggesting that signals derived from the host are able to partially 
rescue mutant graft vascular patterning.   
 
Endothelial cells originating from the presomitic mesoderm have been shown to 
make a significant contribution to the PNVP of the neural tube and the migration of 
angioblasts towards their source has been attributed to a neural tube-derived gradient 
of VEGFA (Ambler et al., 2001; Ambler et al., 2003; Hogan et al., 2004; James et 
al., 2009; Kurz et al., 1996; Wilting et al., 1995).  The distinct localisation of 
heparin-binding VEGFA isoforms and non-heparin binding VEGF120 was 
investigated in the developing hindbrain of mouse embryos.  In VEGF120/120 embryos 
that completely lack heparin-binding isoforms, a VEGFA lacZ reporter identified 
high levels of VEGFA gene expression near the hindbrain midline at 10.5 dpc.  The 
immunostaining of nonpermeabilised hindbrains with an antiserum that detects all 
VEGFA isoforms was also performed in order to visualise the distribution of 
secreted VEGFA protein.  A steep concentration gradient was shown in wild type 
embryos in which VEGFA protein accumulated in patches surrounding the sites of 
production that was highest near the midline and tapered off toward the front of the 
developing subventricular plexus.  In VEGF120/120 mouse embryos, the absence of 
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heparin-binding isoforms resulted in a loss of this steep gradient with VEGFA 
protein appearing more widely dispersed.  The development of blood vessels was 
also examined in VEGF120/120 mouse embryos, which exhibited a reduction in the 
complexity of vascular branching.  VEGF120/120 mice were not viable and displayed 
an altered distribution of endothelial cells resulting in capillary networks with fewer 
branch points and a larger luminal diameter.  Endothelial cells were preferentially 
integrated within existing vessels rather than into additional branch points in the gut, 
somites and all regions of the CNS (Ruhrberg et al., 2002). 
   
The role of VEGFA signalling in the spatially localised molecular communication 
between the neuroepithelium of the quail neural tube and embryonic blood vessels 
has been investigated by James et al. (2009), demonstrating its involvement in the 
ingression of angiogenic sprouts.  Individual VEGFA isoforms were ectopically 
expressed at the thoracic level of the quail neural tube in order to determine their 
effects on neural tube development.  The electroporation of VEGF189 or VEGF165 
at stages HH16-18 of development resulted in an increase in the number of 
ingression points in the dorsal area of the electroporated side, which is normally 
avascular, compared to the non-electroporated control side.  The interaction of 
VEGFA isoforms with the local matrix are therefore crucial for proper vessel 
ingression and the heparin-binding properties of VEGF189/165 enabled these 
isoforms to interact with the matrix and confer the ability to induce localised ectopic 
ingression points.  The ectopic expression of the non-heparin binding isoform 
VEGF121, however, did not affect the number of blood vessel ingression points 
although ingressing vessels became dysmorphogenic.  Complementary to these 
findings, the absence of heparin-binding isoforms in VEGF120/120 mouse embryos 
showed an altered distribution of endothelial cells within the growing vasculature, 
which resulted in a decrease in the formation of capillary branches and an increase in 
vessel lumen size (Ruhrberg et al., 2002).  The loss of endogenous VEGFA 
signalling, achieved by ectopically expressing sFlt-1 into the developing neural tube, 
dramatically blocked normal vessel ingression on the electroporated side (James et 
al., 2009).  The protein sFlt-1 is a natural soluble splice form of the VEGFR1 
receptor that lacks the transmembrane domain and acts as a VEGFA inhibitor by 
binding and sequestering VEGFA to prevent downstream signalling (Kendall & 
Thomas, 1993).  Furthermore, the analysis of several regional markers of neural tube 
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patterning showed that neural tube development was not detectably perturbed by the 
ectopic expression of VEGFA isoforms.  James et al. (2009) confirmed that VEGFA 
signalling is necessary to pattern the angiogenic blood vessels that enter the neural 
tube but not sufficient to explain the stereotypical pattern observed as VEGFA is 
broadly expressed and not localised to sites of ingression.  The data supports a model 
in which positive signals emanating from the neural tube are balanced by neural 
tube-derived negative spatial cues that prevent ingression, of which semaphorins, 
slits and netrins are candidates, leading to ingression at specific points along the 
dorsoventral axis.  The influence of patterning signals therefore needs to be 
investigated further in order to obtain a better understanding of the regulation of 
blood vessel ingression. 
 
1.5 Endothelial sprouting 
 
The arrangement of growing blood vessel sprouts into a leading tip cell and the 
follower stalk cells was first described in the hindbrain and retina of the mouse 
(Ruhrberg et al., 2002; Gerhardt et al., 2003) and has been observed in preliminary 
images of sprouting into the  embryonic G. gallus brain (Fig. 1v).  In addition to its 
involvement in attracting endothelial cells towards the neural tube, VEGFA also has 
a role in the selection of tip cells that initiate ingression by signalling through 
VEGFRs.  Roberts et al. (2004) showed that the formation of developmental blood 
vessels is affected by VEGFR1, which modulates signalling of VEGFA through 
VEGFR2.  Mice lacking the VEGFA receptor VEGFR1 died from vascular 
overgrowth, which was primarily caused by aberrant cell division.  The upregulation 
of VEGFR2 signalling in the mutant was indicated by the increased phosphorylation 
of VEGFR2 identified in differentiated ES cell cultures in which VEGFR1 was 
absent.   
 
The behaviour of endothelial cells is orchestrated by the induction of the Notch 
pathway by VEGFA, resulting in the emergence of tip cells that initiate new sprouts 
and stalk cells that proliferate and contribute to the expansion of the vessel (Gerhardt 
et al., 2003).  Vascular sprouting and vessel branching is controlled by Delta-like 4 
(Dll4)-Notch1 signalling between endothelial cells within the vessel sprout, which is 
crucial in establishing an adequate ratio of tip cells to stalk cells required for normal 
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sprouting patterns (Fig. 1vi).  VEGFA signalling through VEGFR2 increases the 
expression of Dll4 on emerging tip cells.  The Dll4 ligand then binds to Notch 
receptors on adjacent endothelial cells, resulting in an increase in VEGFR1 
expression (Harrington et al., 2008; Funahashi et al., 2010) and reduced expression 
of both VEGFR2 and VEGFR3 (Tammela et al., 2008; Shawber et al., 2007; 
Suchting et al., 2007; Benedito et al., 2012) thereby reducing their sensitivity to 
VEGFA, preventing these cells from becoming tip cells and promoting stalk cell 
identity.  Crosstalk between the VEGFA and Notch pathways is mediated by 
VEGFR1, which maintains VEGFA signalling at appropriate levels for the effective 
use of Notch in lateral inhibition.  VEGFR1 negatively regulates vessel formation as 
it binds VEGFA with 10-fold higher affinity than VEGFR2, limiting the amount of 
VEGFA that can access the VEGFR2 receptors (Roberts et al., 2004; Chappell et al., 
2013).   
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Figure 1v.  Vessel sprouting into the embryonic G. gallus brain.  Endothelial 
cells (blue) and neurons (brown) were detected with an antisense Ets1 probe and a 
TuJ1 antibody against neuron-specific Class III β-tubulin antibody, respectively.  A. 
Endothelial cells line up against the basal lamina of the neural tube (nt) to form the 
PNVP.  B. The first ingressing endothelial cells were detected at HH21, initiated by 
the tip cell (arrow).  C. The ingressing stream of cells then begins to branch (arrow) 
and forms the INVP by HH30. 
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Figure 1vi.  Schematic of tip and stalk cell selection and endothelial sprouting 
into the neural tube.  A. The selection of tip and stalk cells depends on Notch 
signalling between endothelial cells within the PNVP.  An endothelial cell receiving 
more VEGFA via the VEGFR2 receptor compared with neighbouring cells leads to 
an increase in the expression of the transmembrane ligand Dll4, resulting in the 
emergence of a tip cell.  Dll4 signals to the neighbouring cells via the Notch 
receptor, promoting an increase in VEGFR1 that reduces the sensitivity of these cells 
to VEGFA signalling and prevents the formation of more tip cells.  Vessel sprouting 
is promoted by high levels of VEGFR2 and low VEGFR1 in tip cells relative to the 
neighbouring stalk cells, thus establishing an adequate ratio of tip and stalk cells 
required for normal sprouting patterns.  B. The process of vascularisation involves 
the migration of endothelial cells towards the neural tube in response to a gradient of 
VEGFA.  The ECM is remodelled by active proteases during migration and as tip 
cells penetrate the basal lamina at stereotypical ingression points at the initiation of 
vessel sprouting.    
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A recent study has described a tumour suppressor function of Notch.  Activating the 
Notch pathway has been shown to reduce tip cell numbers and branching in retina 
models and reduce glioma growth in the mouse forebrain.  In humans, high Notch 
activity strongly correlates with distinct subtypes of gliomas, lower tumour grade 
and increased patient survival.  Conversely, the inhibition of Notch signalling has 
been shown to promote an increase in tip cell numbers and vessel branching in the 
retina and also accelerates PDGF-driven glioma growth in mice (Hellstrom et al., 
2007; Suchting et al., 2007; Giachino et al., 2015).  The increase in tip cell numbers 
can however be useful to promote vascularisation and restore blood flow to areas of 
ischaemia and may also be important in the recovery of stroke.   
 
The extension of long filopodia from endothelial cells at the tips of vascular sprouts 
has been revealed by isolectin B4 staining in the postnatal mouse retina, indicating 
an active migratory phenotype.  The filopodia were of uniform thickness 
(approximately 100nm) and the longest that exceeded 100μm were largely restricted 
to the tip cell, which was revealed to be a highly polarised endothelial cell identified 
by isolectin B4, vascular endothelial (VE) cadherin, fibronectin and nuclei staining.  
Additional staining for platelet-endothelial cell adhesion molecule (PECAM)-1, 
endomucin and VEGFR2 further confirmed the endothelial identity of this cell.  The 
gene expression profile of tip cells was also found to be distinct from stalk cells by 
their strong expression of platelet-derived growth factor B (PDGF-B) mRNA and 
both VEGFR2 mRNA and protein (Gerhardt et al., 2003).  PDGF-B was previously 
shown to have a crucial role in attracting pericyte progenitor cells to new capillaries, 
thereby stabilising the nascent vessels, through the study of PDGF-B-deficient mice 
(Lindahl et al., 1997).  The migration of tip cells is guided by the distribution of 
VEGFA in the extracellular space, whereas the proliferation of stalk cells is 
regulated by its concentration (Gerhardt et al., 2003).  The directed extension of 
filopodia becomes impaired when the normal VEGFA gradient is disrupted, and 
spatially restricted stimulatory cues are suggested to be provided by heparin-binding 
isoforms in order to guide the initiation of branch formation by sprouting endothelial 
cells.  In embryos that possess only a heparin-binding VEGFA isoform, excess 
endothelial filopodia were observed and abnormally thin branches were present in 
ectopic sites (Ruhrberg et al., 2002).  VEGFA signalling via VEGFR2 has been 
investigated in the retina following the injection of VEGFR2-specific antibodies into 
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the eyes of P5 mice.  The resulting retraction of tip cell filopodia and inhibition of 
plexus spreading shows the necessity of VEGFR2 in the extension and maintenance 
of filopodia (Gerhardt et al., 2003).  Although filopodia are proposed to mediate the 
directional migration of tip cells and guide the formation of vascular sprouts, they 
are not required in the induction of tip cells or the translation of guidance cues from 
the extracellular environment.  Filopodia do however facilitate the rapid and 
persistent migration of endothelial cells.  Upon inhibiting the formation of filopodia 
during sprouting angiogenesis in zebrafish embryos using low concentrations of 
Latrunculin B, endothelial cells generate lamellipodia that can drive migration albeit 
at a reduced velocity.  Furthermore, when the endothelial Notch ligand Dll4 was 
knocked down using a Dll4 splice morpholino, ectopic sprouting was displayed and 
the attraction of aberrant vessels towards VEGF165 also occurred, even when 
filopodia were absent.  The role of filopodia in facilitating vessel anastomosis by 
mediating new contacts was also indicated as their absence resulted in delayed dorsal 
longitudinal anastomotic vessel (DLAV) formation and blocked vein plexus 
formation (Phng et al., 2013). 
 
Urokinase-plasminogen-activated receptor (uPAR) is a glycosylphosphatidylinositol- 
(GPI) anchored protein that is also expressed in tip cells as well as many other cell 
types, which participates in degrading the ECM and facilitating the growth of sprouts 
in the correct direction.  uPAR converts inactive urokinase-plasminogen activator 
(uPA) that binds to the receptor into active uPA.  The active uPAR-bound uPA 
subsequently triggers cell migration by converting cell-bound plasminogen to 
plasmin, resulting in the degradation of the ECM that serves as a storage depot for 
numerous biologically active molecules.  Furthermore, uPAR regulates cell 
migration by interacting with αvβ1 integrin and caveolin, which are also highly 
expressed in tip cells.  ECM degradation leads to the localised release of matrix-
immobilised enzymes and proangiogenic growth factors including fibroblast growth 
factor 2 (FGF2) and VEGFA.  Cell proliferation and differentiation is in part 
regulated by FGF2, which is initially bound to heparan sulfate (HS) in the ECM.  
The release of active FGF2 is brought about by the sequential breakdown of HS-
proteoglycans through the synergistic action of cellular heparanase and ECM-
resident uPA (Quigley et al., 1987; Vlodavsky et al., 1990; Wei et al., 1996; Blasi & 
Carmeliet, 2002).   
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The ECM of the CNS forms a basal lamina surrounding the brain and spinal cord 
that contributes to the overall structural organisation and controls individual cells by 
various mechanisms such as regulating the distribution of growth and differentiation 
factors.  Following the penetration of the basal lamina and invasion of the 
developing neural tube, the ECM provides a substrate on which endothelial cells can 
migrate and the composition of which differs from that of the surrounding 
mesenchyme.  The complex expression patterns of glycoproteins, including 
laminins, tenascins and proteoglycans, are developmentally regulated and control the 
migration and positioning of neurons within the developing brain.  Similar to the 
radial migration by endothelial sprouts towards the ventricular zone, excitatory 
neurons of the neocortex migrate radially from the ventricular zone into the 
developing cortical wall along radial glial cells that extend from the ventricular zone 
to the marginal zone.  Radial migration is also seen  in the cerebellum as Purkinje 
cells and granule neurons migrate along radial glial fibres and Bergman glial fibres, 
respectively.  A disruption to the attachment of radial glial cells to the pial surface in 
the neocortex of β1 integrin-deficient animals have shown that although neurons are 
able to associate with intact radial glial cells and exhibit normal migration, ectopias 
occur near the marginal zone where the endfeet of radial glial cells have detached 
from the basal lamina.  Mice that lack α6 integrin that forms a heterodimer with β1 
integrin to form laminin receptors have also shown similar phenotypes (reviewed by 
Franco & Müller, 2011).  Since ECM glycoproteins and their receptors play a critical 
role in the positioning of neurons that associate with radial glia, a similar function 
could occur in the navigation of endothelial sprouts along radial glia during 
extension towards the ventricular zone.  
 
1.6 The influence of neural tube patterning on the developing vascular network 
 
The temporal and spatial generation of defined types of neurons from multipotent 
neural stem (NS) and progenitor cells is a fundamental element of neurogenesis, 
which occurs prior to the development of the vascular network.  In the embryonic 
mouse telencephalon, endothelial cells express region-specific homeobox 
transcription factors, Nkx2.1, Dlx1/2 and Pax6, which regulate angiogenesis along a 
ventral-to-dorsal gradient and control the development of neuroepithelial domains 
and postmitotic neurons.  The vasculature therefore develops with the support of 
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angiogenesis programs that are intrinsic to the CNS (Vasudevan et al., 2008), and as 
vascularisation of the neural tube shares some of the same molecular pathways as 
neural development and neural tube patterning, such as those involved in axon 
guidance and tip cell migration, the molecular communication existing between the 
two processes is thus revealed.   
 
A correlation between the initiation of PNVP formation and the start of neuronal 
differentiation at HH16-18 has been shown by immunostaining quail embryos with 
QH1 to label endothelial cells and TuJ1 to identify neurons.  Angiogenic sprouts 
initially invade the neural tube on either side of the floor plate and although bilateral 
connections are subsequently formed over the roof plate, the vascular system of both 
sides remain separated by the floor plate and notochord for quite some time.  The 
sprouts ingress into the TuJ1-positive area containing differentiated neurons and 
avoid the TuJ1-negative medial area containing proliferative neural progenitor cells 
(Kurz et al., 1996; James et al., 2009; Kurz, 2009).  In the guidance of tip cells, the 
transmembrane receptor NRP1 is required in addition to VEGFA signalling.  The 
analysis of endothelial tip cell guidance in the mouse hindbrain has revealed a role of 
NRP1 in allowing tip cell filopodia to switch substrate and branch in a new direction 
within the subventricular zone (Gerhardt et al., 2004).  
 
NRP1 and neuropilin-2 (NRP2) are single pass transmembrane proteins highly 
conserved in vertebrates.  Neuropilins (NRPs) were first identified in the developing 
Xenopus nervous system as an epitope recognised by a monoclonal antibody that 
labels specific subsets of axons (Takagi et al., 1987; Fujisawa et al., 1989; Takagi et 
al., 1991) and studied as an adhesion molecule in the developing chick nervous 
system (Takagi et al., 1995).  NRP1 was found to be highly expressed on the axons 
of neurons, acting as a receptor for semaphorins by forming a complex with plexin 
receptors in the control of axon guidance (He & Tessier-Lavigne, 1997; Kolodkin et 
al., 1997; Chen et al., 1997; Giger et al., 1998; Takahashi et al., 1999).  The 
mechanism of semaphorin 3 (SEMA3) proteins in the repulsion of axon growth has 
been well studied (Fujisawa, 2004), although a chemoattractant role was first shown 
for cortical pyramidal neurons in which SEMA3A acts as a chemorepellent for axons 
but as a chemoattractant for apical dendrites (Polleux et al., 2000).  NRP1 was later 
discovered as a co-receptor for VEGF165 in endothelial cells and tumour cells by 
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forming a receptor complex with VEGFR2 to enhance the VEGFA-VEGFR2 
interaction (Soker et al., 1998; Gluzman-Poltorak et al., 2000).  In modulating 
endothelial cell motility in vitro, SEMA3A and VEGF165 compete for NRP1 
binding sites as the binding of SEMA3A to NRP1 inhibits the binding of angiogenic-
promoting VEGF165 to NRP1 and vice versa (Miao et al., 1999).  However, studies 
conducted in vivo have found no evidence for competition between SEMA3A and 
VEGF165 for binding NRP1 during vascular or neuronal growth (Vieira et al., 
2007).  In addition to VEGF165, NRP1 also binds VEGF189 and VEGF121.  
Biochemical studies have shown that VEGF189 binds NRP1 at a higher affinity than 
VEGF165, which is likely due to the presence of exons 6, 7 and 8.  The domain 
encoded by exon 8 carries a C-terminal arginine residue that mediates the binding of 
VEGF121 to NRP1, which occurs at an affinity that is ten times lower than that of 
VEGF165.  In vivo studies involving in situ ligand-binding assays with VEGFA 
isoforms on mouse brain tissue have demonstrated that VEGF165, but not 
VEGF121, can bind NRP1-expressing axon tracts (Vieira et al., 2007; Pan et al., 
2007; Vintonenko et al., 2011; Parker et al., 2012; Tillo et al., 2015).  Further 
studies have also shown that NRP1 present in endothelial cells and β8 integrin in 
neuroepithelial cells cooperatively regulate sprouting angiogenesis by mediating 
adhesion and signalling events between blood vessels and the neuroepithelium 
through balancing TGFβ signalling during embryonic brain development (Hirota et 
al., 2015).  NRP1 is now known to be essential for the vascularisation of the mouse 
spinal cord (Kawasaki et al., 1999), forebrain (Gu et al., 2003), hindbrain (Gerhardt 
et al., 2004) and retina (Fantin et al., 2014; Gelfand et al., 2014; Raimondi et al., 
2014; Fantin et al., 2015; Aspalter et al., 2015) and recent evidence suggests that 
NRP1 can control brain angiogenesis independent of VEGFA.  Mice expressing 
NRP1 with a homozygous mutation of tyrosine 297 (Y297A/Y297A), which is a 
residue important for the high affinity binding of VEGFA165, lead to a loss of 
VEGFA binding and attenuated NRP1 expression.  The NRP1 (Y297A/Y297A) 
mice were born at normal Mendelian ratios although postnatal mortality was 
increased and mild impairment to angiogenesis of the hindbrain was exhibited 
(Fantin et al., 2014).  In addition to this, the brain of NRP1
VEGF-
 mice with abolished 
VEGFA-NRP1 binding exhibited normal developmental angiogenesis and mutants 
survived into adulthood (Gelfand et al., 2014).   
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The class 3 semaphorin SEMA3E is a traditional repulsive axon guidance cue that 
does not bind to NRP1 but instead binds directly to Plexin-D1 (Gu et al., 2005).  
SEMA3E-Plexin-D1-mediated repulsion can however be converted into axonal 
attraction in CNS neurons by the extracellular domain of NRP1 during brain 
development (Chauvet et al., 2007).  SEMA3E-Plexin-D1 signalling is also involved 
in regulating angiogenesis via a VEGFA-induced feedback mechanism.  In the 
developing mouse retina, SEMA3E is secreted by retinal neurons and is evenly 
distributed throughout the retina.  However, SEMA3E-Plexin-D1 signalling is 
spatially regulated by high levels of VEGFA secreted from the avascular periphery, 
which induces Plexin-D1 expression in endothelial cells at the front of sprouting 
vessels.  Gain-of-function experiments have shown that SEMA3E-Plexin-D1 
signalling decreases VEGFA-induced Dll4 expression in vitro and in vivo, whereas 
the loss of SEMA3E-Plexin-D1 signalling has been demonstrated to upregulate Dll4 
expression and Notch activity in the retina, thereby impairing the formation of tip 
cells (Kim et al., 2011). 
 
The Hedgehog (Hh) signalling pathway is also required during CNS vascularisation 
and is positively regulated by NRPs.  The expression of NRPs during mouse 
development has been shown to coordinate with active Hh signal transduction.  A 
positive feedback circuit exists as Hh signalling induces the transcription of NRP1 
and the overexpression of NRP1 results in increased activation of Hh target genes 
(Hillman et al., 2011).  The three mammalian Hedgehog homologues are Shh, Desert 
hedgehog (Dhh) and Indian hedgehog (Ihh), of which Shh is the best studied.  Shh is 
a secreted protein produced by the notochord and floor plate, and is involved in the 
dorsoventral patterning of the neural tube (Echelard et al., 1993).  Shh is also 
involved in modulating angiogenic sprouting and BBB establishment during the 
vascularisation of the CNS.  In the mouse embryo, motor neurons in the ventral 
neural tube in close proximity to the infiltrating vessels express the angiogenic 
factors VEGFA and angiopoietin-1 (Ang-1).  Inhibiting the induction of motor 
neurons in the neural tube of cultured mouse embryos through the application of 
cyclopamine, a pharmacological inhibitor of Shh, dramatically impaired vessel 
ingression and motor neurons were almost completely lost.  A reduction in the 
expression of Ang-1 within the neural tube was found in embryos treated with 
cyclopamine, leading to the suggestion that Shh signalling is indirectly required for 
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regulating angiogenic sprouting in the neural tube by establishing populations of 
Ang-1 positive motor neurons that guide ingressing vessels (Nagase et al., 2005).  
However, impaired vessel ingression may have been brought about by general 
patterning defects as cyclopamine not only results in defective motor neuron 
formation but generally impairs the patterning of the ventral neural tube.  Further 
investigation into the effects of specific patterning molecules on vessel ingression is 
therefore required.  The subsequent formation of the BBB is also promoted by Shh 
signalling.  The secretion of Shh by astrocytes and the expression of Hh receptors by 
associated endothelial cells stabilises the nascent BBB by reducing vascular 
permeability.  Furthermore, the Hh pathway prevents autoimmune attacks by 
decreasing the expression of proinflammatory mediators and also limits the secretion 
of chemokines from the endothelium, which reduces the migration of leukocytes 
(Alvarez et al., 2011). 
 
The tight coordination between neurogenesis and vascularisation of the developing 
brain is further supported by additional factors common to both processes.  Wnt 
signalling is a crucial stem cell regulator and plays an important role in regulating 
synaptic structure and function during the development of the nervous system (Ciani 
& Salinas, 2005; Inestrosa & Arenas, 2010; Kühl & Kühl, 2013).  Neural progenitors 
regulate the ingression of blood vessels into the brain through VEGFA signalling 
and the canonical Wnt pathway, as well as stabilising nascent vessels by 
downregulating Wnt/β-catenin signalling (Santhosh & Huang, 2015).  Whereas 
VEGFA signalling is ubiquitously active in sprouting angiogenesis, canonical Wnt 
signalling is specific for the vascularisation of the CNS and is active in endothelial 
cells of both the PNVP and INVP.  The CNS-specific deletion of Wnt7a and Wnt7b, 
which are normally highly expressed by the embryonic spinal cord, or the vascular-
specific loss of β-catenin in developing mice, resulted in the reduction of neural tube 
vascularisation and disorganisation of neural tissue.  Vessels that did ingress were 
dilated and haemorrhagic and the distribution of INVP endothelial cells and 
pericytes were defective (Stenman et al., 2008; Daneman et al., 2009).  Canonical 
Wnt signalling in endothelial cells is therefore crucial for normal formation of the 
PNVP and the proper ingression of blood vessels to form the INVP.  The integrity of 
nascent brain vessels is also promoted by neural progenitors through αvβ8 integrin 
activation of TGFβ signalling (Santhosh & Huang, 2015).    
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Bone morphogenetic protein (BMP) together with Wnt signals are potent inhibitors 
of neurogenesis and have critical roles in the development of the telencephalon by 
maintaining the proliferation of NS cells (Furuta et al., 1997; Galceran et al., 1999; 
Shou et al., 1999; Lee et al., 2000; Caronia et al., 2010).  BMP signalling has also 
been investigated as a regulator of vessel sprouting.  The analysis of early vascular 
development in zebrafish has identified BMP as a vein-specific angiogenic cue, 
regulating angiogenic sprouting from the axial vein and not the dorsal aorta, 
independently of VEGFA signalling (Wiley et al., 2011).  The same group found 
that the context-dependent proangiogenic function of BMP2 is mediated by a cargo-
specific adapter protein for clathrin, disabled homolog 2 (Dab2), which functions in 
the internalisation of BMP receptors in endothelial cells and the phosphorylation of 
Sma and Mad Related Family (SMAD) 1, 5 and 8 (Kim et al., 2012).  In mouse 
studies, an endothelial-specific member of the BMP/TGF-β receptor family, activin 
receptor-like kinase 1 (ALK1), has been shown to cooperate with the Notch pathway 
to inhibit angiogenesis.  Blocking ALK1 resulted in hypervascularisation and 
arteriovenous malformations of the postnatal mouse retina, further exacerbated by 
the combined blockade of Notch signalling (Larrivée et al., 2012).  The requirement 
of SMAD1 and SMAD5-mediated BMP signalling in the developing vasculature has 
also been investigated in the mouse embryo.  The co-inactivation of endothelium-
specific SMAD1 and SMAD5 resulted in impaired Dll4/Notch signalling, increased 
numbers of tip-cell-like cells at the expense of stalk cells, excessive sprouting and 
embryonic lethality.  Evidence for a regulatory circuit has therefore been provided in 
which BMP/TGF-β-Smad1/5 synergises with Notch signalling in endothelial cells to 
orchestrate the selection of tip and stalk cells during sprouting angiogenesis (Moya 
et al., 2012). 
 
FGF is also involved in angiogenesis in addition to its crucial role in the 
specification of mesoderm together with BMP (Yamaguchi et al., 1994; Deng et al., 
1994; Tang et al., 1998; Saxton & Pawson, 1999; Marom et al., 2005) and its 
differentiation towards haematopoietic and endothelial cell fates (Yamaguchi et al., 
1994; Sirard et al., 1998; Chang et al., 1999).  The FGF family of proteins are highly 
conserved in gene structure and amino-acid sequence and are involved in diverse 
cellular processes during development including cell migration, differentiation, 
proliferation, cell adhesion and apoptosis.  FGFs bind with high affinity to HSPGs 
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both on the cell surface and within the ECM.  The release of HS-bound FGF from 
this reservoir ensues in a controlled manner by the action of HS-degrading enzymes, 
such as heparanases, thereby regulating the growth of capillary blood vessels.  FGF 
binds to and activates RTK cell-surface FGF receptors (FGFRs), FGFR1-4, with 
HSPGs also acting as a co-receptor in order to modulate its biological effects 
(Vlodavsky et al., 1991; Johnson & Williams, 1993; Ornitz, 2000; Ornitz & Itoh, 
2001).  FGF1 and FGF2 are the best studied FGFs and are more potent angiogenic 
factors than VEGFs or PDGF (Cao et al., 2003).  VEGFs, FGF and PDGF each have 
unique roles during angiogenesis, however, combinations of the three growth factors 
have been shown to have synergistic effects and increase angiogenesis in vitro and in 
vivo (Kim et al., 2015). 
 
Crystallography studies have revealed that the low affinity binding of FGF2 to 
FGFR1 is stabilised by the presence of heparin or heparin sulfates, resulting in the 
formation of a dimer containing two FGF:FGFR1 complexes (Plotnikov et al., 
1999).  FGFR1 is required for the development and maintenance of the vasculature 
and has been demonstrated by infecting human umbilical vein endothelial cells 
(HUVECs) and injecting mouse embryos with an adenovirus expressing a dominant-
negative form of FGFR1.  The expression of the dominant-negative FGFR in 
HUVECs resulted in a reduction in endothelial cell number and the activation of 
mitogen-activated protein kinase (MAPK) phosphorylation by FGF2 was selectively 
inhibited.  In embryos, expression of the dominant-negative FGFR resulted in 
abnormal development as neural folds did not fuse and the turning of the embryos 
within the yolk sac was incomplete.  The vascular integrity was also disrupted as 
embryos displayed a poorly developed primitive intracranial vasculature and in 50% 
of embryos, the primary capillary plexus surrounding the forebrain was absent (Lee 
et al., 2000). 
 
FGFR1-mediated signalling is known to activate a number of intracellular signalling 
cascades including the Ras pathway, Src family tyrosine kinases (SRKs) and 
phosphoinositide 3-kinase (PI3K).  In the chicken chorioallantoic membrane (CAM), 
angiogenesis has been shown to be induced by FGF and VEGFA.  The Ras-mitogen-
activated protein kinase (MAPK) signalling cascade is important in FGF-stimulated 
angiogenesis.  The pathway initiates as activated Ras recruits and activates Raf, 
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which phosphorylates the protein kinase, MEK.  MEK activates the final kinase, 
extracellular signal-regulated protein kinase (ERK), in the Ras-Raf-MEK-ERK 
pathway, resulting in the expression of genes involved in the regulation of cell 
proliferation, growth and survival.  Treatment with a specific MEK inhibitor, 
PD98059, which prevents its ability to phosphorylate and activate ERK, blocked 
FGF-induced angiogenesis (Eliceiri et al., 1998).  FGF and VEGFA have been 
shown to stimulate distinct angiogenic pathways in corneal or chorioallantoic 
membrane models as the induction of angiogenesis by FGF depends on αvβ3 
integrin, whereas initiation by VEGFA depends on αvβ5 integrin.  The 
administration of nitric oxide (NO) synthase inhibitors have demonstrated that NO 
synthase lies downstream from VEGFA- but not FGF2-stimulated angiogenesis 
(Friedlander et al., 1995; Ziche et al., 1997).  Furthermore, FGF and VEGFA can 
both activate Src kinase activity.  However, Src activity is selectively required for 
endothelial cell survival during VEGFA-, but not FGF-, induced angiogenesis.  
CAMs were stimulated with either FGF or VEGFA and subsequently infected with a 
kinase-deleted Src 251-containing retrovirus.  The introduction of the dominant 
negative Src kinase cytoplasmic tyrosine kinase was shown to inhibit angiogenesis in 
CAMs stimulated with VEGFA but not those stimulated with FGF (Eliceiri et al., 
1999).  In endothelial cells, PI3K has been found to regulate the expression of 
VEGFA and is also required for normal angiogenesis in the embryo (Jiang et al., 
2000). 
 
Similar to VEGFA, FGF promotes endothelial cell proliferation and stimulates the 
secretion of proteases and plasminogen activators from endothelial cells, leading to 
the degradation of the basement membrane.  Endothelial cells invade the 
surrounding matrix, proliferate and differentiate to form a nascent vessel, the 
stability of which is generated through the secretion of growth factors by the 
endothelial cells, including PDGF, which attract supporting cells such as pericytes to 
the site (Carmeliet, 2000; Cross & Claesson-Welsh, 2001).  CNS pericytes originate 
from neural crest and mesodermal cells and are located at the abluminal surface of 
capillary blood vessels.  The specialised cells vary in morphology and express a 
variety of different histological markers including PDGFRB, CD13, NG2, desmin 
and vimentin, constituting a heterogenic cell population that performs multiple 
functions in vascular homeostasis during angiogenesis, vessel stabilisation and blood 
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flow regulation (reviewed by Trost et al., 2016).  Pericytes induce the polarisation of 
astrocyte end-feet that surround CNS blood vessels and are crucial in determining 
the vascular permeability of the BBB during development.  The interaction between 
pericytes and CNS endothelial cells is necessary in regulating functional aspects of 
the BBB by preventing the exchange of molecules across the endothelium, which 
complements the barrier role of the inter-endothelial tight junctions.  Pericytes 
inhibit the expression of molecules that increase vascular permeability and studies in 
pericyte-deficient mouse mutants have shown an elevation in endothelial 
transcytosis, thus increasing BBB permeability (Armulik et al., 2010; Daneman et 
al., 2010).  The molecular crosstalk between cells that constitute the neurovascular 
unit is regulated by a number of factors including Shh, BMP, PDGF, TGFβ and 
integrins and disruption to these signalling pathways leads to perturbation of the 
BBB (Armulik et al., 2010; Daneman et al., 2010; Li et al., 2011; Hirota et al., 2011; 
Alvarez et al., 2011; Arnold et al., 2012; Allinson et al., 2012).  
 
The homeodomain-containing transcription factor, Pax6, functions in neurogenesis 
and also contributes to CNS angiogenesis.  Radial glial cells, commonly referred to 
as apical progenitors, are a major NS cell population in the developing CNS that 
initially exist in the neural tube as neuroepithelial stem cells (Alvarez-Buylla et al., 
2001; Anthony et al., 2004; Götz & Huttner, 2005; Kriegstein & Alvarez-Buylla, 
2009).  Pax6 is highly conserved among vertebrate and invertebrate species and 
plays an essential role in regulating radial glial cell neurogenesis.  The expression of 
Pax6 has been shown to be localised in radial glial cells within the ventricular zone 
of the developing mouse cortex in a high rostrolateral to low caudomedial gradient, 
with the highest levels present at the onset of corticogenesis (Götz et al., 1998; Heins 
et al., 2002; Bibel et al., 2004; Englund et al., 2005; Manuel et al., 2015).  Studies 
on homozygous mouse mutant embryos that lack the functional Pax6 protein showed 
a disruption in the dorsoventral regionalisation of the telencephalon.  Mutant 
embryos displayed a ventralisation of the molecular patterning, thereby revealing an 
essential role of Pax6 in the regulation of forebrain morphogenesis (Stoykova et al., 
2000).   
 
Pax6 is also involved in the initiation of neurogenesis in the spinal cord.  The timing 
of Pax6 activation in the neural tube is regulated by FGF signalling from the 
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presomitic mesoderm, which  has been shown to exert an inhibitory effect on Pax6 
expression in chick embryos.  FGF8 is present in the presomitic mesoderm in a 
decreasing caudorostral gradient and grafting FGF8-soaked beads at the level of the 
neural tube inhibits the activation of Pax6.  Conversely, disrupting FGF8 signalling 
by blocking FGFR1 transduction with the protein tyrosine kinase (PTK) inhibitor, 
SU5402, results in premature activation of Pax6 in the neural plate (Bertrand et al., 
2000).  Pax6 has also been identified as a downstream target of the Wnt/ß-catenin 
pathway and its activation by the binding of the ß-catenin/Tcf complex to the Pax6 
promoter has been demonstrated in vitro.  Furthermore, the genetic ablation of ß-
catenin in mice has been shown to inhibit the formation of the neocortex by 
disrupting the development of radial glial cells.  The level of Pax6 expression 
observed in the mutants had dramatically decreased in these cells and also in sphere-
forming NS cells (Gan et al., 2014).  
 
The quantitative levels of Pax6, VEGFA and phosphatase and tensin homolog 
(PTEN) expression are independent prognostic genetic markers of outcome for 
patients with astrocytic malignant gliomas (Zhou et al., 2003).  A common 
characteristic of locally advanced solid tumours and malignant progression is 
hypoxia, which induces processes including angiogenesis in order to survive or 
escape the oxygen-deficient environment.  Changes in oxygen levels lead to changes 
in the expression of oxygen homeostasis regulatory genes, one of which is the 
transcription factor hypoxia-inducible factor 1 alpha (HIF-1α).  HIF-1α is degraded 
by the proteosome under normoxic conditions, however under hypoxic conditions, 
HIF-1α is stabilised and mediates the cellular responses in adapting to hypoxic stress 
by activating the expression of specific genes involved in both angiogenesis and 
tumourigenesis.  HIF-1α promotes angiogenesis by inducing the expression of 
VEGFA, thus directing the migration of endothelial cells towards the hypoxic 
environment (Carmeliet et al., 1998; Hewitson & Schofield, 2004; Vaupel, 2004; 
Déry et al., 2005; Ziello et al., 2007).  The HIF-1 pathway is therefore a therapeutic 
target with a major impact in cancer and ischaemic disease.  PTEN suppresses 
VEGFA expression by downregulating HIF-1α which is mediated by inactivating the 
oncogenic PI3K/Akt signalling pathway active in malignant gliomas (Gomez-
Manzano et al., 2003).  A tumour suppressor function of Pax6 has also been 
identified in glioma cells in which it downregulates glioma cell expression of 
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VEGFA resulting in the suppression of angiogenesis, independent of the canonical 
pathway through PI3K/Akt-HIF-1α signalling or the von Hippel-Lindau tumour 
suppressor gene (VHL) (Zhou et al., 2005; Zhou et al., 2010).  Pax6 has been shown 
to increase the susceptibility of glioma cells to detachment, an early event in tumour 
invasion, and to oxidative stress from both the necrotic zone and increased 
intracellular reactive oxygen species (ROS) following detachment (Chang et al., 
2007).  The function of Pax6 in suppressing cell invasion in glioblastoma multiforme 
(GBM) involves repressing the expression of proinvasive genes including MMP-2.  
In vitro Matrigel invasion assays have demonstrated that the invasiveness of GBM 
cells is suppressed by Pax6, which requires its DNA-binding domain.  Reverse 
transcription-polymerase chain reaction (RT-PCR) has also indicated a significant 
reverse correlation between Pax6 and MMP-2 expression in 41 GBMs, 43 anaplastic 
astrocytomas and 7 adjacent normal tissues.  The stable overexpression of Pax6 has 
been shown to repress MMP-2 expression in the GBM cell line U251HF grown in 
vitro and also within intracranial xenografts in nude mice.  Furthermore, 
electrophoretic mobility shift assays have demonstrated that Pax6 binds directly to 
the MMP-2 promoter in a sequence specific manner and a Pax6-specific binding site 
in a 245 base pair (bp) region (-177 to +68) of the MMP-2 promoter has been 
identified (Mayes et al., 2006).  Conversely, in studies of lung cancer tissue and cell 
lines, Pax6 mRNA is highly expressed and promotes cell growth by activating the 
MAPK pathway, resulting in faster progression into the S phase of the cell cycle 
(Zhao et al., 2014). 
 
1.7 The regulation of angiogenesis by ETS and MADS box transcription factors  
 
The development of the vasculature is regulated by intrinsic factors, including the E-
twenty six (ETS) transcription factors and myocyte enhancing factor 2C (Mef2c), in 
addition to the extrinsic factors, such as VEGFA and FGF.  The ETS transcription 
factors play important roles in the development of endothelial cells and are 
characterised by a highly conserved winged helix-turn-helix DNA binding domain 
that recognises the ETS DNA binding site, containing the sequence 5'-GGA(A/T)-3', 
present in the regulatory regions for almost all endothelial cell-specific genes.  While 
many ETS factors act as transcriptional activators, some are associated with 
transcriptional repression, regulating a large number of genes involved in several 
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biological processes including development, migration and proliferation.  Ets1, Etv2, 
Erg and Fli-1 are among a subset of ETS family members that have important roles 
in angiogenesis and vasculogenesis (Sementchenko et al., 2000; Dejana et al., 2007; 
Randi et al., 2009; Heo et al., 2010; Marcelo et al., 2013). 
 
The differentiation of endothelial cells from mesodermal progenitors involves the 
activity of many ETS factors and a critical evolutionarily conserved role for Etv2 
(Etsrp, ETS variant 2), which has been lost in the evolution of birds, has recently 
been identified.  Etv2 is highly expressed in haematopoietic and endothelial cell 
precursors, which targets many ETS genes during development.  In differentiating 
ES cells, Etv2 directly activates other Ets genes, thereby establishing a hierarchical 
expression of ETS factors in which Etv2 functions at the top, followed by sequential 
induction of Fli1, Erg, Elk3, Ets1 and Ets2.  Initially, Etv2 expression is widespread 
within the primitive streak mesoderm and subsequently becomes restricted to the 
developing vascular endothelial cells.  Once endothelial cells begin to mature, its 
expression is rapidly downregulated.  Etv2 is both necessary and sufficient for 
initiating vasculogenesis and in newly forming endothelial cells, Etv2 induces 
VEGFR2 expression, promoting the commitment of these cells to an endothelial fate.  
The morpholino knockdown of Etsrp protein function or mutations within the Etsrp 
gene leads to the complete absence of circulation in developing zebrafish embryos 
and a significant reduction in the expression of vascular endothelial markers 
including VEGFR2 and VE cadherin.  Conversely, the overexpression of Etv2 results 
in an expansion of endothelial cell differentiation in vivo, detected by the ectopic 
expression of endothelial markers in multiple cell types (Sumanas & Lin, 2006; 
Pham et al., 2007; Sumanas et al., 2008; Lee et al., 2008; De Val et al., 2008; 
Salanga et al., 2010; Kataoka et al., 2011; reviewed by Marcelo et al., 2013; Liu et 
al., 2015).   
 
The in vivo expression of Ets1 protein by endothelial cells during angiogenesis has 
been demonstrated by immunohistochemical analysis using a murine model for 
angiogenesis.  Furthermore, in the initiation of angiogenesis, growth factors 
including VEGFA, FGF and epidermal growth factor (EGF) have been shown to 
induce the expression of Ets1 in HUVECs, immortalised HUVECS and human 
omental microvascular endothelial cells (HOMECs), which in turn induces the 
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expression of the serine protease uPA, MMP-1, MMP-3 and MMP-9.  Cell migration 
is also induced, converting these cells to an angiogenic phenotype.  The importance 
of Ets1 as a molecular target for regulating angiogenesis is revealed through the 
study of these downstream mechanisms.  Blocking the expression of Ets1 has been 
shown to significantly inhibit the expression of uPA and MMP-1.  Cell migration is 
prevented as Ets1 also controls the expression of genes involved in cell attachment 
and endothelial cell migration, including αv integrins, β2 and β3 integrins, 
intracellular adhesion molecules (ICAMs) and VE cadherin, ultimately leading to the 
inhibition of angiogenesis (Iwasaka et al., 1996; Sato, 1998; Kita et al., 2001).   
 
The gene regulatory events implicated in controlling sprouting angiogenesis also 
involves the specific induction of the MADS box transcription factor Mef2c, by 
VEGFA and FGF2, which also functions in muscle cell differentiation and the 
specification of numerous cell types.  Embryonic lethality in Mef2c-/- mutant mice 
results from prominent heart defects and vascular malformations in which 
endothelial cells fail to properly arrange into a vascular plexus (Bi et al., 1999; 
Schweighofer et al., 2009; del Toro et al., 2010; Rivera et al., 2011).  Whereas Ets1 
primarily acts to promote angiogenesis, Ets1 directly activates Mef2c in endothelial 
cells resulting in a strong inhibitory effect on angiogenic sprouting, a response 
mediated by alpha-2-macroglobulin (A2M), affecting cell migration and not 
proliferation.  The Mef2c/A2M axis is suggested to adapt sprouting activity to local 
oxygen concentration.  Hypoxia is the initial trigger for VEGFA production and in 
hypoxic conditions Mef2c induction is much less pronounced and A2M upregulation 
is prevented when compared with normoxia.  The Mef2c/A2M pathway therefore 
functions as a negative feedback mechanism in endothelial cells to prevent 
inappropriate sprouting and excess angiogenesis under normoxic conditions when 
sufficient levels of oxygen are reached after neovascularisation (De Val et al., 2004; 
Hickey & Simon, 2006; Sturtzel et al., 2014).   
 
1.8 The role of MMPs in angiogenesis 
 
MMPs play a crucial role in angiogenesis, vascular disease and tumour progression 
with research focusing on elucidating the regulatory networks involved during 
development, physiological conditions and various pathologies in order to identify 
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MMPs and inhibitors as prognostic markers and targets for therapy (Duffy & 
McCarthy 1998, Amin et al., 2016; Yang et al., 2016; King, 2016).  The remodelling 
of the ECM is an integral aspect in developmental processes, liberating cells and 
subsequently enabling their response to a variety of signals.  MMPs, also designated 
matrixins, are a large family of zinc-dependant endopeptidases that can be 
categorised into various groups (Table 1i).  MMPs are involved in remodelling the 
ECM during normal physiological processes, such as embryonic development and 
tissue repair, as well as in pathological conditions including arthritis and tumour 
metastasis (Visse & Nagase, 2003).  Thus, MMPs are likely to be implicated in the 
interaction between the ingressing endothelial cells and the cells and ECM of the 
developing brain.  MMPs hydrolyse structural components present in the ECM such 
as collagen, elastin and gelatin, together with cell surface molecules involved in a 
variety of biological processes including CD44, E-cadherin and Fas-ligand (Visse & 
Nagase, 2003).  The precise and complex regulation of MMP activity ensues at 
multiple levels including transcriptional control, activation of the secreted zymogens, 
or inactive precursors referred to as procollagenases (proMMPs), the presence and 
activity of endogenous inhibitors and interaction with specific components of the 
ECM (Nagase & Woessner, 1999; Woessner & Nagase, 2000; Hiller et al., 2000).   
 
The involvement of proteases in angiogenesis is well-established (Egeblad & Werb, 
2002) and extracellular proteases are essential in remodelling the ECM during CNS 
vascularisation for the migration of endothelial cells towards the neural tube and for 
the penetration of the basal lamina by tip cells during ingression (Fig. 1vi).  It is also 
important to note that the organisation of the endothelial sprout with a leading tip 
cell and the follower stalk cells is similar to invasive cell migration by certain 
cancers, which is facilitated by pericellular proteases.  Extracellular proteolysis and 
ECM degradation play a crucial role in tumour invasiveness and metastasis and a 
well-established correlation exists between metastatic potential and the expression of 
proteases and heparinases.  
 
 
 
 
 
Table 1i.  Classification of MMPs.  Members of the MMP family can be classified 
into various groups based on domain architecture and functional diversity.  The 
activity of MMPs is precisely regulated under normal physiological conditions at both 
transcriptional and translational level through the combination of cis-regulatory 
elements, epigenetic mechanisms, proMMP activation, interaction with ECM 
components and mechanisms of inhibition by endogenous inhibitors.  Collagenases 
include MMP-1, MMP-8, MMP-13 and MMP-18 (Xenopus), which cleave interstitial 
collagens as well as other ECM and non-ECM molecules.  Gelatinases, MMP-2 and 
MMP-9, have three repeats of a type II fibronectin domain located inside the catalytic 
domain, which allows the binding and processing of gelatin, collagens and laminin.  
MMPs -2 and -9 also degrade fibronectin, elastin, aggrecan and vitronectin as well as 
non-ECM molecules.  Stromelysins, MMP-3, MMP-10 and MMP-11, are unable to 
cleave native collagen but can degrade many different ECM components and process 
bioactive substrates including E-cadherin and stromal-cell derived factor-1.  
Stromelysins can also participate in the activation of a number of proMMPs.  
Matrilysins, MMP-7 and MMP-26, lack a hemopexin domain and digest a number of 
ECM components.  MMP-7 also catalyses the ectodomain shedding of cell surface 
molecules including Fas ligand and E-cadherin.  MT-MMPs are classified into type I 
transmembrane proteins and GPI-anchored proteins.  Type I transmembrane proteins 
(MT1-MMP, MT2-MMP, MT3-MMP and MT5-MMP) cleave various substrates and 
are major activators of proMMP-2.  The second subgroup includes MT4-MMP and 
MT6-MMP, which are bound to the cell surface with a GPI-anchor.  MT6-MMP 
processes gelatin, collagen IV, fibrin, fibronectin and proteoglycans, whereas MT4-
MMP shows low enzymatic activity against ECM components.  A third subgroup, 
consisting of MMP-23A and MMP-23B, are type II transmembrane MMPs that have 
the same amino acid sequence but are encoded by distinct genes in the human genome.  
These MMPs lack the cysteine switch motif, the hemopexin domain and the signal 
peptide that are characteristic of all MMPs, but contain cysteine-array and 
immunoglobulin domains in the C-terminal tail.  Several MMPs are not classified in 
the above categories due to their divergence and substrate specificity: MMP-12 is the 
most potent elastolytic enzyme that also digests a number of other proteins and is 
essential for macrophage migration; MMP-19 is a potent enzyme against components 
of basement membranes including type IV collagen and tenascin, as well as gelatin 
and aggrecan; MMP-20 digests amelogenin and is secreted by ameloblasts and 
odontoblasts during the formation of tooth enamel; MMP-27 was first cloned from 
chicken fibroblasts and degrades gelatin and casein; and MMP-28 is mainly expressed 
in keratinocytes and may function in tissue hemostasis and wound repair.  The 
functions of MMP-21 and MMP-22 are not well understood. 
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COLLAGENASES   MEMBRANE-TYPE MMPSs 
MMP-1 (collagenase 1, interstitial collagenase) Type I transmembrane:      Type II transmembrane: 
MMP-8 (collagenase 2, neutrophil collagenase) MMP-14 (MT1-MMP)         MMP-23A 
MMP-13 (collagenase 3)    MMP-15 (MT2-MMP)         MMP-23B 
MMP-18 (collagenase 4, Xenopus)   MMP-16 (MT3-MMP) 
      MMP-24 (MT5-MMP) 
GELATINASES    Glycosylphosphatidylinositol (GPI) anchored: 
MMP-2 (gelatinase A, 72 kDa type IV collagenase) MMP-17 (MT4-MMP) 
MMP-9 (gelatinase B, 92 kDa type IV collagenase) MMP-25 (MT6-MMP) 
 
STROMELYSINS    MATRILYSINS    
MMP-3 (stromelysin 1)    MMP-7 (matrilysin 1)    
MMP-10 (stromelysin 2)    MMP-26 (matrilysin 2)    
MMP-11 (stromelysin 3)  
 
OTHER MMPs    
MMP-12 (macrophage elastase, metalloelastase)     
MMP-19     
MMP-20     
MMP-21 (XMMP, Xenopus) 
MMP-22 
MMP-27 (CMMP, Gallus) 
MMP-28 (Epilysin)         
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Pericellular proteases have an intricate role in degrading matrix proteins during 
endothelial cell migration and invasion in addition to controlling the activation, 
liberation and modification of angiogenic growth factors and cytokines (Peretz et al., 
1990; Leto et al., 1992; Garbisa et al., 1992; Sreenath et al., 1992; Park et al., 1993; 
van Hinsbergh et al., 2006; Wolf et al., 2007).  The major groups of matrix-
degrading proteases involved in regulating angiogenesis include the MMP family 
(Matrisian, 1990, 1992; Nagase et al., 2006), the adamalysin-related membrane 
proteases (ADAM family) (Wolfsberg et al., 1995), cathepsin cysteine proteases 
(Turk et al., 2001) and serine proteases (Kraut, 1977; Yoshida & Shiosaka, 1999), 
which are tightly controlled at several levels by specific activation and inhibition 
mechanisms including tissue inhibitors of metalloproteinases (TIMPs) (Gomez et al., 
1997; Lambert et al., 2004), cystatins, kininogens (Turk et al., 2002), and serpins 
(Schapira & Patston, 1991).  Other matrix-degrading proteases have also been shown 
to cooperate with MMPs as activated plasmin can activate various MMPs, including 
MMP-1, -2, -3 and -9, thus contributing to vascular remodelling (Davis et al., 2001).   
 
The four major subgroups of MMPs include interstitial collagenases, gelatinases, 
stromelysins and membrane type (MT-) MMPs.  Collagens are the most abundant 
proteins present in the ECM and the breakdown of which is initiated by 
collagenolytic MMPs, which cleave types I-III collagens at specific peptide bonds.  
MMP-1 (collagenase 1, interstitial collagenase), MMP-2 (gelatinase A, 72 kDa type 
IV collagenase), MMP-8 (collagenase 2, neutrophil collagenase), MMP-13 
(collagenase 3) and MMP-18 (collagenase 4, Xenopus) are interstitial collagenases 
capable of cleaving triple helical collagen by hydrolysing a single Gly-Ile/Leu bond 
in the collagen α chains three-fourths from the N-terminus, generating 3/4 and 1/4-
length fragments that are further degraded by other proteolytic enzymes (Gross et 
al., 1974; Miller et al., 1976; Birkedal-Hansen et al., 1993; Aimes & Quigley, 1995; 
Visse & Nagase, 2003).   
 
1.8.1     MMP-1 
 
In 1962, MMP-1 was the first MMP to be discovered as the anuran tadpole was 
found to have strong collagenolytic activity during metamorphosis.  MMP-1 was 
subsequently purified from tadpole tail fin and back skin (Gross & Lapiere, 1962; 
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Nagi et al., 1966).  MMP-1, also termed human fibroblast collagenase, was later 
discovered in a form, which when incubated with trypsin, resulted in a significant 
increase in activity that was accompanied by a 10 kDa loss in molecular weight.  
Furthermore, auto-activation of the procollagenase to yield the active enzyme 
form also occurred without a detectable change in molecular weight (Bauer et al., 
1975; Stricklin et al., 1977).  MMP-1 is initially synthesised in a preproenzyme 
form that is co-translationally processed to form the inactive procollagenase, 
which is secreted from the cell. The proenzyme, termed zymogen, has a 
characteristic structure similar to all MMPs consisting of a pro-peptide domain 
(PRO) and a catalytic domain (CAT) joined via a linker region to a hemopexin 
domain (HPX) (Fig. 1vii).  The proteolytic activation of MMP-1 results in the 
removal of 81 amino acid residues from the amino-terminal section of the 
proenzyme, generating the active collagenase (Goldberg et al., 1986; Visse & 
Nagase, 2003; Jozic et al., 2005).    
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Figure 1vii.  Crystal structure of inactive proMMP-1.  The activity of the 
enzyme is inhibited by the PRO domain (blue) that maintains the MMP in 
zymogen form (proMMP) by binding to the CAT domain (purple), which 
interacts with the HPX domain (green).  A water molecule essential for peptide 
hydrolysis is coordinated with the active site zinc present within the CAT domain.  
The activation of proMMPs requires disrupting the bond between the cysteine in 
the PRO domain and the zinc in the CAT domain, referred to as the Cys-Zn
2+
 
cysteine switch.  Removal of the PRO domain proceeds either by proteases or 
non-proteolytic agents as well as other MMPs (Nagase & Woessner Jr., 1999; 
Visse & Nagase, 2003; Jozic et al., 2005).  
 
 
 
 
 
 
 
 
 
 
 
 
 
54 
 
MMP-1 degrades interstitial collagens, types I, II and III and is ubiquitously 
produced by a variety of cells including stimulated fibroblasts, endothelial cells 
and macrophages.  The expression of MMP-1 has been associated with increased 
angiogenesis in xenograft models of breast, melanoma and prostate cancer 
(Vincenti et al., 1996; Benbow et al., 1999; Boire et al., 2005; Blackburn et al., 
2007; Pulukuri & Rao, 2008; Eck et al., 2009) and its activity has also been 
linked to tumour invasion, progression and poor prognosis (Murray et al., 1996; 
Murray et al., 1998; Nakopoulou et al., 1999; Airola et al., 1999, Inoue et al., 
1999; Ito et al., 1999; Pickett et al., 1999; Kanamori et al., 1999; Korem et al., 
1999; Nishioka et al., 2000; Ghilardi et al., 2001; Hinoda et al., 2002; Poola et 
al., 2005; Przybylowska et al., 2006).  The control of angiogenesis occurs at 
multiple levels and several genes encoding matrix-degrading proteases are 
transactivated by the transcription factor Ets1.  The expression of Ets1 and two of 
its target genes, MMP-1 and MMP-9, has been found in endothelial cells and 
stromal fibroblasts at the onset of stroma generation during the early stages of 
breast carcinogenesis, which becomes significantly upregulated in invasive ductal 
and lobular cancers (Behrens et al., 2001).   
 
MMP-1 expression has been associated with increased angiogenesis through the 
activation of the protease-activated receptor (PAR), PAR1.  PARs are G protein-
coupled receptors (GPCRs) that are expressed by a number of cell types within 
the tumour microenvironment including endothelial cells, fibroblasts, 
macrophages and platelets (Ossovskaya & Bunnett, 2004; Boire et al., 2005; 
Blackburn & Brinckerhoff, 2008).  PARs are unique as they carry their own 
ligand, which is masked under resting conditions.  Activation of the receptor by 
proteolytic cleavage within the extracellular amino terminus exposes the tethered 
ligand domain, which binds to the body of the receptor, inducing signalling to 
intracellular G proteins and initiating multiple signalling cascades (Seeley et al., 
2003), leading to changes in cellular morphology, migration, proliferation and 
adhesion (Hollenberg & Compton, 2002).  The role of PAR1, a high-affinity 
thrombin receptor expressed in endothelial cells, has been investigated in breast 
carcinoma cells and its expression is both required and sufficient to promote the 
growth and invasion of xenografts in nude mice.  Furthermore, MMP-1 activity 
derived from fibroblasts in the stromal-tumour microenvironment functions as a 
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protein agonist of the receptor.  MMP-1 cleaves and activates PAR1, resulting in 
the generation of PAR1-dependent Ca
2+
 signals and the promotion of cell 
migration.  The migration of cells is inhibited by blocking the pathway 
downstream of MMP-1 with cell-penetrating pepducin antagonists of PAR1, 
which prohibits signalling between the receptor and intracellular G proteins.  
Knocking down the expression of PAR1 with small interfering RNA (siRNA) 
also revealed that MMP-1 requires PAR1 to induce chemotaxis of cancer cells 
and angiogenesis (Boire et al., 2005).  The role of MMP-1 in melanoma 
metastasis has been investigated in which the proangiogenic effect of tumour-
derived MMP-1 was inhibited in a xenograft model using short hairpin RNAs 
(shRNA).  The reduction of MMP-1 expression in tumour cells expressing MMP-
1 shRNAs had diminished collagenase activity and significantly decreased the 
ability of the primary tumour to metastasize (Blackburn et al., 2007).  Blocking  
PAR1 through the application of PAR1 antagonists in both in vivo and in vitro 
systems has shown to inhibit endothelial cell growth and proliferation as well as 
increase apoptosis, demonstrating that PAR1 has a key role in mediating 
angiogenesis.  Furthermore, MMP-1 is suggested to induce cell proliferation and 
promote angiogenesis by activating nuclear factor-κB (NF-κB), which 
subsequently stimulates VEGFR2 expression in endothelial cells (Zania et al., 
2006; Mazor et al., 2013).  Gene expression analysis in human microvessel 
endothelial cells has also revealed that the activation of PAR1 by MMP-1 results 
in the induction of a different subset of proangiogenic genes compared with 
thrombin-activated PAR1, which may better facilitate angiogenesis (Blackburn & 
Brinckerhoff, 2008).   
 
Tumour-secreted proteinases are involved in breaching the BBB and MMP-1 
plays a critical pathological role in brain metastasis of breast cancer.  Upon 
examination of MMP expression in brain metastasis-free breast cancer patients 
and in breast cancer cell lines known to preferentially metastasise to the brain, 
only MMP-1 was found to be significantly upregulated in brain metastatic cell 
lines.  Immunohistochemical analysis of tumours that metastasised in the brain of 
breast cancer patients revealed a strong expression of MMP-1 in both primary 
lesions and brain metastatic lesions in these patients.  Furthermore, a weak 
expression of MMP-1 was found in primary tumours of patients with high grade 
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breast cancer that had not metastasised in the brain (Wu et al., 2015).  Brain 
metastasis is promoted by MMP-1 by targeting and degrading claudin-5 and 
occludin, which are major components of tight junctions (Liebner et al., 2000; 
Abbott et al., 2010), resulting in enhanced BBB permeability.  The expression of 
MMP-1 is promoted by cyclooxygenase COX2, a gene previously identified to 
mediate the passage of cancer cells through the BBB (Bos et al., 2009) that is 
highly upregulated in brain metastatic cells.  COX2-induced prostaglandins 
directly promote MMP-1 expression and also activate tumour associated 
astrocytes to release chemokine ligand 7 (CCL7), which promotes the self-
renewal of tumour-initiating cells within the brain (Wu et al., 2015). 
 
MMP-1 has also been identified as a key factor in promoting the highly invasive 
behaviour of GBM cells and is regulated by epidermal growth factor receptor 
(EGFR).  The aberrant overexpression of EGFR in GBM leads to sustained 
oncogenic signalling and has been shown to contribute to the induction of MMP-1 
expression and glioma cell invasion in EGF-treated T98G cells, via the MAPK 
pathway.  In addition to enhancing tumourigenicity, an increase in organised 
endothelial growth was detected as a consequence of MMP-1 overexpression.  
Tumour size was enhanced and the expression of anti-angiogenic factors, 
particularly TIMP-4, were inverse to the levels of MMP-1 (Anand et al., 2011; 
Pullen et al., 2012).  A functional single nucleotide polymorphism in the MMP-1 
promoter has also been identified that consists of either the presence or absence of 
a guanine nucleotide at position -1607, resulting in two genotypes referred to as 
the 2G or 1G allele, respectively.  The presence of a guanine base creates a ETS 
DNA binding site that leads to increased MMP-1 transcription and promoter 
genotyping has shown that the 2G/2G genotype is more prevalent in glioblastoma 
tissue compared to healthy individuals (Rutter et al., 1998; McCready et al., 
2005).  
 
1.8.2     MMP-2 and MMP-9 
 
The breakdown of the ECM is a critical event during invasion, therefore 
considerable attention has focussed on the gelatinases, MMP-2 (gelatinase A, 72 
kDa type IV collagenase) and MMP-9 (gelatinase B, 92 kDa type IV 
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collagenase), due to their ability to degrade type IV collagen present in the 
basement membrane (Nakajima et al., 1987; Zeng et al., 1999).  MMP-2 and 
MMP-9 are expressed as proenzymes that become activated to their 62 kDa and 
82 kDa forms, respectively, once secreted into the extracellular environment.  
Three repeats of fibronectin type II domains are inserted in the catalytic domain, 
which bind to gelatin, collagens and laminin.  MMP-2 and MMP-9 are key 
regulators of angiogenesis and analogous to the interaction of integrins with 
uPA/uPAR, they can be localised to the cell surface in their active form by 
binding to αvβ3 integrin and CD44, respectively, to promote focused proteolytic 
activity and cell-mediated invasion (Brooks et al., 1996; Brooks et al., 1998; Yu 
& Stamenkovic, 1999; Silletti et al., 2001; Chapman & Wei, 2001; Blasi & 
Carmeliet, 2002; Visse & Nagase, 2003).   
 
The increased expression of MMP-2 and MMP-9 and the breakdown of type IV 
collagen in the basement membrane have been reported in various human cancers 
including colorectal, breast, prostate, ovarian, endometrial, bladder, skin, lung 
carcinomas and brain cancers (Pyke et al., 1992; Pyke et al., 1993; Brown et al., 
1993; Rao et al., 1993; Davies et al., 1993a; Davies et al., 1993b; Hamdy et al., 
1994; Sato et al., 1994; Tamakoshi et al., 1994; Liabakk et al., 1996; Zeng et al., 
1999; Belotti et al., 2003; Qin et al., 2008) and has been associated with 
angiogenic microvessel density in pancreatic cancer (Xiang et al., 2016).  
Furthermore, a potential role has been suggested for MMP-2 and MMP-9 as 
biomarkers in predicting the response to treatment of high-grade gliomas.  A 
baseline of high MMP-2 and low MMP-9 levels in the plasma prior to the 
administration of bevacizumab, a monoclonal antibody against VEGFA, has been 
associated with a high response rate, prolonged progression-free survival and 
overall survival in recurrent high-grade gliomas that are treated with bevacizumab 
(Tabouret et al., 2015). 
 
Matrix-degrading proteases have a significant role in morphogenetic events and 
tissue remodelling during embryogenesis.  The expression patterns of MMP-2 
have been documented and analysed in the early avian embryo, revealing an 
essential role in cell motility during epithelial-mesenchymal transformations 
(EMTs).  The distribution of MMP-2 RNA was detected using whole-mount in 
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situ hybridisation (ISH), followed by sectioning and labelling with the 
monoclonal antibody HNK-1 against neural crest cells; a transient, multipotent, 
migratory cell population unique to vertebrates that gives rise to diverse cell 
lineages including craniofacial cartilage and bone, smooth muscle, melanocytes, 
peripheral and enteric neurons and glia.  Superimposition of the labelling patterns 
revealed that early migratory neural crest cells express MMP-2 as they detach 
from the neural tube during an EMT but is rapidly extinguished as the cells 
disperse.  MMP-2 was also found to be expressed in the sclerotome and dermis at 
the time of EMT initiation and upon cell migration, which becomes 
downregulated once motility has ceased.  Furthermore, MMP-2 expression was 
detected in mesenchyme where tissue remodelling was in progress, including the 
head mesenchyme, lateral plate mesoderm, limb dermis and in the developing 
feather germs.  Inhibiting MMP activity with BB-94 and TIMP-2 prevented the 
EMT required to generate neural crest cells in tissue culture and in vivo, although 
the migration of cells that had already detached from the neural tube was 
unaffected.  The acquisition of the HNK-1 epitope in cells retained in the dorsal 
neural tube following in ovo incubation with BB-94 revealed that neural crest 
cells do appear to be correctly specified, but were unable to detach.  Similarly, the 
specific knockdown of MMP-2 expression by electroporating antisense 
morpholino oligonucleotides in the dorsal neural tube resulted in perturbation of 
the EMT but also did not affect the migration of neural crest cells that had already 
detached from the neural epithelium.  The expression of MMP-2 therefore 
correlates with the generation of neural crest, sclerotome and dermatome, with a 
critical role in the transformation of epithelia to mesenchyme, together with 
dispersion of mesenchymal tissues later in development (Duong & Erickson, 
2004).    
 
MMP-9 is a target gene of Ets1 and has a critical role in stimulating the onset of 
tumour angiogenesis but subsequently also generates inhibitors including the 
cleavage fragment of basement membrane collagen IV, tumstatin, which 
suppresses angiogenesis through αvβ3 integrin expressed on pathological, but not 
on physiological, angiogenic blood vessels (Hamano et al., 2003).  In supporting 
tumour growth, MMP-9 is supplied to the tumour microenvironment by tumour-
associated macrophages (TAMs) and tumour-associated neutrophils (TANs) 
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(Coffelt et al., 2010; Deryugina et al., 2014).  TAMs and TANs are infiltrating 
leukocytes implicated in regulating angiogenesis and are recruited to tumours by 
the release of tumour cell or stromal-derived chemoattractants (Mantovani et al., 
2002; Fridlender et al., 2009; Ruffell et al., 2012; De Palma & Lewis, 2013; 
Tazzyman et al., 2013; Galdiero et al., 2013).  TANs are major contributors of 
highly angiogenic MMP-9, supporting the intratumoural vasculature required for 
the development of metastasis.  In vivo, the levels of angiogenesis mediated by 
neutrophil and TAN-delivered MMP-9 significantly exceed those induced by 
macrophages and TAMs.  However, MMP-9-producing TAMs do not express its 
natural inhibitor, TIMP-1, but initiate only a relatively low-level production of 
TIMP-free MMP-9 zymogen following differentiation and polarisation compared 
with TANs (Deryugina et al., 2014).   
 
Distinct patterns observed in the spatial distribution of MMP-9 and TIMP-1 
mRNA expression had previously been demonstrated using ISH studies in human 
colorectal cancer (CRC) and liver metastases, suggesting distinct cellular origins 
and regulatory networks.  The expression patterns of MMP-9 and TIMP-1 mRNA 
in liver metastases and primary CRCs were found to be similar and predominantly 
stromal in origin.  MMP-9-positive cells were round in shape localised within the 
peritumour stroma or at the interface between the liver metastases lesion and 
surrounding normal liver.  However, TIMP-1 mRNA was more diffuse and found 
throughout the tumour stroma.  Immunohistochemical staining with the 
monoclonal antibody CD68 identified MMP-9-positive cells as macrophages, 
whereas TIMP-1 was detected in spindle-shaped stromal cells (Zeng et al., 1995).   
 
The influence of MMP-9 on endothelial progenitor cell (EPC)-induced vascular 
remodelling following ischaemia has also been investigated.  In response to 
ischaemia, EPCs are mobilised to the sites of neovascularisation where they 
differentiate into endothelial cells, increasing angiogenesis in the brain (Fan et al., 
2010; Moubarik et al., 2011; Rosell et al., 2013).  Mice subjected to cerebral 
ischaemia were treated with EPCs and after 3 weeks, an increase in the peri-
infarct vessel density was observed in WT mice but not in MMP-9/KO mice, 
identifying MMP-9 as a key factor in stroke recovery (Morancho et al., 2015).  
Mesenchymal stem cell (MSC) treatment in a permanent model for ischaemic 
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stroke in rats has also been investigated, resulting in a significant increase in 
MMP-2 activity, vascular density and greater neurological recovery (Nam et al., 
2015).  Cell therapy involving the transplantation of EPCs and MSCs has 
therefore become a promising strategy for enhancing angio-vasculogenic 
responses in patients with ischaemic diseases.  Recently, membrane-bound MMP-
9 has been used as a marker for identifying and separating proangiogenic cells 
from early EPCs with implications in vascular regeneration (Kanayasu-Toyoda, 
2016).   
    
The effect of microRNAs (miRNAs) and small interfering RNAs (siRNAs) on 
angiogenesis through regulating MMP-2 and MMP-9 expression has also been 
investigated.  miRNAs are small, non-protein-coding RNAs that negatively 
regulate the expression of target mRNAs by destabilising or inhibiting translation.  
The widely studied miRNA-21 (miR-21), is considered an oncogene involved in 
pro-angiogenesis (Zhao et al., 2013), apoptosis (Lan et al., 2015), proliferation 
(Wang et al., 2015), necrosis (Ma et al., 2015) and invasion (Li et al., 2015) and 
is significantly upregulated following spinal cord injury (SCI) in a rat model (Hu 
et al., 2013).  The high expression of miR-21 in endothelial cells previously 
suggested a role in angiogenesis (Voellenkle et al., 2012).  The upregulation of 
miR-21 has been shown to promote the survival, migration and tube formation of 
endothelial cells by targeting and decreasing the expression of TIMP-3, originally 
classified according to its ability to inhibit MMP-1, -2, -3 and -9.  The expression 
and secretion of MMP-2 and MMP-9 are thus promoted, leading to the 
degradation of the ECM and endothelial cell migration (Apte et al., 1995; Zhang 
et al., 2011; Wang et al., 2013; Hu et al., 2016).  TIMP-3 is an ECM component 
and a potent angiogenic inhibitor that limits the density of vessels in the vascular 
bed of tumours and can also curtail tumour growth by direct interaction with 
VEGFR2, blocking VEGFA binding and resulting in the inhibition of 
proliferation, migration and tube formation of endothelial cells, independent of 
MMP inhibition (Anand-Apte et al., 1996; Qi et al., 2003; Visse & Nagase, 2003; 
Cruz-Muñoz et al., 2006a; Cruz-Muñoz et al., 2006b).  Further studies into 
miRNAs have suggested a potential therapeutic role of miRNA-195a-3p, which is 
highly expressed in mesenchymal stem cells (MSCs), as an inhibitor of 
angiogenesis.  miRNA-195a-3p was found to negatively modulate angiogenesis 
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by targeting the transcript of MMP-2, resulting in the reduction of MSC 
proliferation and migration (Gao et al., 2016). 
 
RNA interference technology using siRNAs has also been employed to further 
elucidate the roles of MMP-2 and MMP-9 in angiogenesis.  The knockdown of 
the Annexin II receptor AXIIR in HUVECs, which is also a receptor for 
plasminogen (Flood & Hajjar, 2011), resulted in the significant inhibition of 
proliferation, migration, adhesion and tube formation in vitro and suppression of 
angiogenesis in nude mice.  Cell cycle arrest was induced in the S/G2 phase by 
the siRNA directed against AXIIR and the expression of MMP-2 and MMP-9 was 
inhibited.  A plausible mechanism by which AXIIR siRNA inhibits angiogenesis 
has been suggested in which MMPs are regulated by the PI3K and Ras/MAPK 
pathways.  AXIIR siRNA was found to significantly suppress the phosphorylation 
and activation of AKT and ERK1/2, resulting in the decreased expression of 
MMP-2 and MMP-9 mRNA and protein, and increased expression of TIMP-2 
(Song et al., 2015).   
 
1.8.3     MT-MMPs  
 
The MT-MMP family members are expressed at the cell surface rather than 
secreted, consisting of four type I transmembrane proteins: MMP-14, MMP-15, 
MMP-16, MMP-24, and two GPI-anchored proteins, MMP-17 and MMP-25, 
which are involved in digesting a number of ECM components including 
collagen, laminin-1, laminin-5, fibronectin and aggrecan, as well as releasing and 
modifying growth factors and cytokines.  MT1-MMP (also referred to as MMP-
14) has collagenolytic activity that digests types I, II and III collagens.  Similar to 
all other MT-MMPs, except MT4-MMP, MT1-MMP is capable of locally  
activating the type IV collagenase, proMMP-2 (Sato et al., 1994; Ohuchi et al., 
1997; Visse & Nagase, 2003; Mott & Werb, 2004), therefore proteolytic activity 
is focused on specific cell surface sites during degradation of the basement 
membrane in the initiation of invasion.   
 
MT1-MMP has been investigated in a number of studies, elucidating its role in 
cell migration and angiogenesis as well as in the progression of various cancers 
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including breast adenocarcinoma, metastatic brain tumours and pituitary 
adenomas (Sounni et al., 2002; Liu et al., 2010; Kwak et al., 2012; Hui et al., 
2015).  In regulating migration and adhesion of tumour cells, MT1-MMP 
processes αvβ3 integrin and CD44, to which MMP-2 and MMP-9 respectively 
bind in their localisation to the cell surface, as well as tissue transglutaminase 
(Brooks et al., 1996; Yu & Stamenkovic, 1999; Belkin et al., 2001; Kajita et al., 
2001; Deryugina et al., 2002).  MT1-MMP has been shown to co-localise with β1 
integrins at intercellular contacts and co-localises with αvβ3 integrin at motility-
associated structures on migrating endothelial cells (Gálvez et al., 2002).  MT1-
MMP also binds CD44, which interacts with actin, via its extracellular HPX 
domain.  CD44 therefore closely associates MT1-MMP to the cortical actin 
cytoskeleton within the cell and directs it towards the lamellipodia on the front of 
migrating cells (Mori et al., 2002).  Furthermore, the binding of MMP-2 with 
TIMP-2 to MT1-MMP on the cell surface facilitates the activation of MMP-2 by 
an adjacent molecule of MT1-MMP and the di-/oligomerisation of MT1-MMP 
molecules required for MMP-2 activation is promoted by the interaction of 
CD44H, the dominant form in endothelial cells, with both actin and the HPX 
domain of MT1-MMP, resulting in the degradation of matrix proteins (Henke et 
al., 1996; Mori et al., 2002; Visse & Nagase, 2003).  The stability of newly 
formed microvessels is suggested to be regulated by the selective expression of 
TIMPs from perivascular supporting cells as the expression of TIMP-2 and 
TIMP-3 from pericytes co-cultured with HUVECs can inhibit MT1-MMP 
activity, resulting in the suppression of pro-MMP2 activation (Lafleur et al., 
2001).  EGF receptor has been investigated in a cervical cancer cell line and is 
also suggested to be involved in upregulating MT1-MMP and downregulating 
MMP-2 synthesis via the PI3K/Akt and MAPK/ERK pathways (Zhang et al., 
2009). 
 
In 3D collagen matrices, MT1-MMP is indispensable for driving neovessel 
formation conferring endothelial cells with the ability to form invading capillary-
like structures, whereas neither MMP-2, MMP-9, β3 integrin, CD44, nor 
plasminogen were found to be essential for invasion or neovessel formation 
(Chun et al., 2004).  The regulation of MT1-MMP is involved in the initiation of 
endothelial sprouts in a mechanism involving vimentin, the major intermediate 
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filament protein present in endothelial cells, which forms a complex with MT1-
MMP in a process that requires the cytoplasmic domain.  Vimentin is cleaved by 
calpains to facilitate the translocation of MT1-MMP to the membrane, leading to 
sprout formation (Kwak et al., 2012).   
 
Further studies into the regulatory pathways of MT1-MMP have revealed that 
ELK3, a member of the ETS family of transcription factors that is known to be 
involved in transcriptional repression, has a negative effect on VEGFA-induced 
angiogenesis in HUVECs and in vivo Matrigel plug assays by inhibiting the 
transcriptional activity of angiogenic Ets1 on the MT1-MMP promoter (Giovane 
et al., 1994; Ayadi et al., 2001; Heo et al., 2014).  In both in vitro and in vivo 
studies of human glioma cells and breast adenocarcinoma cells, the 
overexpression of MT1-MMP leads to the upregulation of VEGFA gene 
expression as well as the activation of proMMP-2, resulting in stimulated 
angiogenesis and promotion of tumour growth.  The specific effect on VEGFA 
upregulation requires functional catalytic and cytoplasmic domains of MT1-MMP 
and also involves Src tyrosine kinase activity, a pathway distinct to that involved 
in inducing cell migration involving ERK (Deryugina et al., 2002; Sounni et al., 
2002; Sounni et al., 2004).  The overexpression of MT1-MMP also induces the 
activation of ERK resulting in increased cell migration, which also requires the 
presence of the cytoplasmic domain (Gingras et al., 2001).  An antiangiogenic 
effect of MT1-MMP, which does not require the catalytic domain, has however 
been identified in corneal angiogenesis, as knockouts of MT1-MMP in corneal 
cells significantly increased cell proliferation and migration.  MT1-MMP also 
cleaves VEGFR1 leading to reduced proangiogenic effect of VEGF165 (Azar et 
al., 2010; Han et al., 2015).  The importance of MMPs in angiogenesis is 
highlighted by the consequences resulting from the deletion of reversion-
inducing-cysteine-rich protein with kazal motifs (RECK), a GPI-anchored 
glycoprotein that regulates Notch signalling and the activities of MMPs and 
ADAMs including MMP-2, MMP-9, MT1-MMP and ADAM-10, which disrupts 
vascular development likely by excessive MMP activation, resulting in the 
premature death of mouse embryos (Noda et al., 2003; Muraguchi et al., 2007). 
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1.9 Research aims and strategy 
 
The aims of this research are to characterise the interaction of ingressing cells with 
the brain, test the role of MMPs in the ingression process and investigate the 
influence of neural tube patterning on endothelial ingression. 
 
Anatomy:  
The brain in particular has a high demand for oxygen and nutrients and therefore 
depends on an efficient blood supply.  Endothelial cells will be visualised at the 
different stages involved in the initiation of brain vascularisation using in situ 
hybridisation (ISH) in G. gallus embryos, complemented by immunohistochemistry 
(IHC) for the detection of neural cells.  The process of brain vascularisation in 
amphibians has not yet been documented, anatomically nor molecularly, therefore a 
method of lectin histochemistry (LHC) will also be used to characterise the 
ingression of endothelial cells into the brain of Xenopus laevis during early 
embryonic development. 
 
Mechanism: 
Endothelial sprouting in the brain shares similarities to tumour angiogenesis as the 
ectoderm is invaded by sprouts from the mesoderm, therefore it is possible that 
similar mechanisms are shared between both processes.  We hypothesise that MMP 
activity influences endothelial cell ingression and the focus of this research will be 
on MMP-1, MMP-2 and MMP-9, which are known to have a key role in 
angiogenesis.  The expression patterns of these MMPs will be analysed in the 
developing brain using ISH in comparison to staining for endothelial cells.  The 
presence of active MMPs will be analysed using in situ zymography (ISZ) and the 
role in ingression will be tested by manipulating MMP levels through exposure to 
pharmacological inhibitors and active MMP-1.  The resulting phenotype will be 
analysed by immunostaining for endothelial cells and ECM components. 
 
Regulation: 
The intricate level of molecular communication between the development of the 
neural tube and vasculogenesis is evident from the numerous signalling pathways 
that govern the two processes (Fig. 1viii-ix).  The effect of the dorsoventral 
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patterning molecule, Shh, upon endothelial ingression will be investigated through 
electroporation experiments conducted in the early neural tube, followed by 
endothelial cell detection.  A second focus will be on the inhibition of Notch 
signalling and analysing the effect upon ingression, specifically in the early 
embryonic brain. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1viii.  Gene regulation at the initiation of angiogenesis.  The ETS family 
of transcription factors have important roles in vasculogenesis and angiogenesis, 
regulating genes involved in cell migration and proliferation.  Growth factors 
including VEGFA, FGF2 and EGF induce the expression of Ets1 in endothelial cells 
at the initiation of angiogenesis, resulting in the induction of uPA, MMP-1, MMP-3 
and MMP-9, together with cell attachment and migration genes αv integrins, β2/β3 
integrins, ICAMs and VE cadherin.  Cell migration  is triggered as the GPI-anchored 
uPAR activates uPA that converts plasminogen to plasmin, ultimately resulting in 
MMP activation and the mobilisation of proangiogenic factors following ECM 
degradation.  Furthermore, uPA can act directly on a number of matrix proteins such 
as fibronectin.  Endothelial cell migration is also promoted by the cleavage and 
activation of PAR1 by active MMP-1, together with the interaction of uPAR with 
α5β1 integrin and caveolin that are highly expressed in tip cells.  Sprouting 
angiogenesis is also controlled by the transcription factor Mef2c, which is directly 
activated by Ets1 and mediated by A2M, resulting in a strong inhibitory effect on 
cell migration.  The Mef2c/A2M pathway functions as a negative feedback 
mechanism in normoxic conditions to prevent inappropriate sprouting and excess 
angiogenesis when sufficient levels of oxygen are reached following 
neovascularisation. 
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Figure 1ix.  The selection of tip and stalk cells during sprouting angiogenesis.  
The selection of tip and stalk cells is influenced by the interaction between 
endothelial cells, neuroglial cells and microglia during vascularisation of the CNS.  
Neuroglial cells secrete a number of factors including VEGFA, SEMA3A, 
SEMA3E, SEMA3F, Wnt7a, Wnt7b and Shh.  Microglia, which are the resident 
macrophages of the CNS, synthesise VEGFA, MMP-1, MMP-9 and PARs.  Vessel 
sprouting is regulated by VEGFA and when one endothelial cell within a group 
receives more VEGFA via VEGFR2 this leads to an increase in the expression of the 
transmembrane ligand, Dll4, resulting in the emergence of a tip cell.  The Dll4 ligand 
binds to Notch receptors on adjacent endothelial cells leading to an increase in 
VEGFR1 expression and a decrease in VEGFR2 and VEGFR3, resulting in 
neighbouring cells emerging as stalk cells.  Vessel formation is negatively regulated 
by VEGFR1, which binds VEGFA with 10-fold higher affinity than VEGFR2, 
thereby limiting the amount of VEGFA accessible to VEGFR2.  Tip and stalk cells 
differ in genetic identity with tip cells expressing high levels of Dll4, α5β1 integrins 
and caveolin, together with transmembrane proteins VEGFR1, VEGFR2, VEGFR3, 
PLXND1 and NRP1.  The migration of tip cells is guided by NRP1 and the 
distribution of VEGFA in the extracellular space.  NRP1 acts as a co-receptor for 
VEGF165 by forming a complex with VEGFR2, which enhances the VEGFA-
VEGFR2 interaction.  SEMA3A-NRP1 signalling on the other hand prevents 
VEGF165 from binding NRP1, leading to reduced cell motility.  Stalk cells have 
high expression of VEGFR1, ALK1 and endothelium-specific Smad1 and Smad5, 
which cooperate with Notch to reduce tip cell numbers.  The proliferation of stalk 
cells is regulated by the concentration of VEGFA.  The Dll4-Notch signalling 
pathway is therefore crucial in establishing an adequate ratio of tip cells to stalk cells 
required for normal sprouting patterns. 
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2. MATERIALS AND METHODS 
 
2.1 Ethical statement 
 
All research projects are monitored by the University's ethics committee and current 
work in the laboratory has been approved by the committee.  G. gallus embryos were 
not used beyond half-way through gestation and hence the experiments are not 
subject to the Scientific Procedures Act.  X. laevis experiments were covered by 
existing Home Office licences.  None of the experiments involved human subjects or 
tissues. 
 
2.2 Ets1, MMP and VEGFR PCR amplification 
 
G. gallus genomic DNA was used as template to amplify regions from Ets1, MMPs 
and VEGFRs using nested primers in PCR to increase the yield and provide more 
specific product.  A volume of 1μl genomic DNA (or cDNA for VEGFR PCR) was 
combined with 10.5μl H2O, 12.5μl 2x Pwo master mix (Roche 03789403001) and 
0.5μl each of the outer forward and reverse primers (100pmol/μl).  The PCR was 
conducted with the following parameters: 1' 95
o
C; 5x (15" 95
o
C, 15" 58
o
C, 2' 72
o
C); 
25x (15" 95
o
C, 15" 52
o
C, 2' 72
o
C); 15' 72
o
C.  Inner primers were then used to 
amplify a region within the product by combining 1.0μl of PCR product with 10.5μl 
H2O, 12.5μl 2x Pwo master mix and 0.5μl each of the inner forward and reverse 
primers (100pmol/μl) extended with the Gateway attB cloning sequence (blue) in a 
second reaction using the following parameters: 1' 95
o
C; 5x (15" 95
o
C, 15" 50
o
C, 2' 
72
o
C); 25x (15" 95
o
C, 15" 65
o
C, 2' 72
o
C); 15' 72
o
C.  The PCR2 product was gel 
purified using a NucleoSpin Gel and PCR Clean-up kit (Macherey-Nagel 
740609.250) and stored at 4
o
C. 
 
Ets1 outer primers:  
 cEts1_F1 TGGCAGGGGATTAGTGAAAG 
 cEts1_R1 ATGTTGGATAGACCCCACCA 
Ets1 inner primers: 
 B1_F_cEts1 GGGGACAAGTTTGTACAAAAAAGCAGGCTGCTGAAGTGCCTTTTTC  
 B2_R_cEts1 GGGGACCACTTTGTACAAGAAAGCTGGGTTTGGGAATAGGGGAAGA  
69 
 
MMP-1 outer primers:  
 cMMP1_F1 AGTTTGATCCTCGTGCCAAA 
 cMMP1_R1 TTTAATGCAGCAGGTAAAAGTG 
MMP-1 inner primers: 
 B1_F_MMP1_3 
 GGGGACAAGTTTGTACAAAAAAGCAGGCTTCTTTTCCACATGCACACTG 
 B2_R_MMP1_3 
 GGGGACCACTTTGTACAAGAAAGCTGGGTCTGTGGAATCTAGGCAGGA 
  
MMP-2 outer primers: 
 cMMP2_F1 GCGAGTTTGATCATTACTGCCA 
 cMMP2_R1 TTGGCATTTCATGTTTGGGAC 
MMP-2 inner primers: 
 B1_F_MMP2_3 
 GGGGACAAGTTTGTACAAAAAAGCAGGCTGGTTGCCACGGGATTTGATT 
 B2_R_MMP2_3 
 GGGGACCACTTTGTACAAGAAAGCTGGGTACACCTTCTGTTGCCCAATG  
 
MMP-9 outer primers: 
 CMMP9_F1 AGCCCAGGAGTGCTGTGG 
 CMMP9_R1 TTCCAAAGGACGGCTTTTATTAC 
MMP-9 inner primers: 
 B1_F_MMP9_3 
 GGGGACAAGTTTGTACAAAAAAGCAGGCTCAGGGCTTGCAGTCTCCC 
 B2_R_MMP9_3 
 GGGGACCACTTTGTACAAGAAAGCTGGGTAGCAGGTGAAGGATGGCAT 
 
The primer design for and PCR-amplified sequences for MMPs -1, -2 and -9 are 
shown in Fig. 2i. 
 
VEGFR1 Outer Primers: 
cVEGFR1_F1 TCCTGAGCTGTGAGACAACC 
cVEGFR1_R1 TCACTTTCATTGGCAAGCGA 
VEGFR1 Inner Primers: 
B1_F_VEGFR1 GGGGACAAGTTTGTACAAAAAAGCAGGCTGTGGGCACAAGTATAGCACG 
B2_R_VEGFR1 GGGGACCACTTTGTACAAGAAAGCTGGGTAGGGTCCACTCTTCACATGG 
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VEGFR2 Outer Primers: 
cVEGFR2_F1 ACGAAATAAAGACACAGCCCTG 
cVEGFR2_R1 ATTAACCCGCCCTCTCTACC 
VEGFR2 Inner Primers: 
B1_F_VEGFR2 GGGGACAAGTTTGTACAAAAAAGCAGGCTCTCAGAGTTATCCCGTGCC 
B2_R_VEGFR2 GGGGACCACTTTGTACAAGAAAGCTGGGTGGCAGTTCAGAGGGGAATT 
 
VEGFR3 Outer Primers: 
CVEGFR3_F1 AGGCAGATCTGGTGAGCAG 
CVEGFR3_R1 ACCCACGTGTTCTCCTTCTT 
VEGFR3 Inner Primers: 
B1_F_VEGFR3 
GGGGACAAGTTTGTACAAAAAAGCAGGCTAGCATCACCGAGGAAGAACA 
B2_R_VEGFR3 GGGGACCACTTTGTACAAGAAAGCTGGGTCAAAGACATAGGCGCTGACC 
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MMP-1: 
GGGGACAAGTTTGTACAAAAAAGCAGGCTTCTTTTCCACATGCACACTGCATATTTTTA
AGTGTATATTTTATATGTATATTTTTTATGTGCTGAATTTTTCAGCATTTCATGACTAACA
GTTCAAAATGGATTCCTGCCTAGATTCCACAGACCCAGCTTTCTTGTACAAAGTGGTCC
CC 
 
MMP-2: 
GGGGACAAGTTTGTACAAAAAAGCAGGCTGTTGCCACGGGATTTGATTTGTATTGATGC
ATGATGGAATCATGGCAAGAAACTGTATTAAAGTATTGTTTTAAAGTACTTTCTATTTTA
AAACCTTAGTTCAACTTAGCAATTTGCTTCCTGCACTTTGTTACTACTCTATAACTTGTC
TATACAGACAGAATGACTCAGATGTTTTAAATCAATGTATTATACACAGAAGTCAAGTA
TTACTGTTTACCTTGTTTTATTTTTCTGTTCTTTATAATATTGAGTTTTTGTTTGGTTAGGC
TTTCTGCTTAGGCATTGGGCAACAGAAGGTGTACCCAGCTTTCTTGTACAAAGTGGTCC
CC 
 
MMP-9: 
GGGGACAAGTTTGTACAAAAAAGCAGGCTCAGGGCTTGCAGTCTCCCTGGCAGGATGG
GGCGTGTGCTCCCGGCCCCCACCAGGGGCTGCCCGTCTGGGGAGCGGCGACTCACGCC
AGCTTTGCTGCCCGGAGACGTTTGCCCGGCGCAAACTGCACACGGATTTGTAATGACTT
TATCTTTTCCTGAGCCAGTAACGCTGGGTCGGCCTCGCGCGGGCAGGGACACGGGGCTT
TGTGCCTCCCCCGCCTCGCCGCCGGGTGATGCCATCCTTCACCTGCTACCCAGCTTTCTT
GTACAAAGTGGTCCCC 
 
Figure 2i.  MMP primer design and PCR-amplified sequences for ISH 
experiments.  A. The inner primers designed for the production of RNA probes to 
detect MMPs -1, -2 and -9 were used in PCR with chick genomic DNA as template 
and the products of which are shown on the right following gel purification.  PCR 
products were then cloned in a Gateway pDONR
TM
221 vector, which was used to 
transform competent bacteria.  Template DNA was then synthesised and used to 
make antisense RNA probes for ISH.  B. The amplified sequences for MMP-1, 
MMP-2 and MMP-9 inner primers are shown, extended with the Gateway attB 
cloning sequences (blue).   
  
 
 
 
72 
 
2.3 Gateway cloning reactions for Ets1, MMPs and VEGFRs 
 
The purified Ets1, MMP-1, MMP-2, MMP-9 and VEGFR PCR2 products were 
Gateway cloned in a BP reaction by combining 2μl attB-PCR2 with 1μl Gateway® 
pDONR
TM
221 vector (150ng/μl; Invitrogen 12536017), 1μl TE buffer pH8 and 1μl 
Gateway
®
 BP Clonase
®
 enzyme mix (Invitrogen 11789013) then incubating for 1 
hour at room temperature (RT).  The reaction was terminated by incubating with 
0.5μl Proteinase K (Qiagen 19131) for 10 minutes at 37oC and samples were then 
stored on ice prior to transformation. 
 
2.4 Bacterial transformation and minipreps 
 
The transformation of α select chemically competent cells (Bioline BIO-85026) was 
achieved by adding 50μl α select bacteria to each cloning reaction sample and 
incubating on ice for 10 minutes.  The cells were heat-shocked at 42
o
C for 30 
seconds then immediately placed back on ice before adding 150μl SOC medium 
(Invitrogen 15544034) to each sample and shaking for 1 hour at 37
o
C.  The samples 
were plated on LB agar containing the relevant antibiotic (30μg/ml kanamycin and 
75μg/ml chloramphenicol for Ets1 or 30μg/ml kanamycin for MMPs and VEGFRs) 
and incubated for 15-18 hours at 37
o
C before storing at 4
o
C.  Liquid cultures of 
transformed bacteria were prepared by inoculating 2 ml YT growth medium or LB 
broth, containing the same antibiotics used for the LB plates, with a single colony.  
The cultures were shaken for 17 hours at 37
o
C prior to plasmid purification using a 
High Pure Plasmid Isolation Kit (Roche 11754785001) or a NucleoSpin Plasmid 
QuickPure kit (Macherey-Nagel 740727.250).  Purified plasmid DNA samples were 
sequenced and stored at 4
o
C. 
 
2.5 Template DNA synthesis 
 
Template DNA was synthesised from Ets1, MMP and VEGFR plasmid minipreps by 
combining 0.5μl plasmid DNA with 21.5μl H2O, 25.0μl 2x Biomix Red (Bioline 
BIO-25006), 2.0μl DMSO and 0.5μl each of the M13 forward and reverse primers 
(5'CCAGGGTTTTCCCAGTCACG and 5'TCACACAGGAAACAGCTATG, 
respectively; GIBCO by Life Technologies), then conducting PCR with the 
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following parameters: 1' 95
o
C; 5x (15" 95
o
C, 15" 65
o
C, 2' 72
o
C); 25x (15" 95
o
C, 15" 
50
o
C, 2' 72
o
C); 8' 72
o
C.  Templates were then purified using a High Pure PCR 
Product Purification Kit (Roche 11732676001) or a NucleoSpin Gel and PCR Clean-
up kit and stored at 4
o
C.  Mef2c template DNA was gifted from Dr. Dietrich, 
University of Portsmouth. 
 
2.6 Antisense RNA probe synthesis for ISH 
 
Antisense RNA probes were synthesised from Ets1, Mef2c, MMP and VEGFR DNA 
templates by incubating 3.0μl template with 37.5μl H2O, 5.0μl 10x transcription 
buffer (Roche), 2.0μl DIG RNA labelling mix (Roche; 11277073910), 0.5μl 
Protector RNase inhibitor (Roche 03335399001) and either T7 (for Ets1, MMPs, 
VEGFRs; Roche 10881767001) or T3 (for Mef2c; Roche 11031163001) RNA 
polymerase for 2 hours at 37
o
C.  A volume of 2μl DNase I (RNase free, Roche 
04716728001) was then added to each sample, which were incubated for a further 15 
minutes at 37
o
C.  RNA probes were purified using a SigmaSpin Sequencing 
Reaction Clean-up Kit (Sigma-Aldrich S5059) and stored at -20
o
C. 
 
2.7 Incubation and preparation of G. gallus embryos for ISH and IHC   
 
Chicken eggs were acquired from Henry Stewart & Co. Ltd. and incubated to the 
required developmental stage according to Hamburger & Hamilton (1951) at 38.5
o
C 
in a humidified incubator.  Embryos were harvested in phosphate-buffered saline 
(PBS) and fixed in 4% paraformaldehyde/PBS (PFA/PBS) for at least 24 hours at 
4
o
C.  The embryos were prepared to allow for the diffusion of solutions through the 
tissues during the whole-mount ISH and IHC protocols.  A small incision was made 
to the forebrain of the youngest embryos, up to stage HH13.  Stage HH14-16 
embryos were prepared by removing the left eye and opening the hindbrain, while 
stage HH17-22 embryos were prepared by removing both lens and the left 
telencephalic vesicle, piercing the heart and otic vesicles and opening the hindbrain.  
Embryos older than stage HH22 had both eyes and the telencephalon removed to 
ensure an open passage to the midbrain.  A small hole was cut into the posterior 
midbrain to the right of the midline for the removal of air bubbles and the hindbrain 
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was also opened.  Finally, the majority of the trunk was removed by cutting posterior 
to the otic vesicles.   
 
2.8 Whole-mount ISH protocol 
 
Whole-mount ISH was used to detect endothelial cells by identifying the spatial and 
temporal expression of Ets1 and Mef2c, together with MMP and VEGFR expression 
in G. gallus embryos.  Embryos fixed in 4% PFA/PBS were washed in PBS with 
0.1% Tween-20 (PBT) and dehydrated in 25% MeOH, 50% MeOH then 75% MeOH 
in PBS before bleaching in 6% H2O2/MeOH for 1 hour at 4
o
C, rinsing in MeOH and 
storing overnight at -20
o
C.  Embryos were rehydrated in 75% MeOH, 50% MeOH 
then 25% MeOH in PBS and washed in PBT before washing three times in detergent 
mix (1% IGEPAL, 1% SDS, 0.5% deoxycholate, 50mM Tris-HCl pH8, 1mM 
EDTA, 150mM NaCl) for 20 minutes each time, re-fixing in 4% PFA/PBS for 20 
minutes and rinsing twice in PBT.  Equilibration in pre-hybridisation mix (50% 
formamide, 5x SSC, 2% SDS, 2% BBR, 250μg/ml RNA, 100μg/ml heparin) was 
conducted for 1 hour at 65
o
C prior to overnight incubation with hybridisation mix, 
containing the antisense DIG-labelled RNA probe (10μl/ml), at 65oC.  The following 
day, embryos were rinsed in Solution X (50% formamide, 2x SSC pH4.5, 1% SDS), 
washed four times with Solution X for 30 minutes each time at 65
o
C, before rinsing 
and washing twice in MABT (1x MAB [1 M maleic acid, 1.5 M NaCl], 0.1% 
Tween-20) for 30 minutes each time.  Embryos were left to equilibrate in MABT/2% 
BBR/20% serum for 1 hour before incubating with anti-DIG alkaline phosphatase 
(AP)-conjugated antibody (1:2000; Roche 11093274910) in MABT/2% BBR/20% 
serum for three nights at 4
o
C.  After rinsing three times in MABT, embryos were 
washed extensively with seven changes of MABT for 1 hour each wash before 
leaving in MABT overnight at 4
o
C.  The following day, embryos were washed twice 
in NTMT pH9.5 (0.5mg/ml Levamisole, 100mM NaCl, 100mM Tris-HCl pH9.5, 
50mM MgCl2, 1% Tween-20) for 10 minutes each time and staining was initiated by 
adding the substrate nitro-blue tetrazolium/5-bromo-4-chloro-3'-indolyphosphate 
(NBT/BCIP; Roche 11681451001) to NTMT (2μl/ml).  Once the blue signal was 
sufficiently strong, staining was stopped by washing in NTMT for 10 minutes and 
then rinsing and washing twice in PBT for 10 minutes each time before fixing 
overnight in 4% PFA/PBS at 4
o
C.  Embryos that did not undergo IHC following ISH 
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were washed in PBS before either embedding in 20% gelatin/PBS for vibratome 
sectioning or washed in 20% glycerol, 50% glycerol then 80% glycerol in PBS for 
long-term storage. 
 
2.9 Whole-mount IHC - DAB staining and fluorescence 
 
Embryos undergoing whole-mount IHC following ISH were washed three times in 
PBS for 10 minutes each time and equilibrated in PBS/5% serum/1% Triton X-100 
for 30 minutes, before incubating with the primary antibody in PBS/10% serum/1% 
Triton X-100/0.02% Na-azide for 4 nights at 4
o
C.  Embryos that had been fixed in 
4% PFA/PBS undergoing whole-mount IHC without ISH were instead washed three 
times in PBS for 1 hour each time, bleached overnight in PBS/5% serum/1% Triton 
X-100/0.1% H2O2 at 4
o
C then washed three times in PBS/5% serum/1% Triton X-
100 for 1 hour each time at 4
o
C, before incubating with the primary antibody as 
described above.  All embryos were then washed three times in PBS/1% serum/1% 
Triton X-100 for 1 hour each time at 4
o
C and incubated with the horseradish 
peroxidase (HRP)-conjugated secondary antibody in PBS/5% serum/1% Triton X-
100 overnight at 4
o
C.  The next day, embryos were again washed at 4
o
C, three times 
in PBS/1% serum/1% Triton X-100 for 1 hour each time and twice in 100mM Tris-
HCl pH7.5 for half an hour each time, before equilibrating in inactive 
diaminobenzidine (DAB; ACROS Organics AC328005000, Alfa Aesar J60972) as 
substrate in 100mM Tris-HCl pH7.5 (10 mg/20 ml) filtered with 0.22μm Millex-GP 
syringe filter (Merck Millipore) for 3 hours at 4
o
C in the dark.  Staining was initiated 
by incubating with DAB solution activated with 30% H2O2 (0.6μl 30% H2O2/ml 
inactive DAB) at RT in the dark.  Once the brown signal was sufficiently strong, 
staining was stopped by rinsing three time with tap water and washing twice in PBT 
for 20 minutes each time before fixing overnight in 4% PFA/PBS at 4
o
C.  Embryos 
were then washed in PBS before either embedding in 20% gelatin/PBS for vibratome 
sectioning or washed in 20% glycerol, 50% glycerol then 80% glycerol in PBS for 
long-term storage.  Refer to Table 2i for information regarding primary and 
secondary antibodies. 
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Table 2i. Primary and secondary antibodies.  Antibodies used in ISH, IHC and 
ISZ experiments are provided together with working concentrations and suppliers. 
 
Antibodies Concentration Supplier details 
Primary Antibodies:   
TuJ1 1:2000 R&D Biosystems MAB1195, mouse 
Phosphohistone H3 1:500 EMD Millipore 06-570, rabbit 
Anti-CD34 (AV138) 1:1000 Bio-Rad MCA5936GA, mouse 
Anti-HNK-1/N-CAM 
(CD57) 
1:500 Sigma-Aldrich C6680, mouse 
Anti-laminin (avian) 1:500 Hybridoma bank 3H11, mouse 
Fibronectin (avian) 1:500 Hybridoma bank B3/D6, mouse 
α6 integrin (avian) 1:200 Hybridoma bank P2C62C4, mouse 
β1 integrin (avian) 1:500 Hybridoma bank V(2)E(9), mouse 
Anti-GFP 1:1000 Invitrogen A6455, rabbit serum 
Secondary Antibodies:   
Peroxidase-conjugated 
AffiniPure goat anti-
mouse IgG + IgM 
1:100 Jackson ImmunoResearch  
115-035-044 
Alexa Fluor
®
 546-
conjugated goat anti-
mouse IgG 
1:200 Invitrogen A-11003 
Alexa Fluor
®
 488-
conjugated goat anti-
rabbit IgG 
1:200 Jackson ImmunoResearch  
111-545-003 
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2.10 Gelatin embedding and vibratome sectioning of G. gallus embryos 
 
Embryos in 4% PFA/PBS were washed three times in PBS for 10 minutes each time 
before equilibrating in 20% gelatin/PBS for 2 hours at 65
o
C.  The embryos were 
transferred to embedding moulds containing 20% gelatin/PBS and positioned into 
the correct orientation before the gelatin cooled and solidified.  Gelatin blocks 
containing the embedded embryos were removed from the moulds and fixed in 4% 
PFA/PBS at 4
o
C for at least 5 nights before sectioning.  Sections of 30μm thickness 
were cut using a Leica VT1000 S vibratome and mounted on glass slides with 100% 
glycerol.  Sections of 60μm thickness were cut from embryos that underwent 
fluorescent immunostaining before mounting on glass slides with an aqueous 
mounting medium.  
 
2.11 LHC on X. laevis sections 
 
X. laevis embryos collected from the European Xenopus Resource Centre (EXRC) 
were de-jellied in 2% cysteine pH7.9 then washed extensively with 1x MBS.  
Embryos between stages 40 to 50 (Nieuwkoop & Faber, 1956) were collected by 
anaesthetising in 0.025% tricaine methanesulfonate (MS-222) before fixing in 1x 
MEMFA (0.1M MOPS pH7.4, 2mM EGTA pH8, 1mM Mg2SO4, 3.7% 
formaldehyde) for 1 hour.  Embryos were washed three times in MeOH then stored 
in MeOH overnight at 20
o
C.  The rehydration of embryos proceeded with successive 
washes in 75% MeOH, 50% MeOH, 25% MeOH in PBT and a 5-minute PBT wash 
before bleaching (5% formamide, 0.5x SSC pH4.5, 10% H2O2) atop a light box.  
Embryos were washed twice in PBT for 5 minutes each time before equilibrating in 
20% gelatin/PBS for 1 hour at 65
o
C.  The embryos were transferred to embedding 
moulds containing 20% gelatin/PBS and positioned into the correct orientation 
before the gelatin cooled and solidified.  Gelatin blocks containing the embedded 
embryos were removed from the moulds and fixed in 4% PFA/PBS at 4
o
C for at 
least 5 nights before sectioning.  Sections of 100μm thickness were cut using a Leica 
VT1000 S vibratome and transferred to a 24-well plate containing 4% PFA/PBS.  
Sections were washed twice in PBS for 5 minutes each time and PBT for 30 minutes 
then equilibrated in PBT/20% serum for 1 hour prior to overnight incubation with 
biotinylated Lycopersicon esculentum (Tomato) lectin (LEL) 1:200 (Vector 
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Laboratories B-1175) in PBT/20% serum/0.02% Na-azide at 4
o
C.  The following 
day, sections were washed extensively with five changes of PBT for 30 minutes each 
wash and PBT/20% serum for 1 hour.  Sections were incubated overnight in HRP-
conjugated streptavidin 1:200 (Vector Laboratories SA-5004) in PBT/20% serum at 
4
o
C then washed extensively in PBT the next day, followed by a 30-minute wash in 
100mM Tris-HCl pH7.5.  After equilibrating in inactive DAB solution for 30 
minutes at 4
o
C in the dark, staining was conducted with active DAB as previously 
described.  Sections were fixed overnight in 4% PFA/PBS at 4
o
C and washed in PBS 
the next day before successive washes in 20%, 50% and 80% glycerol/PBS.  
Sections were then mounted on slides with 80% glycerol/PBS prior to microscope 
analysis. 
 
2.12 Bead experiments with MMP inhibitors, active MMP-1 and Notch inhibitor, 
 followed by IHC 
 
Bead implantation experiments were conducted on stage HH22 G. gallus embryos to 
investigate the effects of ARP 100 (Santa Cruz Biotechnology sc-203522), SB-3CT 
(Santa Cruz Biotechnology sc-205847), Batimastat BB-94 (Tocris 2961), active 
MMP-1 (gifted from Dr. Pickford, University of Portsmouth, dialysed using a Pierce 
7K MWCO Slide-A-Lyzer Dialysis Cassette [ThermoFisher Scientific 66372] in 1L 
of 100mM Tris-HCl pH7.5 as buffer) and DAPT (Insight Biotechnology CAS 
208255-80-5) on vascularisation.  Acrylic beads were soaked in reagents for at least 
one hour prior to implantation and all eggs were disinfected with 70% EtOH before 
removing 1.5ml albumin from each egg and cutting a window from the shell.  
Embryos were hydrated with 50 units penicillin and 50μg streptomycin/ml PBS.  A 
single bead was implanted in ovo into the head mesoderm on the right side of each 
embryo, positioned just beneath the surface ectoderm adjacent to the ventral 
midbrain.  The shell was placed back into position to cover the exposed embryo and 
eggs were incubated for a further 29 hours at 38.5
o
C then harvested in PBS at stage 
HH26 (Fig. 2ii, A-B).  Embryos were fixed overnight in 4% PFA/PBS at 4
o
C before 
undergoing IHC with CD34 to detect endothelial cells, followed by embedding in 
20% gelatin/PBS, vibratome sectioning and microscope analysis.  The number of 
endothelial cells were then counted on the side containing the bead and was 
compared with the contra lateral control side of each embryo (Fig. 2ii, C).  A paired 
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t-test was performed for each control and experimental condition using Minitab 17 in 
order to determine if there was a significant difference in the number of endothelial 
cells present within the brain in the control side compared to the side exposed to a 
pharmacological inhibitor or active MMP-1. 
 
MMP inhibitors ARP 100 and SB-3CT were used at a concentration of 8mM in 
either DMSO or PBS, and Batimastat was used at a concentration of 1mM in 
DMSO.  Active MMP-1 was used at 25nM and 1μM concentrations in 100mM Tris-
HCl pH7.5 dialysis equilibration buffer.  The Notch inhibitor DAPT was used at a 
concentration of 10mM in DMSO.  Control experiments involved implanting beads 
soaked in the relevant buffer excluding the inhibitor or active MMP-1.   
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Figure 2ii.  Bead placement for bead implantation studies and method for cell 
counting.  The activity of enzymes and signalling molecules is altered by implanting 
acrylic beads soaked in a pharmacological inhibitor (ARP100, SB-3CT, Batimastat 
or DAPT) or active MMP-1 into the mesoderm just beneath the surface ectoderm 
adjacent to the basal plate of the midbrain.  The beads are implanted into stage HH22 
chick embryos in ovo (A, blue asterisk), which are then incubated to stage HH26 (B).  
Harvested embryos undergo further analysis, for example, immunostaining with a 
CD34 antibody to detect endothelial cells.  Endothelial cells are counted within the 
ventral half of the midbrain on the side containing the bead and compared with the 
contra lateral control side, down to the horizontal line posterior to the bead in all 
sections in which the bead is detected (C).  Scale bar = 250μm.   
 
 
 
 
 
 
 
 
 
81 
 
2.13 Roller culture experiments  
 
G. gallus embryos were harvested at stage HH8 and cultured ex ovo using a modified 
Cornish pasty method (Fig. 2iii, MC method, Nagai et al., 2011) in which each 
embryo is folded along the axis parallel to the primitive streak.  Embryos were 
transferred to L15 medium containing 10% chick serum, gentamicin (30μg/ml) and 
either 1μM or 10μM ARP 100 and rolled in an incubator for 40 hours at 37oC.  
Embryos were then removed and fixed overnight in 4% PFA/PBS before conducting 
whole mount IHC, as previously described, with an anti-HNK-1 antibody.  Embryos 
were then embedded in 20% gelatin/PBS and fixed in 4% PFA/PBS at 4
o
C for at 
least 5 nights before cutting 30μm sections with a vibratome.  Control embryos were 
roller cultured in DMSO then underwent IHC with an anti-HNK-1 antibody for 
comparison with experimental embryos. 
 
2.14 Whole-mount ISZ with DQ gelatin, followed by IHC 
 
G. gallus embryos were harvested at stage HH26 in ice cold PBS, fixed in 4% 
PFA/PBS for 15 minutes at 4
o
C then washed in PBS.  Incisions were made to the 
telencephalic vesicles before removing the heads and incubating in 20μg/ml 
fluorescein-conjugated DQ™ Gelatin (Molecular Probes D12054) in reaction buffer 
at pH7.5 (150mM NaCl, 5mM CaCl2, 0.02% NaN3, 50mM Tris-HCl pH7.5) for 24 
hours in a dark, humidified chamber at 37
o
C.  Control embryos were either incubated 
in reaction buffer alone or 10mM EDTA in reaction buffer.  Samples were then 
washed extensively with eight changes of PBS for 30 minutes each wash and fixed 
overnight in 4% PFA/PBS at 4
o
C in the dark.  Whole-mount fluorescent IHC was 
conducted with all steps performed at 4
o
C in the dark.  The samples were washed 
three times in PBS and twice in PBS/5% serum/1% TritonX-100 for 1 hour each 
time before incubating with CD34 (1:1000) in PBS/10% serum/1% Triton X-
100/0.02% Na-azide for 4 nights.  The following day, the samples were washed three 
times in PBS/1% serum/1% TritonX-100 for 1 hour each time then incubated 
overnight in Alexa Fluor
®
 546 conjugated-goat anti-mouse secondary antibody 
(1:200) in PBS/5% serum/1% TritonX-100.  Washes were conducted with PBS/1% 
serum/1% TritonX-100 for 1 hour each time before fixing overnight in 4% PFA/PBS 
then embedding in 20% gelatin/PBS and cutting 60μm sections with a vibratome. 
82 
 
 
 
Figure 2iii.  MC method for roller culture experiments.  The embryo is folded 
along the axis parallel to the primitive streak to form a half-moon shape.  Once in 
culture medium, fluid transport causes the embryo to inflate and rise to the surface of 
the medium, whilst maintaining epiblast tension required for early development 
(Nagai et al., 2011; Riken, 2011).  
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2.15 VEGFA RT-PCR  
 
Total RNA was isolated from whole G. gallus embryos between stages HH11-21 of 
development, or from the head only at stages HH21-28, using an RNeasy Protect 
Mini Kit (Qiagen 74124) immediately after harvesting.  Genomic DNA was 
removed from RNA preparations with a DNase I digest followed by purification 
using a SigmaSpin Sequencing Reaction Clean-Up Kit (Sigma-Aldrich) before 
storing at -70
o
C.  The synthesis of cDNA from total RNA was conducted for each 
developmental stage using a Transcriptor High Fidelity cDNA Synthesis Kit (Roche 
05091284001).  The cDNA was then used as template to amplify VEGFA in PCR 
with nested primers by combining 1.0μl of stage-specific cDNA with 10.5μl H2O, 
12.5μl 2x Pwo master mix (Roche) and 0.5μl each of the outer forward primer 
(cVEGF_F1 GGAGACCCCGAAGAGGAGAC) and outer reverse primer 
(cVEGF_R1  TGTCCAGGCGAGAAATCAGG) at 100 pmol/μl.  The PCR was 
conducted with the following parameters: 1' 95
o
C; 5x (15" 95
o
C, 15" 60
o
C, 2' 72
o
C); 
25x (15" 95
o
C, 15" 55
o
C, 2' 72
o
C); 15' 72
o
C.  Inner primers that were designed to 
amplify particular groups of VEGFA isoforms depending on the presence of exons 6 
and 7, were then used in three separate reactions by combining 1.0μl of PCR product 
with 10.5μl H2O, 12.5μl 2x Pwo master mix and 0.5μl each of the inner forward and 
reverse primers at 100pmol/μl.  The forward primers cVEGFA_Ex4_F 
AACCCCATCAGAGTCAGCAC and cVEGFA_Ex6_F 
ATCAAAGCGAGGAAAGGGGA were combined with reverse primers 
cVEGFA_Ex8_R CTTCTTTTCCGCTGCTCACC and cVEGFA_Ex7_R 
GCGCTCGTTTAACTCAAGCT in the following three reactions: set A- Exon4_F, 
Exon8_R (all isoforms), set B- Exon4_F, Exon7_R (isoforms with exon 7) and set 
C- Exon6_F, Exon7_R (isoforms with both exons 6 and 7).  The PCR was conducted 
with the following parameters: 1' 95
o
C; 5x (15" 95
o
C, 15" 60
o
C, 1' 72
o
C); 25x (15" 
95
o
C, 15" 57
o
C, 1' 72
o
C); 15' 72
o
C.  The PCR2
A
, PCR2
B
 and PCR2
C
 products were 
gel purified using a NucleoSpin Gel and PCR Clean-up kit (Macherey-Nagel) or a 
High Pure PCR Product Purification Kit (Roche) and stored at 4
o
C.   
 
The purified PCR2 products were then blunt-end cloned in pCR
TM
 Blunt II-TOPO
®
 
vector a using a Zero Blunt
®
 TOPO
®
 PCR Cloning Kit (Invitrogen 450245) and 
were stored on ice prior to transformation of α select chemically competent cells 
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(Bioline) as previously described.  Plating on LB agar/kanamycin, inoculations and 
minipreps were also conducted as previously described.  Screening for recombinants 
was performed with EcoRI restriction digests or by PCR amplification using M13 
primers with the following parameters: 1' 95
o
C; 5x (15" 95
o
C, 15" 65
o
C, 2' 72
o
C); 
25x (15" 95
o
C, 15" 50
o
C, 2' 72
o
C); 8' 72
o
C.  Purified plasmid DNA samples were 
sequenced and stored at 4
o
C. 
 
2.16 Electroporation of Shh into the G. gallus mesencephalon, followed by IHC 
     
Electroporation experiments were conducted on stage HH11-12 G. gallus embryos to 
investigate the effect of altering neural patterning on brain vascularisation.  All eggs 
were disinfected with 70% EtOH before removing 1.5ml albumin from each egg, 
cutting a window from the shell and hydrating the embryos with 50 units penicillin 
and 50μg streptomycin/ml PBS.  The vitelline membrane was removed from the 
anterior end of the embryo and both pXEX-Shh (1mg/ml; gifted from Prof. Cliff 
Ragsdale; Agarwala et al., 2001) and pCAG-GFP (0.5mg/ml; gifted from Dr. 
Jonathon Gilthorpe; Yaneza et al., 2002) expression constructs, together with 0.1% 
fast green dye loaded in a glass needle (settings: 990, 900, 770; Sutter Instrument P-
30 vertical needle puller), were injected into the mesencephalon.  The constructs 
were electroporated into the left side of the mesencephalon using an Intracel TSS20 
Ovodyne electroporator with the following settings applied for the current: 12.5V, 3 
pulses, 20ms width, 100ms space.  Control embryos were either unelectroporated or 
electroporated with only the GFP construct.  Embryos were rehydrated and the shell 
was placed back into position.  Eggs were incubated for a further 72 hours at 38.5
o
C, 
harvested in PBS and fixed overnight in 4% PFA/PBS at 4
o
C (Fig. 2iv). 
 
Fluorescent immunostaining was conducted with CD34 to detect endothelial cells 
and anti-GFP to identify cells that had successfully taken up the expression 
constructs.  Embryos were then fixed in 4% PFA/PBS for an hour and a half before 
embedding in 20% gelatin/PBS for 4 nights and sections of 60µm were cut using a 
vibratome.  Sections were mounted on glass slides with aqueous mounting medium. 
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Figure 2iv.  Schematic of electroporation experiments.  Eggs were windowed and 
embryos at stage HH11-12 were hydrated with PBS containing penicillin and 
streptomycin before injecting expression constructs for pXEX-Shh and pCAG-GFP, 
together with fast green dye, into the mesencephalon.  The constructs entered the left 
side of each embryo upon application of the current.  Control embryos were either 
unelectroporated or electroporated with only the GFP construct.  The eggs were then 
incubated for a further 72 hours at 38.5
o
C before harvesting. 
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2.17 Microscope analyses 
 
Whole and sectioned embryos were visualised and analysed following DAB or 
fluorescent IHC using a Zeiss Axio Zoom.V16 microscope with ZEN imaging 
software and a Nikon Eclipse E800 microscope.  Image editing was performed using 
Jasc PaintShop Pro 8 photo editing software. 
87 
 
3. ANATOMICAL CHARACTERISATION OF VASCULAR 
 INGRESSION INTO THE EMBRYONIC VERTEBRATE BRAIN 
 
The investigation into vascular ingression in the embryonic vertebrate brain has 
focused on characterising both the anatomy and molecular control involved in the 
ingression process.  Extensive research into blood vessel patterning events of the 
neural tube previously conducted in avian embryos, mainly through studies of the 
spinal cord (Kurz et al., 1996; James et al., 2009), support the choice of G. gallus as 
the main model organism for analysing events in the brain, with comparative 
anatomical work conducted in X. laevis.  
 
The ingressing endothelial cells are presented with a number of challenges as they 
enter the brain and subsequently form a new capillary network.  The cells must switch 
to a migratory behaviour, leading to the formation of the PNVP, before penetrating the 
basal lamina of the brain and navigating radially between the cells in the 
neuroepithelium.  The ependymal layer must then be recognised by the endothelial 
cells as a signal to branch and fuse to form the INVP.  The process of vascularisation 
has been studied in the spinal cord of avian embryos (Kurz et al., 1996; Hogan et al., 
2004; James et al., 2009) but very little work has been conducted in the rostral brain.  
A detailed anatomical description of vascular ingression was therefore conducted in 
order to document the spatial and temporal location of endothelial cells involved in the 
ingression process of the G. gallus brain during early embryonic development.   
 
3.1 Brain vascularisation involves endothelial cell migration, PNVP formation, 
 sprouting and INVP formation 
 
The ETS transcription factors are major regulators of vascular development and 
almost all endothelial-specific genes contain the ETS DNA binding site.  The ETS 
gene, Ets1, is expressed in endothelial cells and is important for the regulation of 
angiogenesis as it has been shown to induce the expression of uPA, MMP-1, MMP-3 
and MMP-9 and also controls cell migration by regulating the expression of αv 
integrins, β2 and β3 integrins, ICAMs and VE cadherin (Iwasaka et al., 1996; Sato, 
1998; Kita et al., 2001).  Whole-mount ISH was therefore performed in G. gallus 
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embryos to stain endothelial cells blue using an antisense probe against Ets1.  ISH 
was coupled with IHC using a TuJ1 antibody against neuron-specific Class III β-
tubulin to stain neurons brown in order to identify if the position of the differentiated 
neurons correlates with the position of the developing PNVP or the points at which 
the endothelial sprouts invade the brain.  The embryos were then embedded in 
gelatin and sectioned with a vibratome through the prosencephalon, mesencephalon 
and rhombencephalon as indicated in Fig. 3i.   
 
Ets1-positive cells were seen migrating above and below the level of the somites 
towards the left and right sides of the anterior spinal cord at stage HH11 (Fig. 3ii, A).  
The PNVP began to form at stage HH13 as Ets1-positive cells were identified close 
to the neural tube and lined up against the mesencephalon as the embryos grew to 
stage HH15 (Fig. 3ii, B-C, arrows).  However, the PNVP did not appear to develop 
in correlation with the position of the differentiated neurons.  The first ingressing 
endothelial cells were identified as Ets1-positive cells appeared in the formation of 
narrow individual sprouts that had penetrated the basal lamina of the brain and 
invaded the ventral mesencephalon and rhombencephalon at stage HH21 (Fig. 3iii, A 
and C, arrows).  The staining of the PNVP appeared dark and thick as numerous 
endothelial cells were present around the mesencephalon at this stage.  The dorsal 
migration of isolated angioblasts, however, could not be detected using the antisense 
Ets1 probe between stages HH19 and HH26 of development (Fig. 3iv, C).  Sprouting 
continued throughout the mesencephalon at stage HH26 (Fig. 3iii, A, arrows), 
whereas sprouting into the diencephalon first began at this developmental stage (Fig. 
3iv, B, arrow).  The location at which endothelial sprouts invaded the brain did not 
appear to correlate with the position of the differentiated neurons.  Upon reaching 
the ependymal layer, Ets1-positive cells were not seen to migrate farther towards the 
ventricular zone.  Instead, Ets1-positive cells began to branch and continued to 
migrate in a different direction, parallel with the ventricular surface of the brain, 
leading to the initiation of INVP formation through the anastomosis of neighbouring 
sprouts, which was first observed in both the ventral mesencephalon and 
rhombencephalon at stage HH24 (Fig. 3iii, B-C, arrows).  The sprouting process 
initiated as a single specialised endothelial cell, referred to as the tip cell, penetrated 
the basal lamina.  Multiple stalk cells were seen aligned behind the tip cell, which 
leads the endothelial sprout into the brain (Fig. 3v, arrowheads).    
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Figure 3i.  Planes of sectioning following whole-mount ISH and IHC.  
Endothelial cells (blue) and neurons (brown) were detected with an antisense Ets1 
probe and a TuJ1 antibody against neuron-specific Class III β-tubulin antibody, 
respectively.  Embryos were embedded in 20% gelatin/PBS before cutting 30μm 
sections through the prosencephalon (A), mesencephalon (B) and rhombencephalon 
(C) using a vibratome.  Typical sections taken through a stage HH22 chick embryo 
from each plane are displayed on the right (D). 
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Figure 3ii.  Endothelial cell migration and PNVP formation.  Endothelial cells 
(blue) and neurons (brown) were detected with an antisense Ets1 probe and a TuJ1 
antibody, respectively.  A. Endothelial cells can be seen migrating towards the neural 
tube at stage HH11 of chick development and the formation of the PNVP around the 
mesencephalon begins thereafter at stage HH13 (B, arrow).  The PNVP continues to 
develop around the mesencephalon at stage HH15 (C, arrow).  Scale bar = 50μm. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3iii.  Vascularisation of the G. gallus mesencephalon and 
rhombencephalon using ISH with an Ets1 antisense probe and IHC with a TuJ1 
antibody.  Endothelial cells (blue) and neurons (brown) were detected in the basal 
plate of the mesencephalon (A), ventral mesencephalon (B) and rhombencephalon (C) 
of stage HH19-26 chicken embryos.  Endothelial cell sprouting into the brain is first 
observed in the ventral mesencephalon and rhombencephalon at stage HH21 (A and 
C, arrows), continuing in the basal plate of the mesencephalon at stage HH26 (A, 
arrows).  The formation of the INVP is seen to begin in both the ventral 
mesencephalon and rhombencephalon at stage HH24 (B-C, arrows).  HH19 n=3; 
HH21 n=3; HH24 n=8; HH26 n=7.  Scale bar = 50µm.   
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Figure 3iv.  Vascularisation of the G. gallus prosencephalon and mesencephalon 
using ISH with an Ets1 antisense probe and IHC with a TuJ1 antibody.  
Endothelial cells (blue) and neurons (brown) were detected in the telencephalon (A), 
diencephalon (B), dorsal (C) and alar plate (D) of the mesencephalon of stage HH19-
26 chicken embryos.  Endothelial cell sprouting begins in the diencephalon at stage 
HH26 (B, arrow), occurring later than the rest of the brain.  Ingression into the alar 
plate of the mesencephalon can be seen at the same developmental stage (D, arrows).  
HH19 n=3; HH21 n=3; HH24 n=8; HH26 n=7.  Scale bar = 50µm.   
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Figure 3v.  The arrangement of tip and stalk cells within endothelial sprouts.  
Endothelial cells in the diencephalon at HH26 were detected with an antisense Ets1 
probe using whole-mount ISH and are stained blue.  A single specialised endothelial 
cell, referred to as the tip cell (arrowheads), leads each sprout through the basal 
lamina into the brain.  The tip cell is followed by a number of stalk cells during 
ingression.  Scale bar = 10µm.    
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3.2 Fibronectin expression occurs in close proximity to invading endothelial cells  
 
Since endothelial cells are known to synthesise fibronectin, which is suggested to 
mediate the adherence of migrating endothelial cells (Clark et al., 1986; Peters et al., 
1990), Ets1 staining was coupled with IHC to identify the location of fibronectin in 
relation to vascular ingression (Fig. 3vi).  Fibronectin was not detected prior to the 
initiation of ingression at stage HH19, but as Ets1 was detected in endothelial cells 
that began to ingress into the ventral mesencephalon at stages HH21 and HH22, the 
staining patterns indicated the presence of fibronectin in close proximity to the 
invading sprouts.  The co-localisation of endothelial cells and fibronectin within the 
mesencephalon became more apparent at stage HH24 as staining appeared darker, 
particularly in the region of the INVP.  The staining for fibronectin continued to 
increase in abundance and strength as the internal capillary network continued to 
develop at stage HH26.       
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Figure 3vi.  Time-course analysis of fibronectin production within the midbrain 
of stage HH19-26 G. gallus embryos.  Endothelial cells (blue) are detected using 
whole-mount ISH with an Ets1 antisense probe, coupled with IHC using the 
fibronectin antibody B3/D6 (n=1 for each stage).  Fibronectin is detected together 
with the invading sprouts when ingression into the ventral midbrain begins at stage 
HH21 and  is also present in the basal lamina.  The ingressing endothelial cells are 
likely to produce fibronectin as staining is present in close proximity to the location 
of vessel sprouts and coordinates with the developing INVP as the embryos grow.  
Scale bar = 50μm.  
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3.3 The detection of Mef2c and CD34 can also be used to identify the location of 
 endothelial cells during brain vascularisation  
 
Sprouting angiogenesis involves the specific induction of the transcription factor 
Mef2c by Ets1, which is mediated by A2M, resulting in a strong inhibitory effect on 
angiogenic sprouting in order to prevent excess angiogenesis when local oxygen 
concentration is sufficient following neovascularisation (De Val et al., 2004; Hickey 
& Simon, 2006; Sturtzel et al., 2014).  Whole-mount ISH with an antisense probe 
against Mef2c was therefore also performed in G. gallus embryos to label 
endothelial cells at stages HH19-26 of development.  Following gelatin embedding 
and sectioning, Mef2c-positive cells were seen migrating into the dorsal 
prosencephalon at stage HH19 (Fig. 3vii, B, arrows) and in the mesencephalon at 
stage HH21 (Fig. 3vii, C, arrow).  Since Ets1 induces Mef2c expression it is 
interesting that isolated angioblasts migrating into the dorsal brain were Mef2c-
positive but could not be detected with the antisense Ets1 probe.  It may be possible 
that Ets1 was expressed at a level too low for detection using ISH or that Mef2c was 
induced by an unknown factor at this stage.  Similar to the staining achieved with the 
antisense Ets1 probe, the initiation of sprouting was also detected at stage HH21 as 
Mef2c-positive cells were seen invading the ventral mesencephalon (Fig. 3viii, A-B, 
arrows).  Sprouting was also seen to begin in the telencephalon at stage HH26 (Fig. 
3vii, A, arrow).  The branching and fusion of Mef2c-positive sprouts, indicating the 
formation of the INVP, was clearly visible in the ventral mesencephalon and 
rhombencephalon at stage HH24 (Fig. 3viii, B-C, arrowheads).  Comparing the 
staining patterns of Ets1 and Mef2c, the expression of Ets1 was more diffuse 
throughout the PNVP, whereas Mef2c appeared to be expressed more specifically in 
individual cells that were discernible within the PNVP (Fig. 3ix).  A summary of the 
ingression process is provided in Fig. 3x that documents the earliest stage at which 
each event was detected, including the formation of the PNVP and endothelial 
sprouting.  The subsequent formation of the INVP was detected at stage HH28 as an 
extensive capillary network was seen developing throughout the mesencephalon 
(Fig. 3x, M).  A schematic summary showing the progression of vascularisation of 
the embryonic G. gallus brain is also provided in Fig. 3xi.  
 
 
Figure 3vii.  Vascularisation of the G. gallus prosencephalon and mesencephalon 
using ISH with a Mef2c antisense probe.  Endothelial cells (blue) were detected in 
the telencephalon (A), diencephalon (B), dorsal (C) and alar plate (D) of the 
mesencephalon of stage HH19-26 chicken embryos.  The formation of the PNVP 
appears to continue between stages HH19 and HH24 of development.  Angioblasts 
begin to migrate into the diencephalon and dorsal mesencephalon at stages HH19 and 
HH21, respectively (B-C, arrows).  Endothelial cell sprouting into the telencephalon is 
also observed to begin at stage HH26 (A, arrow).  HH19 n=4; HH21 n=6 ; HH24 n=6 ; 
HH26 n=3.  Scale bar = 50µm. 
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Figure 3viii.  Vascularisation of the G. gallus mesencephalon and 
rhombencephalon using ISH with a Mef2c antisense probe.  Endothelial cells 
(blue) were detected in the basal plate of the mesencephalon (A), ventral 
mesencephalon (B) and rhombencephalon (C) of stage HH19-26 chicken embryos.  
Endothelial cell sprouting is first seen in the ventral half of the mesencephalon at stage 
HH21 (A-B, arrows).  The formation of the INVP is clearly visible in both the ventral 
mesencephalon and rhombencephalon at stage HH24 (B-C, arrowheads).  HH19 n=4; 
HH21 n=6 ; HH24 n=6 ; HH26 n=3.  Scale bar = 50µm. 
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Figure 3ix.  Ets1 and Mef2c expression in the PNVP of the mesencephalon.  
Embryos at stages HH21 and HH24 were stained using ISH to label endothelial cells 
blue with either an antisense Ets1 probe (left) or Mef2c probe (right).  Ets1 staining 
is coupled with  IHC using a TuJ1 antibody to label neurons brown.  The dense Ets1 
staining marks the location of the PNVP.  The expression of Mef2c is detected in 
individual cells within the PNVP, which is indicated by the discontinuous and more 
specific staining in this region.  Scale bar = 50µm. 
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Figure 3x.  Summary of events involved in the vascularisation of the G. gallus 
brain.  Embryos at stages HH11-28 were stained using ISH to label endothelial cells 
blue with either an antisense Ets1 or Mef2c probe in order to detect the earliest stage 
at which each event occurs.  Ets1 staining is coupled with  IHC using a TuJ1 
antibody to label neurons brown.  A. Endothelial cells are first seen migrating 
towards the anterior neural tube at HH11, leading to the start of PNVP formation 
around the mesencephalon by HH13 (B).  Dorsal migration of angioblasts occurs in 
the diencephalon at HH19 (C) and mesencephalon at HH21 (D).  Sprouting is first 
observed in both the ventral mesencephalon (E-F) and rhombencephalon (G-H) at 
stage HH21, continuing throughout the tectum at stage HH26 (I).  Sprouting in the 
prosencephalon begins later than in the mesencephalon and rhombencephalon, 
initiating at HH26 in both the diencephalon (J-L) and telencephalon (N-P).  The 
formation of the INVP begins as neighbouring sprouts anastomose in the ventral 
mesencephalon (Q-R) and rhombencephalon (S-T) at HH24, then throughout the 
tectum at stage HH28 (M).  Scale bar = 50µm (K-L = 10µm). 
Figure 3xi.  Schematic summary showing the progression of vascularisation of the 
embryonic G. gallus brain.  Lateral and transverse cross sections depict the major 
vascularisation events between stages HH11 and HH26 of chick development.  A. 
Endothelial cells migrate towards the mesencephalon at HH11, leading to the start of 
PNVP formation by HH13 (B).  C. Dorsal migration of angioblasts occurs in the 
diencephalon at HH19 and in the mesencephalon at HH21 (D), during which sprouting 
initiates in both the ventral mesencephalon and rhombencephalon.  E. The INVP 
begins to form in the ventral mesencephalon and rhombencephalon at HH24 and 
sprouting continues throughout the tectum at stage HH26 (F) when sprouts begin to 
invade the telencephalon and diencephalon. 
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IHC experiments using an anti-CD34 antibody were also used to detect the spatial 
and temporal location of endothelial cells as an alternative to ISH studies (Fig. 3xii).  
Ets1-staining appeared to be weaker within the sprouts compared to the PNVP, 
which may indicate the loss of Ets1 expression during ingression.  However, it is 
also possible that diffusion problems may have occurred in which the probe may not 
have been able to diffuse as readily through the brain tissue compared to the 
mesoderm and so access to the RNA by the probe may have been hindered.  It is 
therefore difficult to determine the precise time at which each event occurs during 
brain vascularisation using the method of ISH, particularly if gene expression levels 
fluctuate and diffusion problems occur as the embryos develop.  The staining of 
sprouts through the use of Mef2c ISH and CD34 IHC was comparable, although 
more cells present within the INVP were detected using the anti-CD34 antibody.  
The reliable identification of endothelial cells can therefore also depend on the 
chosen method of detection and the progress of vascularisation.   
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Figure 3xii.  The detection of endothelial cells using ISH and IHC methods.  A. 
Chick embryos are stained using ISH to label endothelial cells blue with either an 
antisense Ets1 probe or Mef2c probe.  Ets1 staining is coupled with IHC using a 
TuJ1 antibody to label neurons brown.  Scale = 10μm.  B.  Endothelial cells can be 
detected using whole-mount IHC with a CD34 antibody as a faster alternative to ISH 
experiments.  Visualisation is achieved with the addition of DAB substrate to the 
HRP-conjugated secondary antibody, staining endothelial cells brown.  The two 
methods can be used to successfully stain endothelial cells, particularly with the use 
of Ets1 for the PNVP, Mef2c and CD34 for the invading sprouts, and CD34 for the 
INVP.  Immunostaining experiments provide a versatile method for the spatial and 
temporal location of biomarkers in embryos and are useful for double-labelling 
studies involving fluorescent detection.  CD34 concentration used at 1:1000.  Scale = 
50μm. 
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3.4 Endothelial cell migration and PNVP formation occur earlier in the brain than 
 in the spinal cord 
 
The sequence of events involved in the vascularisation of the avian brain closely 
follows previous observations in quail and mouse as described in the literature.  In 
concordance with key research previously conducted in the quail spinal cord by Kurz 
et al. (1996) and James et al. (2009), the initiation of vascularisation occurs earlier at 
more anterior levels of the CNS with the PNVP forming around the brain at stage 
HH13 compared with the thoracic spinal cord at stage HH16.  The dorsal migration 
of angioblasts at HH19 and ventral sprouting at HH21 in both the brain and cervical 
spinal cord also occur slightly earlier than in the thoracic spinal cord at stage HH22.  
(Fig. 3xiii). 
 
The observation of these events initiating earlier at more anterior levels of the CNS 
likely reflects the importance of developing the complex structure and function of 
the brain, which requires a greater level of molecular control compared with the 
spinal cord.  Furthermore, as development progresses in an anterior to posterior 
direction, the brain continues to grow in size and may experience tissue hypoxia 
earlier than the spinal cord.  Studies conducted in mouse and rat indicate that 
angiogenesis is induced by exposure to hypoxia (Harik et al., 1995; Masamoto et al., 
2013), thus supporting the hypothesis that low oxygen concentrations resulting from 
growth in size of the brain leads to the initiation of angiogenesis.  The developing 
mouse hindbrain is a popular model for studying sprouting angiogenesis and the 
vascularisation of which appears to proceed in a similar pattern to that observed in 
the G. gallus brain, as sprouts from the PNVP grow radially towards the ventricular 
zone, migrate at near right angles and extend parallel to the surface of the hindbrain, 
leading to the formation of the SVP (Fantin et al., 2013). 
 
 
 
 
 
 
Figure 3xiii.  Comparison of spinal cord and brain vascularisation events in the 
avian embryo.  A. Schematic summary of the major blood vessel patterning events in 
the spinal cord of quail embryos.  A series of steps involved in the vascularisation 
process are described by the visualisation of endothelial cells through the use of QH1 
immunostaining by Kurz et al. (1996) at cervical level (B) and James et al. (2009) at 
thoracic level (C), compared with the vascularisation of the brain achieved through 
ISH using an Ets1 or Mef2c probe in chick embryos (D).  The migration of endothelial 
cells and formation of the PNVP occur earlier in the brain at stages HH11-13.  In the 
spinal cord, the PNVP begins to form along the lateral surface of the neural tube at 
HH16-18 (C) and continues to develop at both cervical and thoracic level as the 
embryo grows beyond HH20 (B) to HH22-24 (C).  Later events occur at similar stages 
of embryonic development in both the brain and spinal cord with the dorsal migration 
of angioblasts and ventral invasion of endothelial sprouts initiating at stages HH19 and 
the HH21, respectively. 
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3.5 Endothelial cells proliferate throughout the process of vascularisation  
 
Endothelial cells that constitute the blood vessels within the brain were found to 
originate from the cephalic mesoderm (Couly et al., 1995), although cell 
proliferation during brain vascularisation has not yet been fully documented.  The 
proliferation of endothelial cells is essential for the normal development of blood 
vessels.  Immunostaining was therefore used to investigate cell replication during 
endothelial ingression into the G. gallus brain by labelling mitotic cells with a 
phosphohistone H3 antibody, following ISH with the Ets1 probe (Fig. 3xiv).  Some 
phosphohistone H3-positive cells were detected within the PNVP and in the sprouts 
in the prosencephalon, mesencephalon and rhombencephalon during stages HH22 to 
HH26 of development, indicating that these cells were actively dividing.  Mitotic 
activity was identified within the stalk cells of invading sprouts most clearly at stage 
HH26 in the prosencephalon and mesencephalon, observed as a line of 
phosphohistone H3-positive cells extending from the basal lamina towards the 
ventricular surface of the developing brain (Fig. 3xiv, A-B, arrows).  Numerous 
phosphohistone H3-positive cells in the ventricular zone revealed the position of 
proliferating neuronal precursor cells.  Cell division was also detected in regions 
where sprouts began to branch and within the nascent INVP (Fig. 3xiv, C-D, 
arrowheads).   
 
The results provide a novel contribution to the process of brain vascularisation, 
supporting research conducted in the early postnatal retina by Gerhardt et al. (2003) 
that reported vessel expansion through abundant proliferation in stalk cells of the 
invading sprouts in response to VEGFA signalling, as well as in the immature 
capillary plexus.  Endothelial tip cell division has also been described in the 
literature as asymmetric division results in post-mitotic asymmetry of VEGFR.  The 
heterogeneity of daughter cells as tip or stalk cells, independent of Dll4/Notch 
signalling, integrates proliferation and collective migration in angiogenesis (Costa et 
al., 2016).  However, it is unclear whether or not endothelial tip cell proliferation has 
been identified in this study.  Proliferation could be identified by using NF-κB as 
another potential marker (Mazor et al., 2013) or by conducting bromodeoxyuridine 
(BrdU) labelling.  BrdU is a synthetic analog of the nucleoside thymine, which 
becomes incorporated into DNA during DNA synthesis.  Cells in S phase therefore 
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become labelled, whereas the phosphohistone H3 antibody identifies the mitosis-
specific phosphorylation of histone H3.  
 
Previous research by Couly et al. (1995) described the recruitment of angiogenic 
cells from the cephalic mesoderm to provide the brain with its vasculature.  Building 
upon this knowledge, not all endothelial cells within the brain originate from the 
outside as cell replication was identified at various stages throughout the process of 
brain vascularisation.  
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Figure 3xiv.  Investigating cell replication during brain vascularisation.  Mitotic 
cells (brown) are labelled using whole-mount IHC with a phosphohistone H3 
antibody, following ISH with an antisense Ets1 probe to label endothelial cells (blue) 
in the prosencephalon (A), mesencephalon (B) and rhombencephalon (C).  
Endothelial cells are seen dividing within the PNVP across stages HH22-26 
throughout the brain and in the stalk cells of invading sprouts (A-B, arrows).  D. Cell 
division is also detected in regions of vessel branching (arrowheads) and within the 
developing INVP.  Endothelial cells contributing to the brain vasculature initially 
originate from the mesoderm and replicate throughout the process of vessel 
ingression.  HH22 n=3; HH24 n=4; HH26 n=6.  Scale bar A-C = 25µm; D = 10µm. 
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3.6 The process of brain vascularisation is evolutionarily conserved throughout 
 vertebrate evolution 
 
Investigating the major events involved in the vascularisation of the chick brain 
provides useful information that builds upon the knowledge previously acquired 
through studies in both the brain and spinal cord of chick, quail and mouse embryos 
(Kurz et al., 1996; James et al., 2009; Fantin et al., 2013).  Studying these avian and 
mammalian model organisms is advantageous due to their evolutionary proximity to 
humans and shared similarities in mechanisms of development.  However, research 
into the vascularisation of the amphibian brain is currently limited and was therefore 
conducted to identify whether or not the sequence of events by which the brain 
becomes vascularised is conserved throughout vertebrate evolution.   
 
A method of LHC was established to elucidate the initial vascular patterning events 
occurring in the brain of X. laevis (Fig. 3xv).  Lectins are carbohydrate-binding 
proteins that have previously been useful in microvascular analysis (Thurston et al., 
1996; Jilani et al., 2003; Mazzetti et al., 2004) and the L. esculentum agglutinin 
lectin was utilised, which binds specifically to N-acetyl-D-glucosamine-β(1,4)N-
acetyl-D-glucosamine oligomers on the surface of endothelial cells.  Preliminary 
experiments revealed the presence of endothelial cells lining up along the mid-level 
of the lateral surface of the midbrain by stage 42, which was indicative of a 
developing PNVP.  Sprouting was first detected at this stage as endothelial cells 
formed narrow individual sprouts that invaded the ventral midbrain, similar to the 
observations in G. gallus, which was then followed by medial angiogenic sprouting 
at stage 46.  The pattern of long continuous groups of endothelial cells sprouting into 
the midbrain at stage 46 and 48 developed into what appeared to be the presence of 
extensive discontinuous sprouts or scattered groups of endothelial cells within the 
brain at stage 50.  The formation of an internal capillary network was unrecognisable 
at this stage, although the pattern may differ from that observed in G. gallus embryos 
as ingression may proceed in a number of different angles.   
 
Some similarities in the vascularisation of the X. laevis brain and that of the avian 
and mouse models, specifically the formation of a PNVP and initial sprouting into 
the ventral brain followed by medial angiogenic sprouting, support the notion that 
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particular events involved in the process of brain vascularisation is conserved in 
vertebrate evolution.  However, the dorsal migration of angioblasts and the 
formation of an obvious capillary network within the Xenopus brain were undetected 
by stage 50.  A network of capillaries may already be forming within the brain and 
this could be determined by performing sagittal sections and analysing X. laevis 
embryos beyond stage 50 of development.  
 
Studies conducted in zebrafish also provide extra support for an evolutionarily 
conserved process across numerous model organisms.  Zebrafish embryos are 
particularly useful for studying vascular development due to their accessibility and 
optical clarity.  Previous studies have described the origin and fates of vessels in the 
zebrafish trunk (Childs et al., 2002) and a number of transgenic lines have been 
generated as in vivo models for the imaging of blood vessels using Fli1 or VEGFR2 
promoters to drive the expression of GFP (Lawson & Weinstein, 2002; Cross et al., 
2003).  The direct observation of angiogenesis in TG(fli1:EGFP) embryos reveals 
that enhanced GFP (EGFP) is first detected at the three-somite stage.  Individual 
angioblasts have been seen to exit a strip of lateral mesodermal EGFP-positive cells, 
which then migrate towards the trunk midline and a vascular network is established 
as tip cells join with neighbouring anterior and posterior cells.  Endothelial cells of 
the segmental arteries and the dorsal longitudinal anastomotic vessel undergo 
extensive proliferation during the formation of the trunk.  Observations in the 
hindbrain have shown that central arteries are present at 3 days post-fertilisation 
(dpf), displaying extensive filopodial activity and pathfinding behaviour similar to 
neuronal growth cones (Lawson & Weinstein, 2002; Blum et al., 2008).  A more in-
depth analysis could however be conducted in order to identify the early events 
involved in vascular patterning of the embryonic zebrafish brain, from the initial 
migration of angioblasts to the formation of an internal vessel network.  
  
 
 
 
 
 
 
Figure 3xv.  Vascularisation of the X. laevis midbrain using LHC on sections.  
Endothelial cells were detected in stage 42-50 embryos using a biotinylated  L. 
esculentum agglutinin lectin.  Visualisation was achieved through the addition of 
HRP-conjugated streptavidin and DAB substrate to stain endothelial cells brown.  The 
PNVP can be seen developing along the mid-level of the lateral surface of the brain by 
stage 42 of development when sprouting initiates in the ventral midbrain (arrow).  
Medial angiogenic sprouting is observed at stage 46, which continues as the embryos 
grow.  Extensive sprouting is exhibited by stage 50, although the formation of an 
internal capillary network remains unrecognisable at this stage.  Stage 42 n=6; stage 
44 n=8; stage 46 n=7; stage 48 n=5; stage 50 n=6.  Scale bar = 10µm. 
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3.7 Vascular ingression proceeds in correlation with the pattern of neurogenesis in 
 the early brain 
 
The early axon scaffold in the embryonic vertebrate brain is established from the 
arrangement of early nerve connections that follow a well-conserved pattern.  The 
development of the early axon scaffold in the G. gallus embryo has previously been 
analysed by Ware & Schubert (2011), revealing that the first neurons in the brain 
differentiate in the diencephalon at stage HH11 and begin to form the first axon tract 
known as the medial longitudinal fascicle (MLF).  Shortly afterwards, the first 
neurons of the descending tract of the mesencephalic nucleus of the trigeminal nerve 
(DTmesV) appear at the dorsal midline of the mesencephalon and neurons of the 
tract of the postoptic commissure (TPOC) appear in the rostral hypothalamus.  A 
continuous ventral longitudinal tract (VLT) is formed by the TPOC and MLF at 
HH15 and axons of the DTmesV move towards the alar-basal boundary in the 
mesencephalon.  The DTmesV axons then turn caudally towards the midbrain-
hindbrain boundary (MHB) during which axons from the mamillo-tegmental tract 
(MTT) neurons in the caudal hypothalamus join the VLT.  The major axon tracts 
increase in complexity as the embryo develops and at HH17 additional neurons 
differentiate in the rostral diencephalon and in the alar plate of the mesencephalon. 
 
Endothelial ingression begins after neurogenesis and proceeds in a fashion that 
follows the pattern of which neurons and axon tracts first appeared in the brain.  
Similar to the differentiation of the first neurons in the brain, the migration of 
angioblasts is also first observed in the diencephalon, albeit dorsally, then in the 
mesencephalon where axons from the MLF neurons are projected.  The progression 
of vessel sprouting into the brain, which first occurs in the ventral mesencephalon 
and later continues throughout the tectum, is consistent with neurogenesis as neurons 
also begin to differentiate in the tegmentum, followed by the tectum.  Sprouting 
initiates at the ventral mesencephalon in which the VLT system has formed and also 
in the rhombencephalon, following the movement of DTmesV axons from the 
mesencephalon to the rhombencephalon.  Sprouting then continues throughout the 
alar plate as the embryo grows and initiates in both the diencephalon and 
telencephalon, after the differentiation of additional neurons in these regions.  The 
vascularisation of the brain therefore appears to progress in a similar pattern to 
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neurogenesis as endothelial ingression is observed in regions of the brain in the same 
sequence preceded by neuronal differentiation (Fig. 3xvi).  The results demonstrate 
the cross-talk between neural cells and endothelial cells as neurovascular interaction 
ensues to regulate the formation of an efficient network of blood vessels required to 
support the growth and development of the brain.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3xvi.  Vascularisation of the brain progresses in a similar pattern to 
neurogenesis in the G. gallus embryo.  A. The development of neurons and axon 
tracts during early development.  The first MLF neurons differentiate in the 
diencephalon at HH11 and project axons caudally.  Axons of the TPOC project from 
the rostral hypothalamus towards the diencephalon-midbrain boundary at HH14.  A 
continuous VLT is then formed by the TPOC and MLF.  Axons of the DTmesV move 
towards the alar-basal boundary in the mesencephalon then turn caudally towards the 
MHB at HH16.  Axons from the MTT neurons join the VLT system and additional 
neurons differentiate in the prosencephalon and in the mesencephalic alar plate, 
continuing to rise in number at HH18.  B. The vascularisation of the brain begins as 
angioblasts first migrate into the dorsal diencephalon at HH19 then in the 
mesencephalon at HH21.  Sprouting also initiates at this developmental stage into the 
ventral mesencephalon, where the VLT system has formed, and into the 
rhombencephalon, leading to the subsequent formation of the INVP in both regions at 
HH24.  Sprouting is then observed at HH26 in the prosencephalon and continues 
throughout the tectum at stage HH26, following the differentiation of additional 
neurons within these brain regions.  III, oculomotor nerve; DTmesV, descending tract 
of the mesencephalic nucleus of the trigeminal nerve; LLF, lateral longitudinal 
fascicle; MLF, medial longitudinal fascicle; MTT mamillo-tegmental tract; TB, tecto-
bulbar axons; TN, terminal nerve; TPC, tract of the posterior commissure; TPOC, tract 
of the postoptic commissure.   
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4. THE INFLUENCE OF MMP ACTIVITY ON ENDOTHELIAL CELL 
 INGRESSION 
 
CNS vascularisation is distinct from general angiogenesis as the neuroectoderm is 
absent of endothelial cells and is also unable to give rise to angioblastic cells.  The 
vascularisation of the neural tube therefore relies solely on an extraneuroectodermal 
origin of endothelial cells and angioblasts, which are recruited from the surrounding 
mesodermal tissue (Couly et al., 1995).  The remodelling of the ECM is an essential 
aspect in angiogenesis.  In addition to the well-established role of MMPs in matrix 
degradation, which subsequently liberates cells and growth factors from the matrix, 
the capabilities of these proteolytic enzymes extend to regulating other proteinases and 
proteinase inhibitors, latent growth factors, cleaving and activating cell-surface 
receptors and targeting cell-cell adhesion molecules (Brooks et al., 1996; Yu & 
Stamenkovic, 1999; Nagase & Woessner, 1999; Woessner & Nagase, 2000; Belkin et 
al., 2001; Kajita et al., 2001; Egeblad & Werb, 2002; Deryugina et al., 2002; Visse & 
Nagase, 2003; Boire et al., 2005).  In vitro studies suggest that the migration of 
cultured vascular smooth muscle cells (VSMCs) through basement membrane barriers, 
of which type IV collagen is a major component, is dependent on MMP-2 activity 
(Pauly et al., 1994).  Furthermore, type IV collagen has been shown to promote the 
activation of proMMP-2 by HT1080 fibrosarcoma cells (Maquoi et al., 2000).  It is 
therefore conceivable that MMP activity is likely to be implicated in influencing brain 
vascularisation as endothelial cells can respond to a variety of signals that may lead to 
their migration towards the developing brain and penetration of the basal lamina upon 
the initiation of ingression.  Very little is known about MMPs in CNS vascularisation, 
therefore the expression patterns of MMPs were analysed using ISH as a first step in 
the analysis of MMP activity during the vascularisation of the embryonic G. gallus 
brain.  The primary focus was on MMP-1, which is known to cleave and activate 
PAR1 leading to the promotion of cell migration, as well as MMPs -2 and -9 that 
degrade type IV collagen present in the basement membrane.  Gelatinase activity was 
also investigated in the developing brain of G. gallus embryos using ISZ studies.  The 
levels of MMP activity were then manipulated by exposing embryos to 
pharmacological inhibitors and active MMP-1 in order to investigate the role of MMPs 
in ingression. 
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4.1 MMPs are expressed in the PNVP and the nascent INVP, with differential 
 expression identified within the invading sprouts 
 
Gene fragments for MMPs -1, -2 and -9 were cloned and used to synthesise antisense 
probes for whole-mount ISH experiments in G. gallus embryos at stages HH19-24 of 
development in order to identify the spatial and temporal expression patterns of these 
MMPs immediately prior to ingression, during ingression and as the INVP began to 
form in the mesencephalon.  Specific staining was observed for each MMP at stage 
HH19 within the PNVP surrounding the ventral half of the mesencephalon, with 
particularly strong staining for MMP-1 close to the basal lamina of the brain as 
endothelial cells prepare to ingress (Fig. 4i, arrows).  The absence of staining in the 
dorsal half of the mesencephalon at stage HH19 indicated a lack of obvious 
expression of MMPs -1, -2 and -9 in this region (Fig. 4ii).  The expression of each 
MMP within the PNVP appeared to become more specific when the embryos 
developed to stage HH21 as individual cells were visible within the PNVP 
surrounding both the prosencephalon (Fig. 4iii) and the ventral half of the 
mesencephalon, with MMP-2 particularly present along the basal lamina of the brain 
(Fig. 4iv, arrows).  Staining for all three MMPs remained absent from the dorsal half 
of the mesencephalon at this stage, either from a lack of expression in this region or 
due to levels that remained too low for ISH detection (Fig. 4v).  The involvement of 
other proteases in the dorsal migration of angioblasts, which initiates in the 
mesencephalon at HH21, is therefore highly likely.  The expression of each MMP 
also occurred within the invading sprouts at stage HH24 (Fig. 4vi, arrows) with 
strong staining of MMP-2 and MMP-9 observed parallel to the ventricular surface of 
the brain, indicative of the region where the INVP was being established (Fig. 4vi, 
B, arrows).  Staining was first detected in the mesenchyme surrounding the dorsal 
mesencephalon at this developmental stage (Fig. 4vii, arrows).   
 
Upon closer observation, the staining patterns seemed to indicate differential 
expression within the endothelial sprouts.  MMP-1 appeared to be expressed more 
towards the tip of the sprout with lower levels present in the stalk cells.  Staining for 
MMP-9 showed expression within the stalk cells and in the INVP, whereas MMP-2 
was present throughout the sprout with strong expression also detected in the INVP 
(Fig. 4viii).  Identifying differential expression patterns of MMPs -1, -2 and -9, 
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particularly within the ingressing endothelial sprouts, is fundamental in 
understanding the proteolytic function involved in the focused migration and 
navigation of sprouts through the ECM and also understanding how MMPs integrate 
and function within the complex signalling networks involved in brain angiogenesis. 
 
The roles of tip cell migration and stalk cell proliferation resulting from differential 
gene expression between both cell types likely involves regulation by specific 
MMPs.  The promotion of cell migration through the cleavage and activation of 
PAR1 by MMP-1 has been described in the literature (Boire et al., 2005; Blackburn 
& Brinckerhoff, 2008) and a stronger expression of MMP-1 identified towards the 
tip of the endothelial sprout than the base possibly indicates a role in directing the 
migration of the tip cell.  MMP-2 and MMP-9 present in the base of the sprout and 
in the INVP suggests that these MMPs may influence the structure of the sprout and 
formation of the internal capillary network.  The differential expression of MMPs 
observed within the invading sprouts is a novel contribution to the knowledge of 
angiogenesis within the brain and may contribute to the understanding of tumour 
progression since sprouts are also formed by invading cancer cells.  Activated 
endothelial cells have been shown to express MMP-1, MMP-9 and MT1-MMP 
during sprouting angiogenesis and the formation of lumina-containing tubules.  In a 
pancreatic cancer model, MMP-9 activity mediates endothelial sprouting and the 
release of ECM-bound VEGF and FGF2, thus acting to increase the bioavailability 
of proangiogenic factors in vitro.  MT1-MMP also plays a key role in angiogenesis 
and the vascular expression and activity are largely confined to the sprouting tip of 
neovessels and migrating tumour cells, regulating collagen degradation at the leading 
edge of developing capillary structures (Bergers et al., 2000; Gálvez et al., 2005; 
Saunders et al., 2006; Yana et al., 2007; Ra & Parks, 2007; van Hinsbergh & 
Koolwijk, 2008; Packard et al., 2009; Deryugina & Quigley, 2010). 
 
 
 
 
 
 
 
Figure 4i.  MMP expression in the ventral half of the mesencephalon of stage 
HH19 G. gallus embryos.  Whole-mount ISH was used with antisense probes against 
MMPs -1, -2 and -9, followed by vibratome sectioning (n=1 for each MMP).  MMP 
expression in the basal plate (A) and ventral mesencephalon (B) compared to 
Ets1/TuJ1 staining for endothelial cells (blue) and neurons (brown) shown in the left-
hand column.  MMP-2 and MMP-9 are expressed within the PNVP beside the ventral 
half of the mesencephalon (arrows).  Specific staining for MMP-1 is particularly 
strong within the PNVP and is present close to the basal lamina.  MMP expression 
appears absent from the dorsal half of the mesencephalon, which is indicated by a lack 
of staining in this region.  Scale bar = 50μm. 
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Figure 4ii.  MMP expression in the dorsal half of the mesencephalon of stage 
HH19 G. gallus embryos.  Whole-mount ISH was used with antisense probes against 
MMPs -1, -2 and -9, followed by vibratome sectioning (n=1 for each MMP).  MMP 
expression in the dorsal mesencephalon (A) and alar plate (B) compared to Ets1/TuJ1 
staining for endothelial cells (blue) and neurons (brown) shown in the left-hand 
column.  The lack of staining indicates an absence of MMP expression in this region 
of the brain.  Scale bar = 50μm. 
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Figure 4iii.  MMP expression in the prosencephalon of stage HH21 G. gallus 
embryos.  Whole-mount ISH was used with antisense probes against MMPs -1, -2 and 
-9, followed by vibratome sectioning (n=2 for each MMP).  MMP expression in the 
telencephalon (A) and diencephalon (B) of the prosencephalon compared to Ets1/TuJ1 
staining for endothelial cells (blue) and neurons (brown) shown in the left-hand 
column.  All three MMPs are expressed in specific cells within the PNVP of the 
prosencephalon.  MMPs -1 and -2 staining patterns appear particularly close to the 
basal lamina of the brain.  Scale bar = 50μm. 
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Figure 4iv.  MMP expression in the ventral half of the mesencephalon of stage 
HH21 G. gallus embryos.  Whole-mount ISH was used with antisense probes against 
MMPs -1, -2 and -9, followed by vibratome sectioning (n=2 for each MMP).  MMP 
expression in the basal plate (A) and ventral mesencephalon (B) compared to 
Ets1/TuJ1 staining for endothelial cells (blue) and neurons (brown) shown in the left-
hand column.  The specific staining for each MMP is more apparent compared to the 
expression patterns observed in the ventral half of the mesencephalon at stage HH19.  
All three MMPs are expressed in specific cells within the PNVP (arrows) with MMP-2 
appearing along the basal lamina of the brain.  Scale bar = 50μm. 
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Figure 4v.  MMP expression in the dorsal half of the mesencephalon of stage 
HH21 G. gallus embryos.  Whole-mount ISH was used with antisense probes against 
MMPs -1, -2 and -9, followed by vibratome sectioning (n=2 for each MMP).  MMP 
expression in the dorsal mesencephalon (A) and alar plate (B) compared to Ets1/TuJ1 
staining for endothelial cells (blue) and neurons (brown) shown in the left-hand 
column.  The lack of staining indicates that MMP expression remains absent in this 
region of the brain.  Scale bar = 50μm. 
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Figure 4vi.  MMP expression in the ventral half of the mesencephalon of stage 
HH24 G. gallus embryos.  Whole-mount ISH was used with antisense probes against 
MMPs -1, -2 and -9, followed by vibratome sectioning (n=2 for each MMP).  MMP 
expression in the basal plate (A) and ventral mesencephalon (B) compared to 
Ets1/TuJ1 staining for endothelial cells (blue) and neurons (brown) shown in the left-
hand column.  Staining is observed for each MMP within the invading sprouts with 
notable staining for MMP-2 and MMP-9 in the region where the INVP is being 
established (B, arrows).  Scale bar = 50μm. 
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Figure 4vii.  MMP expression in the dorsal half of the mesencephalon of stage 
HH24 G. gallus embryos.  Whole-mount ISH was used with antisense probes against 
MMPs -1, -2 and -9, followed by vibratome sectioning (n=2 for each MMP).  MMP 
expression in the dorsal mesencephalon (A) and alar plate (B) compared to Ets1/TuJ1 
staining for endothelial cells (blue) and neurons (brown) shown in the left-hand 
column.  Expression is observed for all three MMPs in the mesenchyme surrounding 
the dorsal mesencephalon (arrows).  Scale bar = 50μm. 
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Figure 4viii.  MMP expression within endothelial sprouts.  Whole-mount ISH was 
conducted in stage HH24 embryos with antisense probes against MMP-1 (A, n=2), 
MMP-2 (B, n=2) and MMP-9 (C, n=2), followed by vibratome sectioning.  Staining 
patterns appear to indicate differential expression within ingressing endothelial 
sprouts.  MMP-1 expression is stronger towards the tip of the sprout with lower levels 
present in the stalk cells.  MMP-9 staining reveals a strong expression in the base of 
the sprout and in the INVP, while MMP-2 appears to be expressed equally throughout 
the sprout with a strong expression in the INVP (D).  Scale bar = 25μm. 
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4.2 Gelatinase activity is present in specific cells in the PNVP and within the 
 invading sprouts 
 
The method of whole-mount ISH was useful for identifying the spatial and temporal 
location of MMP mRNA during vascular ingression, although further experiments 
involving the double staining of endothelial cells and MMPs in the same embryo 
would be beneficial for a more direct comparison in expression and to aid in 
determining whether or not the location of MMPs are associated with the ingressing 
endothelial cells.  ISH studies, however, cannot provide information regarding the 
translation of MMP mRNA into protein and do not allow direct conclusions to be 
made regarding MMP activity, which is highly regulated at post-translational level.  
A method for identifying both the location and activity of gelatinases, including 
MMP-2 and MMP-9, was established in whole G. gallus embryos and is referred to 
as whole-mount ISZ.  DQ gelatin was used as a fluorogenic substrate (fluorescein-
conjugated gelatin), which is initially self-quenched due to the heavily-packed high 
concentration of fluorophores interacting with one another.  Hydrolysis is catalysed 
by the presence of active gelatinases, which leads to the proteolysis of the substrate.  
The compact formation of fluorophores is subsequently disrupted, resulting in the 
release of fluorescence.  Normally, ISZ is conducted on frozen sections of unfixed 
tissues as tissue fixation is generally believed to inhibit enzyme activity.  The exact 
localisation of activity is therefore difficult to determine as frozen sections present 
impaired tissue morphology compared with paraffin-embedded tissues fixed with 
ethanol- or zinc-based fixatives that exhibit stronger signals and better morphology 
for a more precise detection of gelatinolytic activity (Galis et al., 1995; Porto et al., 
2009; George & Johnson, 2010; Hadler-Olsen et al., 2010).  However, adapting ISZ 
to a technique that can be applied to freshly-harvested embryos that are briefly fixed 
in 4% PFA/PFS prior to experimentation is novel in achieving the precise detection 
and localisation of gelatinase activity in whole embryo samples of good structural 
integrity in which the fine morphological details of the tissues were preserved, whilst 
also maintaining a high level of enzyme activity.  Since sprouting was observed to 
occur throughout the mesencephalon at stage HH26 of development (Fig. 3x, I), 
embryos at this stage were incubated with DQ-gelatin in order to investigate if 
gelatinase activity coordinates with the location of the ingressing sprouts.  ISZ was 
then combined with fluorescent immunostaining using a CD34 antibody for the co-
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localisation of endothelial cells.  Control embryos were either incubated in reaction 
buffer alone or 10mM EDTA in reaction buffer.  Embryos incubated only in reaction 
buffer did not exhibit any fluorescence relating to gelatinolytic activity following 
IHC due to the absence of DQ-gelatin (Fig. 4ix, A).  The addition of EDTA to the 
zymography buffer should have resulted in the inhibition of fluorescence generated 
by DQ-gelatin cleavage as EDTA is a general divalent cation chelator and MMP 
antagonist.  However, in the presence of EDTA, embryos became extremely fragile 
and tissue morphology was severely lost.  
 
Compared to the data observed using ISH in which MMP expression was identified 
in specific cells within the PNVP that surrounded the prosencephalon and only the 
ventral mesencephalon at stage HH21, ISZ revealed the presence of active 
gelatinases in specific cells within the PNVP surrounding the prosencephalon (Fig. 
4ix, B, arrow) and both the tegmentum and tectum of the mesencephalon at stage 
HH26 of development (Fig. 4x, arrow), which was indicated by the presence of 
intermittent fluorescence in this region.  The intermittent green fluorescence 
indicates that active gelatinases were not associated with all cells within the PNVP, 
which would otherwise be identified as continuous fluorescence, but located only to 
cells that may be in a preparatory phase prior to degradation of collagen IV in the 
basal lamina by these proteinases upon the initiation of ingression.  A similar pattern 
of intermittent fluorescence associated with MMP gelatinolytic activity has 
previously been observed in angiogenesis, co-localising with microvessels in the 
adult mouse brain under VEGF hyperstimulation (Lee et al., 2009).  Gelatinase 
activity was also coincident with the location of endothelial sprouts that were seen 
beginning to invade the prosencephalon as fluorescence was detected extending from 
the PNVP into the brain (Fig. 4ix, C, arrow).  Gelatinase activity was observed 
throughout the vessel sprouts in the mesencephalon and as the sprouts branched to 
form the nascent internal capillary network (Fig. 4x, arrowhead).  In contrast to the 
intermittent fluorescence relating to active gelatinases observed within the PNVP, 
the pattern of fluorescence throughout the sprouts in the mesencephalon appeared to 
be more continuous, suggesting that active gelatinases were present in the majority 
of cells within the invading sprouts.  Gelatinase activity therefore appeared to 
correlate with major events of brain vascularisation, possibly functioning in 
endothelial cell invasion and also in the structure of the vessel sprouts.   
Figure 4ix.  Whole-mount ISZ in the prosencephalon of stage HH26 embryos.  
Chick embryos harvested at HH26 were fixed in 4% PFA/PBS prior to incubation with 
DQ-gelatin to detect gelatinolytic activity (green), which was then combined with 
fluorescent IHC with a CD34 antibody to detect endothelial cells (red).  Sections of 
60μm were cut from gelatin-embedded embryos using a vibratome before fluorescence 
was visualised.  A. Control buffer at pH7.5 does not detect gelatinolytic activity due to 
the lack of DQ-gelatin substrate, n=2.  B. Buffer containing DQ-gelatin substrate 
reveals the presence of gelatinolytic activity in specific cells within the PNVP as 
indicated by intermittent green fluorescence (arrow), n=4.  C. Enlarged region of 
dorsal diencephalon indicates the expression of active gelatinases by endothelial cells 
during ingression into the brain (arrow).  Scale bar A, B = 100μm; C = 10μm. 
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Figure 4x.  Whole-mount ISZ in the mesencephalon of stage HH26 embryos.  
Chick embryos harvested at HH26 were fixed in 4% PFA/PBS prior to incubation with 
DQ-gelatin to detect gelatinolytic activity (green), which was then combined with 
fluorescent IHC with a CD34 antibody to detect endothelial cells (red).  Sections of 
60μm were cut from gelatin-embedded embryos using a vibratome before fluorescence 
was visualised.  The detection of intermittent green fluorescence indicates the presence 
of gelatinolytic activity in specific cells within the PNVP (arrow).  Gelatinolytic 
activity is also present within endothelial sprouts that are invading the brain and are 
branching to form the INVP (arrowhead), n=4.  Scale bar = 100μm. 
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While ISZ with DQ-gelatin detects and locates gelatinolytic activity in situ, it is 
important to note that this method assesses the net activity of gelatinases, which is 
regulated by a number of factors such as the presence of ubiquitous proteinase 
inhibitors including TIMPs.  However, the ability to observe protease activity in 
whole embryos is a powerful technique that can contribute significantly to the 
understanding of proteolytic activity involved in vascularisation of the brain and also 
permits the role of gelatinases to be explored in pathobiology.  The visualisation of 
active MMP-1 would be advantageous and if detected and located to invading 
sprouts similar to the pattern observed with MMP-1 mRNA, particularly at the 
leading edge, the analysis would support the hypothesis of the involvement of MMP-
1 in tip cell migration.     
 
4.3 Altering MMP activity leads to changes in endothelial cell ingression  
 
The analysis of MMP mRNA by ISH and active gelatinases by ISZ provides 
valuable information that confirms the presence of MMPs during brain 
vascularisation and is a crucial step prior to elucidating the function of MMPs in 
endothelial cell ingression.  The tip cells that initiate vascular ingression are faced 
with the specific challenge to penetrate the basal lamina of the brain, which requires 
the remodelling of the ECM by active proteases.  The role of MMPs in brain 
vascularisation was investigated by manipulating the level of MMP activity to which 
ingressing endothelial cells were exposed (Fig. 4xi).  MMPs play a major role in 
hydrolysing structural components present in the ECM, therefore a change in the 
level of MMP activity could result in a change to vessel sprouting into the brain.  
The local activity of MMPs was altered through the in ovo implantation of acrylic 
beads soaked with pharmacological inhibitors or active MMP-1.   
 
 
 
 
 
 
 
Figure 4xi.  Signalling pathways involved in angiogenesis affected by altering 
MMP levels.  The endogenous levels of MMPs are determined by a network of 
regulatory pathways primarily induced by VEGFA signalling and active uPA.  A 
reduction in the level of MMPs -2 and -9 through exposure to MMP inhibitors ARP 
100 and SB-3CT would likely result in a reduction of angiogenesis due to decreased 
degradation of the ECM leading to the release of fewer proangiogenic factors.  
Conversely, increasing the level of active MMP-1 may promote angiogenesis by 
increasing cell migration and enhancing the release of growth factors from the matrix. 
 
131 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
132 
 
The grafting of beads into the developing embryo is an approach that is widely used 
to directly test the effects of specific growth factors or inhibitors on gene expression 
at defined developmental stages.  The technique has been employed in a number of 
studies that include the identification of factors that alter the patterning of the limb, 
such as Shh and retinoic acid, and in studying the roles of signals involved in 
regulating muscle development, including BMPs, hepatocyte growth factor (HGF) 
and FGF18 (Tickle et al., 1982; Riddle et al., 1993; Brand-Saberi et al., 1996; 
Amthor et al., 1998; Mohammed & Sweetman, 2016).   
 
The pharmacological inhibitors ARP 100, SB-3CT and Batimastat were used to alter 
MMP activity in the developing G. gallus embryo.  ARP 100 (Santa Cruz 
Biotechnology; Chetty et al., 2010; Miyake et al., 2015) is a selective inhibitor of 
MMP-2 (IC50 = 12nM), displaying selectivity over MMP-9 (IC50 = 200nM), MMP-3 
(IC50 = 4.5μM), MMP-1 (IC50 = 50μM) and MMP-7 (IC50 = >50μM).  SB-3CT 
(Santa Cruz Biotechnology; Bonfil et al., 2006; Kim et al., 2008) is a selective 
inhibitor of MMP-2 and MMP-9 that has been shown to directly bind to the catalytic 
zinc ion on MMP-2 (MMP-1: Ki = 206µM; MMP-3: Ki = 15µM; MMP-7: Ki = 
96µM; MMP-2: Ki = 13.9nM; MMP-9: Ki = 600nM; ADAM17/TACE: Ki = 4µM).  
Batimastat (Tocris Bioscience; Wylie et al., 1999; Duong & Erickson, 2004) is a 
potent, broad spectrum inhibitor of MMPs (IC50 values are 3, 4, 4, 6 and 20nM for 
MMP -1, -2, -9, -7 and -3 respectively).  Active MMP-1 (gifted from Dr. Pickford, 
University of Portsmouth) was synthesised as proMMP-1, which was expressed, 
purified, activated using APMA and MMP-3 then re-purified.  MMP-3 cuts at a 
specific point between the PRO and CAT domains therefore resulting in a much 
higher activity compared with auto-activation.  APMA interrupts the interaction 
between Cys92 and the catalytic zinc ion, which leads to the unfolding of the PRO 
domain and subsequent removal by proteolysis.  The MMP inhibitors were tested at 
concentrations that were much higher than the known IC50 concentrations as the 
extent to which each inhibitor diffuses away from the bead and becomes diluted over 
time is unknown.  The beads were positioned in the mesoderm of stage HH22 G. 
gallus embryos just beneath the surface ectoderm adjacent to the basal plate of the 
mesencephalon, immediately after the initiation of sprouting in the ventral 
mesencephalon.  The embryos were incubated further and harvested at stage HH26, 
during which sprouting normally occurs at multiple points throughout the 
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mesencephalon (Fig. 3x, I).  Endothelial cells were then detected with IHC using a 
CD34 antibody (Fig. 4xii) and counted (Fig. 2ii and Appendix A).   
 
A paired t-test was performed using Minitab 17 in order to determine if there was a 
significant decrease in the number of endothelial cells present within the brain in the 
side exposed to a pharmacological inhibitor compared with the contra lateral control 
side (Appendices B-J).  In control embryos that were implanted with beads 
containing only DMSO, endothelial cells ingressing into both sides of the 
mesencephalon were similar in number (Fig. 4xii, A, and Appendix B).  Two-thirds 
of the embryos implanted with beads containing 8mM ARP 100 in DMSO, an 
inhibitor of MMP-2, showed fewer cells ingressing into the mesencephalon on the 
experimental side compared with the control side.  The reduction in the number of 
ingressing cells was likely to be an effect that arose as a result of the inhibitor rather 
than from the encapsulation of a foreign body, although this difference was not 
statistically significant (Fig. 4xii, B, and Appendix C).  Furthermore, no significant 
difference was observed in the number of endothelial cells ingressing into the control 
and experimental sides in embryos implanted with beads containing either 8mM SB-
3CT in DMSO, an inhibitor of MMP-2 and MMP-9 (Fig. 4xii, C, and Appendix D), 
or the broad spectrum inhibitor, 1mM Batimastat in DMSO (Fig. 4xii D, and 
Appendix E). 
 
ARP 100 and SB-3CT stock solutions were prepared with DMSO, although 
additional results were acquired from preliminary experiments in which the 
inhibitors were diluted in PBS rather than DMSO (Fig. 4xiii).  In control embryos 
that were implanted with beads containing only PBS, endothelial cells ingressing 
into both sides of the mesencephalon were similar in number (Fig. 4xiii, A, and 
Appendix F).  However, no significant difference was observed in the number of 
endothelial cells ingressing into the control and experimental sides in embryos 
implanted with beads containing either 8mM ARP 100, 1mM ARP 100, 8mM SB-
3CT or 1mM SB-3CT in PBS (Fig. 4xiii and Appendices G-J).  
 
 
 
Figure 4xii.  Sections through the mesencephalon of embryos following the 
implantation of beads containing MMP inhibitors in DMSO.  Acrylic beads 
containing DMSO (blue) are positioned in the mesoderm beneath the surface ectoderm 
of the mesencephalon in stage HH26 embryos.  A similar number of endothelial cells, 
which are detected using IHC with a CD34 antibody (brown), are seen ingressing into 
both sides of the mesencephalon at the level of the bead in control embryos (A, n=7).  
In two thirds of embryos implanted with beads containing 8mM ARP 100 in DMSO, 
fewer endothelial cells are seen ingressing into the mesencephalon on the experimental 
side containing the bead compared with the control side (B, n=6).  In embryos 
implanted with beads containing either 8mM SB-3CT (C, n=5) or 1mM Batimastat (D, 
n=6) in DMSO, a difference in the number of endothelial cells ingressing into the 
experimental and control sides was not detected.  Clusters of endothelial cells (arrows) 
were observed within the mesencephalon in close proximity to the implanted bead in 
one embryo exposed to 8mM ARP 100 and three embryos exposed to 8mM SB-3CT.  
Endothelial cell clusters were absent from all control embryos.  Scale bar = 100μm.  
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Figure 4xiii.  Sections through the mesencephalon of embryos following the 
implantation of beads containing MMP inhibitors in PBS.  Acrylic beads 
containing PBS (blue) are positioned in the mesoderm beneath the surface ectoderm of 
the mesencephalon in stage HH26 embryos.  A similar number of endothelial cells, 
which are detected using IHC with a CD34 antibody (brown), are seen ingressing into 
both sides of the mesencephalon at the level of the bead in control embryos (A, n=7).  
In embryos implanted with beads containing either 8mM ARP 100 (B, n=5), 1mM 
ARP 100 (C, n=9), 8mM SB-3CT (D, n=7) or 1mM SB-3CT (E, n=10) in PBS, no 
significant difference occurs between the mean number of endothelial cells on the 
control side and the mean number of endothelial cells containing the bead.  Similar to 
an effect seen with MMP inhibitors in DMSO, clusters of endothelial cells (arrows) 
were observed within the mesencephalon in close proximity to the implanted bead in 
one embryo exposed to 8mM ARP 100 and three embryos exposed to 8mM SB-3CT.  
Endothelial cell clusters were absent from all control embryos.  Scale bar = 100μm.  
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Decreasing MMP activity was hypothesised to reduce the number of endothelial 
cells ingressing into the brain as the ability of endothelial cells to penetrate the basal 
lamina may be hindered.  The loss-of-function experiments that were conducted 
through the application of MMP inhibitors, specifically ARP 100, resulted in a 
reduction in vascular ingression, although this result was not statistically significant.  
MMP-2 may be necessary for normal sprouting patterns into the developing brain as 
it is known to degrade collagen IV in the basement membrane, therefore the decrease 
in MMP-2 activity may have prevented the ingression of endothelial cells in close 
contact with the inhibitor.  The presence of MMP-9 however may have been 
sufficient to enable the ingression of cells affected by ARP 100.  The inhibition of 
multiple MMPs through exposure to SB-3CT or Batimastat did not significantly 
affect the number of endothelial cells invading the experimental side compared with 
the control side.  The results were unexpected as an increase in MMP inhibition 
would presumably show further reduction in ingression compared with the effect of 
ARP 100, as less degradation of the ECM would lead to the release of fewer growth 
factors from the matrix, including VEGFA, which would in turn lead to fewer 
endothelial cells migrating towards the brain and greatly lowering the ability of these 
cells to penetrate the basal lamina and migrate once inside the brain.  The reason for 
this is unclear, but as MMPs are involved in complex regulatory networks it is likely 
that the effect of SB-3CT, for example, could be counteracted by alterations to 
certain MMP activators and inhibitors such as MT1-MMP, MT3-MMP, TIMP-1 and 
TIMP-3, in order to re-establish local MMP-2 and MMP-9 activity to the correct 
levels required for normal endothelial ingression.  Furthermore, other matrix-
degrading enzymes such as proteases of the ADAM family, cathepsin cysteine 
proteases and serine proteases, might also compensate for the decrease in MMP 
activity.   
 
The effect of ARP 100 on inhibiting MMP-2 was previously confirmed in vivo 
through the inhibition of neural crest cell formation (Duong & Erickson, 2004), 
although studies conducted in vitro and in vivo have described the effects of ARP 
100, SB-3CT and Batimastat more specifically in angiogenesis.  The inhibition of 
MMP-2 using ARP 100 has been shown to decrease MMP-2 interaction with αvβ3 
integrin, leading to the decreased expression of VEGF in lung cancer angiogenesis 
and also significantly inhibited the formation of capillary tube-like structures in 
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HUVECs (Chetty et al., 2010; Miyake et al., 2015).  Inhibiting both MMP-2 and 
MMP-9 using SB-3CT reduced intratumoral vascular density in an experimental 
mouse model of prostate cancer bone metastases and inhibited bone marrow 
endothelial cell invasion and tubule formation in vitro (Bonfil et al., 2006).  
Furthermore, birds treated with SB-3CT displayed a decreased endothelial mitotic 
index to the adult vocal control centre and the recruitment of neurons was 
substantially diminished (Kim et al., 2008).  The effect of the broad spectrum 
inhibitor, Batimastat, has also been investigated in vivo and was shown to limit 
tumour metastasis in mice by inhibiting angiogenesis through the reduction in 
vascular volume of liver metastasis (Wylie et al., 1999).  Continuing the 
investigation with larger sample numbers for ARP 100, SB-3CT and Batimastat 
would be advantageous and further investigation into the inhibitory effects of each 
inhibitor on MMP activity in vivo would support the current literature and help to 
verify the changes observed in endothelial ingression into the brain.  
 
Further to the ISH experiments in which MMP-1 was expressed more towards the 
tips of endothelial sprouts (Fig. 4viii), a gain-of-function experiment was then 
conducted in order to investigate if an increase in MMP activity would lead to an 
increase in the number of endothelial cells ingressing into the brain.  Acrylic beads 
soaked in 1μM or 25nM MMP-1 that was activated using APMA and MMP-3 (gifted 
from Dr. Andy Pickford, University of Portsmouth; Chung et al., 2004; Arnold et 
al., 2011), were implanted just beneath the surface ectoderm adjacent to the 
mesencephalon using the method described above.  The embryos were incubated 
further and harvested at stage HH26.  Endothelial cells were then detected with IHC 
using a CD34 antibody (Fig. 4xiv) and counted (Fig. 2ii and Appendix A).  A paired 
t-test was performed using Minitab 17 in order to determine if there was a significant 
increase in the number of endothelial cells present within the brain in the 
experimental side that was exposed to active MMP-1 compared with the contra 
lateral control side (Appendices K-N).   
 
 
 
 
 
Figure 4xiv.  Sections through the mesencephalon of embryos following the 
implantation of beads containing active MMP-1 in Tris-HCl.  Acrylic beads 
containing 100mM Tris-HCl pH7.5 (blue) are positioned in the mesoderm beneath the 
surface ectoderm of the mesencephalon in stage HH26 embryos.  A similar number of 
endothelial cells, which are detected using IHC with a CD34 antibody (brown), are 
seen ingressing into both sides of the mesencephalon at the level of the bead in control 
embryos (A, n=4).  In embryos exposed to 25nM active MMP-1 (B, n=5), more 
endothelial cells are shown to ingress on the experimental side in 80% of embryos, 
although this increase was not statistically significant.  An increased density of 
endothelial cells within the INVP can be seen in one embryo on the side containing the 
bead in comparison to the control side (B, arrow).  In embryos implanted with beads 
containing 250nM active MMP-1 (C, n=3), no difference was found in the number of 
endothelial cells ingressing into the experimental and control sides.  Embryos 
implanted with beads containing 1μM active MMP-1 exhibit a larger number of 
endothelial cells ingressing into the mesencephalon on the experimental side 
containing the bead compared with the control side (D, n=5), although this increase 
was not statistically significant.  Endothelial cells are seen pushing through the 
ventricular surface of the midbrain in one embryo and a cluster of endothelial cells is 
detected in close proximity to the bead in another (D, arrows).  Endothelial cell 
clusters were absent from all control embryos.  One embryo also shows the presence 
of densely-packed endothelial cells within the INVP (D, arrowheads).  Scale bar = 
100μm.  
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In control embryos that were implanted with beads containing only 100mM Tris-HCl 
pH7.5, endothelial cells ingressing into both sides of the mesencephalon were similar 
in number (Fig. 4xiv, A, and Appendix K).  The majority of embryos exposed to 
25nM active MMP-1 showed an increase in endothelial cell ingression on the 
experimental side compared with the contra lateral control side, although this 
increase was not statistically significant (Fig. 4xiv, B, and Appendix L).  An 
increased density of endothelial cells within the INVP was also observed in one 
embryo on the side containing the bead  in comparison to the control side (Fig. 4xiv, 
B, arrow).  In embryos implanted with beads containing 250nM active MMP-1, no 
difference was observed in the number of endothelial cells ingressing into the control 
and experimental sides (Fig. 4xiv, C, and Appendix M).  Upon exposure to beads 
containing 1μM active MMP-1 in Tris-HCl, a larger number of endothelial cells 
were seen on the experimental side compared with the control side, although the 
increase in number was not statistically significant (Fig. 4xiv, D, Fig. 4xv and 
Appendix N).  A number of effects that did not arise in the control embryos were 
however detected.  Endothelial cells were seen pushing through the ventricular 
surface of the brain in one embryo and the formation of a cluster of endothelial cells 
was also present in close proximity to the bead in another embryo (Fig. 4xiv, D 
arrows), which was similar to the appearance of clusters arising from reduced MMP 
activity through the application of pharmacological inhibitors.  An expansion in the 
size of the invading sprouts and increased density of endothelial cells within the 
INVP were also observed (Fig. 4xiv, D arrowheads).   
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Figure 4xv.  The effect of 1uM active MMP-1 on endothelial cell ingression.  The 
mean number of endothelial cells on the side containing the bead (n=5) is compared 
with the mean number of endothelial cells on the contra lateral control side (n=5) 
after exposure to 1uM active MMP-1.  Error bars represent the standard error of the 
mean.  A larger number of endothelial cells was identified on the experimental side, 
although this increase was not found to be statistically significant (p value = 0.066, 
Appendix N).  
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A graph to show the effect of 1µM active MMP-1 on the number 
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While increased exposure to the pharmacological inhibitor, ARP 100, lead to a 
reduction in endothelial cell ingression into the brain, increasing the level of active 
MMP-1 resulted in an increase in the number of ingressing endothelial cells, 
however, neither were statistically significant.  Since MMP-1 does not degrade 
collagen IV, it is likely that MMP-2 and MMP-9 have a larger role in penetrating the 
basal lamina at the initiation of ingression.  Any increase in the number of 
endothelial cells observed on the experimental side of the mesencephalon may 
therefore have resulted from an increase in cell proliferation, which has been shown 
to occur throughout the process of brain vascularisation, indicated by few invading 
sprouts that appeared larger in size and the detection of densely-packed endothelial 
cells within the developing INVP.  The similarity in the size and density of the 
PNVP on both experimental and control sides suggest that the proposed increase in 
cell proliferation occurs once the endothelial cells have entered the brain, an effect 
that may have been promoted by the elevated level of active MMP-1.  A study by 
Mazor et al. (2013) conducted in vitro suggests a mechanism by which MMP-1 has a 
role in sensitising endothelial cell functions that are mediated by VEGFR2.  
Endothelial cells treated with MMP-1 consistently and significantly stimulated an 
up-regulation of VEGFR2 mRNA and functional protein that enhanced VEGFA 
signalling and accelerated cell proliferation when compared to controls and cells 
treated with MMP-8 or MMP-9.  The up-regulation of VEGFR2 by MMP-1 was 
found to be mediated by activation of the NF-κB pathway in endothelial cells, a 
response that was dependent upon MMP-1 activation of PAR-1 (Zania et al., 2006; 
Mazor et al., 2013).  Further to the effect on endothelial cell proliferation, MMP-1 
has also been described in the upregulation of cell growth and proliferation in 
various other cell types including lung alveolar epithelial cells (Herrera et al., 2013) 
and breast cancer cells (Liu et al., 2012) and is therefore critical in medical research 
regarding pathogenesis, tumourigenicity and metastatic ability. 
 
The effect of increasing active MMP-1 was more prominent in embryos exposed to 
1μM active MMP-1 compared with the lower concentrations as some cells were seen 
to migrate farther and penetrated the ventricular surface of the mesencephalon.  
Previous studies have investigated the cleavage and activation of PAR1 by MMP-1, 
which leads to the induction of proangiogenic genes that promote cell migration in 
both angiogenesis and tumourigenesis (Boire et al., 2005; Blackburn & 
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Brinckerhoff, 2008).  However, it is currently unknown if the same mechanism 
exists in the migratory stage of brain vascularisation and is therefore yet to be 
established.  Identifying the temporal and spatial location of PAR1 during early brain 
development would be a good strategy, particularly if the expression patterns are 
found to coincide with the strong expression of MMP-1 mRNA towards the tips of 
endothelial sprouts.  The analysis would help in providing a deeper insight into the 
mechanism of ingression, investigating whether or not MMP-1-activated PAR1 is 
also involved in augmenting endothelial cell proliferation and migration in a new 
context to those previously studied, specifically, in the process of brain 
vascularisation.  
  
4.4 Altering MMP activity leads to the formation of endothelial cell clusters 
 
The modification of MMP protein levels, either through the application of active 
MMP-1 as well as pharmacological inhibitors ARP 100 and SB-3CT, resulted in the 
distinct formation of densely packed endothelial cell clusters on the experimental 
side of the mesencephalon.  Endothelial cell clusters were absent from all control 
embryos, suggesting that MMP activity plays an important role in forming or 
maintaining the structure of the invading sprouts that normally comprises a leading 
tip cell and follower stalk cells.  The study conducted by Mazor et al. (2013) in 
HUVECs and bovine aortic endothelial cells (BAECs), which describes the NF-κB-
mediated upregulation of VEGFR2 by MMP-1 leading to enhanced VEGFA 
signalling and proliferation of endothelial cells, may provide an explanation into the 
formation of clusters upon exposure to increased active MMP-1.  The expression of 
VEGFR2 is characteristic of endothelial tip cells, yet stalk cells are highly 
proliferative.  It is possible that cells present within the clusters may consist of 
endothelial cells that either remained unspecialised or have lost the phenotypic 
specialisation as tip or stalk cells.  A more in-depth analysis could therefore be 
performed using additional staining methods in order to assay for tip and stalk cell 
markers such as VEGFR1, VEGFR2 and NRP1, in addition to using a 
phosphohistone H3 antibody to establish whether or not these cells are proliferative.  
Further investigation could also be conducted to identify if these cells are associated 
with pericytes that normally associate with endothelial cells during sprout assembly 
(Gerhardt & Betsholtz, 2003).   
143 
 
The structural integrity of a new sprout is maintained due to the adherent and tight 
junctions established by the endothelial stalk cells (Dejana et al., 2009; Phng & 
Gerhardt, 2009; Ribatti & Crivellato, 2012) and a number of studies in the literature 
have shown that the breakdown of tight junctions by MMP activation, particularly 
MMP-2 and MMP-9, facilitates the permeability of the BBB and blood-retinal 
barrier (BRB) in pathological conditions by degrading tight junction proteins, 
occludin and claudin-5 (Giebel et al., 2005; Yang et al., 2007; Yang & Rosenberg, 
2011; Feng et al., 2011; Che et al., 2014).  The decrease in MMP protein levels, 
achieved by the application of pharmacological inhibitors, was therefore 
hypothesised to result in the breakdown of fewer tight junction complexes, thus 
maintaining the stability of the sprout.  The unexpected formation of endothelial cell 
clusters, however, suggests a disruption to the typical arrangement of the sprout that 
normally consists of a single migratory tip cell followed by highly proliferative stalk 
cells.  Furthermore, the formation of clusters appeared more frequently upon 
exposure to SB-3CT, which inhibits both MMP-2 and MMP-9, compared with ARP 
100 that only inhibits MMP-2.  Considering the directional regulation of cell 
migration in angiogenesis, motility is controlled by chemotaxis driven by growth 
factors such as VEGFA (Hogan et al., 2004; James et al., 2009; Kurz et al., 1996; 
Ruhrberg et al., 2002), although the ECM also regulates motility by haptotaxis in 
which cells migrate in response to an increasing concentration of ECM proteins and 
an associated gradient of cellular adhesion sites (Hsu et al., 2005; Rozario & 
DeSimone, 2010).  Investigation into the motility of BAECs has shown that cells 
exhibit directional motility towards a higher concentration of fibronectin, and 
BAECs on higher fibronectin concentrations have decreased cell motility due to 
increased adherence compared to cells in low fibronectin density (Bennett, 2012).   
 
Integrins are transmembrane receptors that mediate the interactions between 
endothelial cells and the ECM.  Endothelial β1 integrins have been shown to regulate 
sprouting and the formation of complex networks of endothelial tubes in murine ES 
cells as vessel development in β1 integrin-deficient EBs was strongly defective due 
to reduced endothelial cell maturation, migration and elongation, together with 
increased apoptosis (Malan et al., 2010).  A study conducted on resected invasive 
colorectal tumours has shown that upregulated MMP-2 expression enhances cell 
motility by significantly reducing adhesion to collagen and fibronectin through the 
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increased partial cleavage of β1 integrin to which it associates.  Conversely, the 
degradation of β1 integrin can be abolished by inhibiting MMP-2 activity (Kryczka 
et al., 2012).  In the context of brain vascularisation, lowering the level of MMP-2 
may lead to a similar effect of reduced migration by preventing the cleavage of β1 
integrin and altering intracellular signalling pathways that in turn enhances the 
adhesion of endothelial cells to the ECM.  In addition to MMP-2, MMP-9 has also 
been shown to associate with β1 integrin and is localised at the surface of cell 
membranes to promote tumour cell invasion (Radjabi et al., 2008).  Lowering MMP-
9 activity in addition to MMP-2 may initially reduce the invasive capabilities of 
endothelial cells when passing through the basal lamina and prevent the migration of 
cells that do ingress into the brain.  Reduced levels of MMP-2 and MMP-9 would 
result in less degradation of ECM components, which could also negatively affect 
motility.  Endothelial cells may be unable to migrate due to the physical restrictions 
imposed by the matrix, thereby resulting in aberrant angiogenesis and disorganised 
patterns of vascularisation during the development of the embryonic brain.  
However, this remains unclear since endothelial cells have previously been shown to 
migrate into areas containing a higher density of collagen (Hsu et al., 2005).  
Moreover, although MMP-2 correlates with neural crest cell-generation but does not 
affect the migration of cells that have already detached from the neural epithelium 
(Duong & Erickson, 2004), it is possible that MMP-2 may have an important role in 
the initial formation of endothelial sprouts then contribute to the degradation of β1 
integrin during the migration of sprouts within the brain.  It is therefore important to 
recognise that different cell types may use different mechanisms in order to migrate.  
 
4.5 Lowering MMP-2 activity leads to reduced breakdown of fibronectin and α6 
 integrin 
 
Staining patterns have previously revealed the presence of fibronectin in close 
proximity to endothelial sprouts invading the brain during early development (Fig. 
3vi).  In order to investigate the effect of MMP-2 activity on ECM remodelling 
during vascular ingression, preliminary experiments were performed in which  beads 
containing ARP 100 were implanted into the mesoderm beneath the surface 
ectoderm of the mesencephalon at stage HH22.  IHC was then conducted at HH26 to 
identify if the decrease in MMP-2 activity, brought about by the application of ARP 
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100, would alter the presence of laminin, fibronectin, α6 integrin and β1 integrin 
when sprouting normally occurs throughout the mesencephalon (Fig. 4xvi).   
 
The levels of fibronectin and α6 integrin appeared to be higher on the experimental 
side containing the ARP 100 bead, compared to the control side, suggesting a 
possible role of MMP-2 in the breakdown of these components within the brain.  
However, further studies need to be conducted to provide a better understanding of 
MMP activity on ECM remodelling.  Beads containing MMP inhibitors or active 
MMP-1 could be implanted into the embryo as previously described, followed by 
ISZ with DQ-gelatin to analyse the effect on MMP activity and IHC to detect the 
effect on endothelial cell ingression, as well as the expression of integrins, 
fibronectin and collagen IV in vivo. 
 
The inhibitory effect of ARP 100 on MMP-2 was tested as a positive control 
experiment as MMP-2 is known to be expressed in neural crest cells during 
detachment from the neural tube (Duong & Erickson, 2004).  Stage HH8 embryos 
were subjected to varying concentrations of ARP 100 in roller cultures then the 
formation of neural crest cells was analysed using IHC with an anti-HNK-1 antibody 
after 40 hours of incubation (Fig. 4xvii).  The anti-HNK-1 antibody is a reliable 
marker that thoroughly labels migratory neural crest cells due to the HNK-1 epitope 
that becomes present in large amounts on the cell surface (Loring & Erickson, 1987; 
Del Barrio & Nieto, 2004; Giovannone et al., 2015).  Fewer HNK-1-positive 
migratory neural crest cells were detected compared with the DMSO control as the 
concentration of ARP 100 increased, thus supporting the use of ARP100 as an 
effective inhibitor of MMP-2 in the bead implantation experiments.   
 
 
 
 
 
 
 
 
 
Figure 4xvi.  Preliminary investigation into the effect of MMP-2 inhibitor, ARP 
100, on components of the ECM.  The acrylic beads containing 8mM ARP 100 in 
DMSO (blue) are positioned in the mesoderm beneath the surface ectoderm of the 
midbrain, delivering the inhibitor to the surrounding tissues.  Whole-mount IHC in 
stage HH26 embryos is used to detect laminin (A, n=2), fibronectin (B, n=2), α6 
integrin (C, n=1) and β1 integrin (D, n=1), which are stained brown.  The presence of 
fibronectin and α6 integrin is detected at a higher level on the experimental side 
containing the bead compared to the contra lateral control side, suggesting a possible 
role of MMP-2 in the breakdown of these two components within the brain.  Scale bar 
= 100μm. 
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Figure 4xvii.  Roller culture experiments with ARP 100 followed by neural crest 
cell detection using IHC with an anti-HNK-1 antibody.  The inhibitory effect of 
ARP 100 on MMP-2 was tested by incubating stage HH8 embryos with 1µM or 
10µM concentrations of ARP 100 in roller cultures for 40 hours during which they 
grew to stage HH15.  The embryos underwent IHC with an anti-HNK-1 antibody to 
label neural crest cells brown.  The DMSO control identifies the normal location of 
neural crest cells and highlights the migration path away from the neural tube (n=6).  
Fewer migratory neural crest cells are observed at 1µM concentration of ARP 100 
(n=5), an effect that increases with a higher concentration of inhibitor.  Only a few 
cells are exposed to active MMP-2 at 10µM ARP 100, allowing these cells to 
undergo the EMT required in the formation of neural crest cells (n=7).  The results 
support previous findings by Duong & Erickson (2004) and the selection of ARP100 
for use as an effective inhibitor of MMP-2 in bead implantation experiments.  Scale 
bar = 25μm. 
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The implantation of beads is a valuable but laborious and technically challenging 
technique in which many variables are difficult to control in order to obtain valid and 
consistent repeats, including the implantation of beads into the same position in each 
embryo, the depth of specific staining against the background and cutting sections at 
the same angle, in addition to the individual differences possessed by each embryo.  
The substances loaded onto the beads also require further testing to analyse certain 
properties such as the rate of diffusion from the bead into the surrounding tissues and 
to identify the vicinity of the brain within which each substance can diffuse.  In 
doing so, concentrations can be optimised in order to reduce any off-target effects 
that may have occurred as a result of applying high concentrations of inhibitors or 
active MMP-1 to the beads.  The diffusion of the inhibitors from the beads, for 
example, may also be affected by binding to MMPs therefore the importance of 
analysing dissociation constants should also be taken into account.  Alternative 
methods involving the detection and analysis of endothelial cells and ECM 
components in MMP-knockout mice would be extremely valuable for investigating 
the roles of specific MMPs on endothelial cell ingression into the embryonic brain.  
 
Brain vascularisation is a carefully orchestrated process and changes to local MMP 
activity not only appeared to result in an effect on endothelial cell ingression but 
may also lead to defective cell proliferation and migration.  The outcome of these 
experiments develops a more comprehensive understanding of the molecular 
mechanisms involved in angiogenic sprouting in vivo, providing a particularly novel 
insight into the roles of MMPs -1, -2 and -9 in endothelial cell ingression into the 
developing brain.  The process involves the invasion of the ectoderm by sprouts 
from the mesoderm with the arrangement of a leading tip cell and follower stalk cells 
reminiscent of cancer progression and so the mechanism underlying endothelial 
sprouting in the brain may share similarities with the process of tumour 
angiogenesis.  MMPs have been found to play a major role in the growth and 
metastasis of malignant tumours due to the large variety of MMP substrates in 
addition to ECM components.  A major element in tumour metastasis is the 
invasiveness of cancer cells in which MMPs are required for focalised proteolysis as 
well as integrins for adhesion.  The analyses of MMPs and integrins are therefore 
crucial for clarifying the roles of these proteases and receptors in both angiogenesis 
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and tumour invasiveness in order to aid in identifying specific targets for therapy, 
particularly with regards to brain metastasis. 
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5. THE INFLUENCE OF NEURAL TUBE PATTERNING ON BRAIN 
 VASCULARISATION 
 
5.1 The identification of VEGFA isoforms and VEGFR expression during the 
 vascularisation of the embryonic G. gallus brain 
 
The neural tube plays an important role in organising its vasculature and the 
signalling pathways that govern neural development and patterning are also involved 
in controlling the development of blood vessels.  A substantial amount of work on 
the influence of brain-derived signals on endothelial ingression focusing on VEGFA 
has already been described in the literature.  The alternative splicing of the VEGFA 
primary transcript yields distinct isoforms that interact with the ECM and the extent 
to which each isoform can bind is determined by the presence of exons 6 and 7, 
which encode heparin-binding domains (Ruhrberg et al., 2002; Ambler et al., 2003; 
Hogan et al., 2004; James et al., 2009; Bautch, 2012).  In addition to this research, 
RT-PCR was conducted in order to identify the VEGFA isoforms present during 
brain vascularisation and to detect any changes in the expression level of each 
isoform as the embryos develop.  The experiment was designed to utilise different 
primer sets in separate reactions to amplify either all VEGFA isoforms present, 
isoforms containing exon 7, or isoforms containing both exons 6 and 7.  A total of 
four VEGFA isoforms were identified in the G. gallus brain between stages HH11 
and HH28 of development (Fig. 5i-ii). 
 
The expression level of the full VEGFA isoform appears to coincide with endothelial 
ingression detected using ISH with an antisense Ets1 probe as this isoform was 
detected in the head at stage HH21 (Fig. 5ii) when ingression into the ventral 
mesencephalon begins (Fig. 3x, E).  The concentration of this isoform increased at 
stage HH24 when ingression continues and as the INVP begins to develop (Fig. 3x, 
Q-T), then dramatically decreased at stage HH26 although sprouting throughout the 
mesencephalon continues (Fig. 3x, I).  An increase in the expression of the shorter 
isoform that lacks both exons 6 and 7 was detected at this stage (Fig. 5ii).  The 
expression of VEGFA isoforms then appears to decrease in the head after stage 
HH26 when an extensive INVP is detected (Fig. 3x, M).  The identification of the 
full isoform at the initiation of ingression supports previous research in which the 
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electroporation of heparin-binding isoforms VEGF189 and VEGF165 into the quail 
neural tube has been shown to induce localised ectopic ingression points (James et 
al., 2009).  The full VEGFA isoform therefore appears to be important during the 
vascularisation of the brain as the heparin-binding properties enable interaction with 
the matrix, resulting in endothelial ingression from HH21 and as the embryo 
develops to HH24.  However, a decrease in the level of this isoform was detected at 
stage HH26 during which an increase in the shorter isoform was detected when 
sprouting continues throughout the mesencephalon.  In the quail electroporation 
study, the ectopic expression of the non-heparin binding isoform VEGF121 into the 
neural tube resulted in ingressing vessels that became dysmorphogenic but the 
number of blood vessel ingression points was not affected (James et al., 2009).  The 
full isoform may therefore be important during the initial stages of ingression, 
whereas the shorter isoform could play a role in guiding the migration of tip cells.   
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Figure 5i.  Nested primers used in RT-PCR for the identification of VEGFA 
isoforms in G. gallus embryos at stages HH11-28 of development.  A number of 
different isoforms of VEGFA are produced from a single gene due to the alternative 
splicing of the initial VEGFA transcript.  The presence of exon 6 and exon 7 
determines the distribution of secreted VEGFA as these exons encode heparin-
binding domains that confer the ability of each isoform to interact with the ECM.  
RNA isolated from homogenised chick embryos is reverse-transcribed to form 
cDNA from each developmental stage for use in PCR with nested primers, which are 
designed to increase the yield and provide more specific product.  Outer primers are 
used in the first round of PCR and the product of which is used as template in the 
second round, utilising different primer sets in three separate reactions to amplify 
certain groups of isoforms: all isoforms (set A), isoforms with exon 7 (set B) and 
isoforms with both exons 6 and 7 (set C).  RT-PCR was conducted using whole 
embryos at stages HH11-21 and from the head only at stages HH21-28.   
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Figure 5ii.  VEGFA isoforms present in G. gallus embryos identified by RT-
PCR.  Sequencing results obtained from extracted gel bands identify four different 
VEGFA isoforms present between stages HH11 and HH28 of chick development.  
The full isoform is detected at stage HH21 in the head, which is the stage when 
endothelial ingression into the ventral midbrain begins.  The concentration of this 
isoform increases at stage HH24 when the INVP begins to develop and is indicated 
by a single bright band of DNA.  The level then dramatically decreases at stage 
HH26 even though sprouting continues throughout the rest of the midbrain, although 
there is an increased expression of the shorter isoform.  The expression of VEGFA 
isoforms decreases after stage HH26 as the level of ingression falls, which is 
consistent with ISH results identifying the established INVP. 
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VEGFA signalling through VEGFRs is involved in the migration of endothelial cells 
towards the neural tube, the selection of tip cells and the initiation of ingression 
(Ambler et al., 2003; Gerhardt et al., 2003; Hogan et al., 2004; Roberts et al., 2004; 
James et al., 2009).  The expression patterns of VEGFRs were therefore investigated 
in the mesencephalon of stage HH19-28 G. gallus embryos using whole-mount ISH 
(Fig. 5iii-viii).  Prior to the initiation of vascular ingression, VEGFR1, VEGFR2 and 
VEGFR3-positive cells were detected within the PNVP around the mesencephalic 
basal plate from stage HH19 as the expression of each VEGFR appeared to occur in 
specific cells that lined up against the basal lamina of the brain (Fig. 5iii, 5v and 5vii, 
C-D, arrows).  In the process of vascular ingression, previous studies have shown 
that the gene expression profile of tip cells is distinct due to the strong expression of 
VEGFR2, whereas the expression of VEGFR1 is prominent within the stalk cells 
(Gerhardt et al., 2003).  VEGFR1 appeared to be particularly prominent in 
coordinating with the invading sprouts from stage HH21 (Fig. 5iii, C-D, arrowheads) 
as the pattern of expression was similar to that observed from the detection of 
endothelial cells invading the ventral brain (Fig. 3x, E-H).  VEGFR1 was then 
detected in the ventral mesencephalon at stage HH22 in the region where the INVP 
subsequently develops (Fig. 5iii, D, arrow), with continued expression in the nascent 
INVP from stage HH24 (Fig. 5iv, C-D, arrows).  The dorsal mesencephalon was 
absent of VEGFR1-positive cells until stage HH24 onward (Fig. 5iv, A).  In the alar 
plate, the pattern of expression at stage HH26 (Fig. 5iv, B, arrowheads) appeared to 
be similar to the detection of endothelial cells in this region at the same 
developmental stage (Fig. 3x, I), suggesting that VEGFR1 may continue to 
coordinate with the invading sprouts throughout the mesencephalon.  Strong 
expression was observed in the established INVP throughout the mesencephalon at 
stage HH28 of development.  In comparison to the VEGFR1 expression pattern, 
VEGFR2 and VEGFR3-positive cells were observed within the PNVP surrounding 
the dorsal half of the mesencephalon at stage HH21, lining up against the basal 
lamina of the brain (Fig. 5v and 5vii, A-B, arrowheads).  Few VEGFR2-positive 
cells were identified within the ventral mesencephalon at this stage (Fig. 5v, D, 
arrow), although this became more apparent when more sprouts were invading the 
brain at stage HH22 (Fig. 5v, D, arrowheads).  VEGFR2 expression was then 
observed in the alar plate at stage HH26 (Fig. 5vi, B, arrows), possibly coordinating 
with the ingressing sprouts.  The expression of VEGFR3 was first observed in the 
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ventral mesencephalon at stage HH22 (Fig. 5vii, D, arrow) in a pattern that also 
appeared to resemble the ingressing sprouts.  Expression was then detected in the 
alar plate at stage HH28 (Fig. 5viii, B, arrows), occurring a little later in 
development than VEGFR2.  In the ventral mesencephalon at stage HH24, VEGFR2 
(Fig. 5vi, D, arrowhead) and VEGFR3 (Fig. 5viii, D, arrowhead) expression was 
also identified within the developing INVP in addition to VEGFR1 (5iv, C-D, 
arrows). 
 
Upon comparing the temporal and spatial expression pattern of VEGFR2 with 
MMP-1 expression, VEGFR2-positive cells were present within the PNVP at the 
dorsal half of the mesencephalon at stage HH21 (Fig. 5v) prior to the expression of 
MMP-1, which was not detected in this region until stage HH24 (Fig. 4vii).  Before 
ingression into the brain, endothelial cells may begin to specialise into tip and stalk 
cells through VEGFA-VEGFR2 and Dll4-Notch signalling as described in the 
literature, which could be enhanced by the subsequent expression of MMP-1 leading 
to invasion, then followed by an increase in cell proliferation as identified through 
phosphohistone H3 immunostaining.  The results could offer support to the 
mechanism proposed by Mazor et al. (2013) in which MMP-1 sensitises VEGFR2-
mediated functions in endothelial cells although further analysis is required.  
Identifying the location of active collagenases in the brain using collagen 
zymography experiments and assaying for endothelial markers, together with MMP-
1 gain- and loss-of function experiments, would be particularly useful for 
investigating the role of MMP-1 in endothelial cell ingression. 
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Figure 5iii.  VEGFR1 expression in the mesencephalon of stage HH19-22 G. 
gallus embryos.  Whole-mount ISH was used with an antisense probe against 
VEGFR1, followed by vibratome sectioning.  VEGFR1 expression levels (blue) are 
shown in the dorsal (A), alar plate (B), basal plate (C) and ventral (D) areas of the 
mesencephalon.  VEGFR1 is present in the PNVP by the basal plate at HH19 
(arrows) and the expression pattern appears to coordinate with endothelial sprouting 
into the ventral mesencephalon at stage HH21 (arrowheads).  VEGFR1-positive cells 
were also detected at stage HH22 in the region where the INVP would subsequently 
develop (arrow).  The receptor was not expressed in the dorsal half of the 
mesencephalon.  Scale bar = 25μm. 
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Figure 5iv.  VEGFR1 expression in the mesencephalon of stage HH24-28 G. 
gallus embryos.  Whole-mount ISH was used with an antisense probe against 
VEGFR1, followed by vibratome sectioning.  VEGFR1 expression levels (blue) are 
shown in the dorsal (A), alar plate (B), basal plate (C) and ventral (D) areas of the 
mesencephalon.  Expression by the dorsal mesencephalon is first observed at stage 
HH24 and continued expression in the nascent INVP is also detected at this stage 
(arrows).  VEGFR1-positive cells were present in the alar plate at stage HH26 
(arrowheads), which appear to coordinate with endothelial sprouting throughout the 
mesencephalon.  VEGFR1 is strongly expressed in the established INVP at stage 
HH28.  Scale bar = 25μm. 
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Figure 5v.  VEGFR2 expression in the mesencephalon of stage HH19-22 G. 
gallus embryos.  Whole-mount ISH was used with an antisense probe against 
VEGFR2, followed by vibratome sectioning.  VEGFR2 expression levels (blue) are 
shown in the dorsal (A), alar plate (B), basal plate (C) and ventral (D) areas of the 
mesencephalon.  VEGFR2 is seen in the PNVP by the basal plate at stage HH19 
(arrows).  Expression by the dorsal midbrain and in the PNVP by the alar plate is 
detected at stage HH21 (arrowheads).  VEGFR2-positive cells were also detected in 
the ventral mesencephalon at this stage (arrow), which became more apparent at 
stage HH22 (arrowheads), appearing to coordinate with the invading sprouts.  Scale 
bar = 25μm. 
159 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5vi.  VEGFR2 expression in the mesencephalon of stage HH24-28 G. 
gallus embryos.  Whole-mount ISH was used with an antisense probe against 
VEGFR2, followed by vibratome sectioning.  VEGFR2 expression levels (blue) are 
shown in the dorsal (A), alar plate (B), basal plate (C) and ventral (D) areas of the 
mesencephalon.  Expression by the dorsal mesencephalon is prominent at stage 
HH24.  The INVP in the ventral mesencephalon is identifiable at this stage but few 
VEGFR2-positive cells were observed in this region (arrowhead).  VEGFR2 
expression was detected in the alar plate of the mesencephalon at stage HH26 of 
development (arrows).  Scale bar = 25μm. 
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Figure 5vii.  VEGFR3 expression in the mesencephalon of stage HH19-22 G. 
gallus embryos.  Whole-mount ISH was used with an antisense probe against 
VEGFR3 (Flt-4), followed by vibratome sectioning.  VEGFR3 expression levels 
(blue) are shown in the dorsal (A), alar plate (B), basal plate (C) and ventral (D) 
areas of the mesencephalon.  VEGFR3 is present within the PNVP by the basal plate 
at stage HH19 (arrows).  Expression by the dorsal mesencephalon and in the PNVP 
by the alar plate is detected at stage HH21 (arrowheads) and subsequently in the 
ventral mesencephalon at stage HH22 (arrow) in a pattern that appears to coordinate 
with the ingressing sprouts.  Scale bar = 25μm. 
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Figure 5viii.  VEGFR3 expression in the mesencephalon of stage HH24-28 G. 
gallus embryos.  Whole-mount ISH was used with an antisense probe against 
VEGFR3, followed by vibratome sectioning.  VEGFR3 expression levels (blue) are 
shown in the dorsal (A), alar plate (B), basal plate (C) and ventral (D) areas of the 
mesencephalon.  VEGFR3-positive cells are seen in the developing INVP in the 
ventral mesencephalon at stage HH24 (arrowhead) and in the alar plate at stage 
HH28 of development (arrow), which appears to coordinate with the ingressing 
sprouts.  Scale bar = 25μm. 
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5.2 Ectopic expression of Shh leads to PNVP expansion, disrupted sprout 
 formation and ectopic endothelial ingression 
 
The development of blood vessels is preceded by the process of neurogenesis and is 
regulated in part by molecular signals that are relayed from the neural network to the 
endothelial cells, resulting in the formation of an elaborate and highly efficient 
vascular network required for supporting the developing brain.  The influence of 
neural regulation on brain vasculature was explored as regional differences in 
vascular ingression were identified, particularly along the dorsoventral axis of the 
brain (refer to chapter 3).  In order to investigate if these differences occurred due to 
the dorsoventral patterning of the brain, electroporation experiments were conducted 
using an expression construct for Shh.  Shh is involved in the spatial organisation of 
neuronal cell types and is well established as the main ventralising signal for the 
neural tube.  The dorsoventral pattern is established very early on in development 
(Wilson & Maden, 2005), therefore the Shh construct was electroporated into one 
side of the mesencephalon of stage HH11-12 G. gallus embryos with the aim of 
transferring the tectum into tegmentum and investigating if the vasculature would 
respond to the ventralisation by resulting in ectopic sprouting in the alar plate as 
would normally occur in the basal plate.  The embryos were incubated further and 
then fixed at stages HH26-29.  
 
The electroporation of Shh into the mesencephalon resulted in perturbation to the 
growth of the developing brain.  A distinct phenotype was identified in which the 
side receiving ectopic Shh was notably smaller compared with the non-
electroporated control side and control embryos (Fig. 5ix).  Upon comparing the size 
and shape of the mesencephalon in sections taken from GFP control and Shh-
electroporated embryos, a number of malformations were observed in the tectum 
(Fig. 5x).  Instead of the normal expansion that occurs during embryonic 
development, the tectum on the electroporated side remained compact and an 
increase in the size of the ventricular zone was also observed on the electroporated 
side (Fig. 5x, arrow).  The detection of endothelial cells by fluorescent IHC with a 
CD34 antibody identified a thickening that was indicative of the tegmentum in one 
embryo (Fig. 5xi, arrow), which was consistent with a change in brain patterning 
resulting from ectopic Shh expression.  The ingression of endothelial sprouts into the 
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restructured mesencephalon was also observed (Fig. 5xi, arrowheads).  Experiments 
involving the misexpression of this dorsoventral patterning molecule have shown 
that an ectopic source of Shh is sufficient to induce a duplicate set of tegmental arcs, 
which allocate neurons to distinct nuclear fates (Agarwala et al., 2001; Agarwala & 
Ragsdale, 2002).  The results therefore appear to show the ventralisation of the 
dorsal mesencephalon and abnormal patterning or partial duplication of the 
mesencephalic arcs.  Additional staining using ISH with multiple probes to detect 
specific transcription factors such as GATA2 and FOXA2 can be performed in order 
to detect the location of these territories.   
 
Further to the abnormalities in the size and shape of the mesencephalon, altering 
neural patterning through the electroporation of Shh also resulted in defects to the 
developing vasculature.  An expansion of the PVNP was detected on the 
electroporated side (Fig. 5xii, arrow) and endothelial cells were observed ingressing 
into the mesencephalon, although sprout formation appeared to be disrupted and the 
development of the INVP was disorganised (Fig. 5xii, arrowheads).  The described 
effects resulting from the ectopic expression of Shh were absent from the non-
electroporated control side and control embryos (Fig. 5xiii).  A study conducted in 
zebrafish embryos has suggested a signalling cascade in which Shh activates VEGF, 
leading to the activation of Notch signalling (Lawson et al., 2002).  Conducting 
fluorescent IHC for VEGF in addition to CD34 immunostaining would therefore be 
important to test the proposed cascade.  Detecting a higher expression of VEGF on 
the electroporated side could then provide an explanation to the observed expansion 
of the PNVP as an increase in VEGF signalling would act to promote endothelial 
cell migration towards the mesencephalon leading to a larger quantity of endothelial 
cells present alongside the brain that may further increase in number due to cell 
division, thus expanding the size of the PNVP.  The disruption to the formation of 
endothelial sprouts may have resulted from the downstream effect of ectopic Shh 
signalling on promoting Notch activation that would in turn increase the number of 
tip cells present within the mesencephalon.  Abnormal sprout formation would 
consequently affect the formation of the internal capillary network resulting from 
changes to normal branching and fusion patterns that occur during normal 
development.     
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Figure 5ix.  G. gallus embryos following the electroporation of an expression 
construct for Shh into the mesencephalon.  The co-electroporation of Shh and 
GFP expression constructs was performed in the left side of the mesencephalon of 
stage HH11-12 embryos.  The embryos were incubated and fixed in 4% PFA/PBS 
upon reaching stages HH26-29 of development.  The left and right sides of the 
mesencephalon from control embryos that were either unelectroporated (A) or 
electroporated with the GFP construct (B) appear to be similar in morphology.  The 
development of the mesencephalon from embryos electroporated with the Shh and 
GFP expression constructs (C) reveals a phenotype in which the electroporated side 
appears to be underdeveloped and distinctly smaller compared with the non-
electroporated control side and the mesencephalon of control embryos. 
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Figure 5x.  Sections taken from the mesencephalon of stage HH28 embryos 
following electroporation of a Shh expression construct compared with the GFP 
control.  The phenotype observed from embryos electroporated with both Shh and 
GFP expression constructs reveal a malformed mesencephalon on the electroporated 
side compared with the non-electroporated control side as the tectum appears 
compact.  An increase in the size of the ventricular zone is also detected (arrow).  
The effect that Shh has on the morphology is substantially different from that of the 
control embryo electroporated only with the GFP expression construct in which the 
left and right sides of the mesencephalon appear similar in both shape and size.   
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5xi. Abnormal development of the mesencephalon following ectopic expression 
of Shh.  Whole-mount fluorescent IHC was conducted using a CD34 antibody to 
detect endothelial cells (red) and an anti-GFP antibody to identify cells that 
successfully took up the expression construct (green).  The ectopic expression of Shh 
results in the aberrant development of the mesencephalon as a thickening was 
detected on the electroporated side (n=1, arrow) compared to the controls.  The 
invasion of endothelial sprouts into the electroporated region was observed 
(arrowheads).  Scale bar = 100μm. 
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Figure 5xii.  Endothelial cell detection using fluorescent IHC following the co-
electroporation of Shh and GFP expression constructs into the mesencephalon.  
Whole-mount fluorescent IHC was conducted using a CD34 antibody to detect 
endothelial cells (red) and an anti-GFP antibody to identify cells that successfully 
took up the expression construct (green).  The ectopic expression of Shh leads to an 
expansion in the size of the PNVP by the basal plate, indicated by a large area of 
red-fluorescing cells (arrow) compared with the control side (6/6 embryos).  
Endothelial cells have ingressed into the electroporated side of the mesencephalon 
although the normal formation of vessel sprouts with a leading tip cell and follower 
stalk cells appears to be disrupted (3/6 embryos) and the development of the INVP is 
also disorganised compared with the control side (4/6 embryos, arrowheads).  Scale 
bar = 100μm. 
 
 
Figure 5xiii.  Endothelial cell detection using fluorescent IHC in the 
mesencephalon of control embryos.  Embryos were either unelectroporated wild 
type (A, n=1) or electroporated with a GFP expression construct (B, n=4).  Whole-
mount fluorescent IHC was conducted using a CD34 antibody to detect endothelial 
cells (red) and an anti-GFP antibody to identify cells that successfully took up the GFP 
construct (green).  A low level of auto fluorescence is emitted from the tissues in both 
controls although a higher intensity of green fluorescence in electroporated embryos 
on the side receiving GFP (arrow) indicates that these cells have successfully taken up 
the expression construct.  The fluorescence for CD34 indicates the location of 
endothelial cells and ingressing sprouts, which appears to be similar in the left and 
right sides of both controls.  Scale bar (sections) = 100μm. 
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The ectopic expression of a single regulatory molecule has been shown to coordinate 
both size and shape of the brain and to indirectly regulate the intricate pattern of 
vascular development through changes to the neural patterning of the 
mesencephalon.  However, further analysis is required to identify and understand the 
cascade of signals existing between Shh expression and endothelial ingression into 
the embryonic brain.  Previous studies have suggested that Shh signalling regulates 
angiogenic sprouting by establishing populations of motor neurons that express pro-
angiogenic Ang-1, which acts to guide vessel ingression in the neural tube.  The 
subsequent stabilisation of the nascent BBB is partly regulated by cross-
communication between Shh-secreting astrocytes and associated endothelial cells 
(Nagase et al., 2005; Alvarez et al., 2011).  However, whether or not a similar 
process occurs in the embryonic G. gallus brain is unclear.  The observed effects that 
Shh had upon brain vasculature nevertheless resulted from the tight coordination of 
the developing nervous and vascular systems and the complex relay of molecular 
information existing between the two systems.  The exact effect on neural patterning 
resulting from Shh electroporation should first be analysed by immunostaining for 
the expression of genes involved in dorsoventral patterning, such as GATA2 and 
Pax7, in addition to motor neuron and astrocyte markers including Islet1 and GFAP, 
respectively, in order to provide a more detailed understanding regarding the effect 
of neural organisation on ingression.   
 
5.3 Notch activity affects endothelial cell ingression and may play a role in 
 maintaining endothelial sprout integrity after ingression 
 
The behaviour of endothelial cells in sprouting angiogenesis is known to be 
regulated by the Notch pathway, which is induced by VEGFA (Gerhardt et al., 
2003).  Previous research conducted in the mouse retina has shown that the 
inhibition of Notch signalling promotes an increase in tip cell numbers and vessel 
branching, whereas Notch activation results in fewer tip cells and vessel branches 
(Hellström et al., 2007; Suchting et al., 2007).  The effect of Notch signalling on 
endothelial sprout invasion was investigated in order to build upon this research and 
provide a deeper understanding of the process occurring within the brain.  The level 
of Notch signalling to which endothelial cells were exposed was reduced through the 
in ovo implantation of acrylic beads soaked with the Notch inhibitor, DAPT, which 
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is an inhibitor of γ-secretase that blocks the proteolytic activation of Notch receptors.  
DAPT has been shown to cause a reduction in amyloid-beta 40 and amyloid-beta 42 
levels in human primary neuronal cultures (IC50 values are 115nM and 200nM for 
total amyloid-beta 40 and amyloid-beta 42, respectively) and in brain extract, 
cerebrospinal fluid and plasma in vivo (Insight Biotechnology).  DAPT was tested at 
a concentration much higher than the known IC50 values as the extent of diffusion 
from the bead and dilution across the tissue over time are unknown.  The beads were 
positioned just beneath the surface ectoderm adjacent to the basal plate of the 
mesencephalon of stage HH22 chick embryos.  Embryos were incubated further and 
harvested at stage HH26, during which sprouting normally occurs at multiple points 
throughout the mesencephalon (Fig. 3x, I).  Endothelial cells were detected with IHC 
using a CD34 antibody (Fig. 5xiv) and counted (Fig. 2ii and Appendix O).   
 
Research conducted in the mouse retina gave rise to a hypothesis in which a decrease 
in the level of Notch would increase the number of endothelial cells ingressing into 
the brain.  A paired t-test was performed using Minitab 17 in order to determine if 
there was a significant increase in the number of endothelial cells present within the 
brain in the side exposed to DAPT compared with the contra lateral control side.  In 
control embryos that were implanted with beads containing only DMSO or PBS 
(Fig. 5xiv, A and C) endothelial cells ingressing into both sides of the 
mesencephalon were similar in number (Appendices P-Q).  Embryos implanted with 
beads containing 10mM DAPT in DMSO showed a significant increase in the 
quantity of endothelial cells ingressing into the mesencephalon on the experimental 
side compared with the control side (Fig. 5xiv, B, Fig. 5xv and Appendix R).  
Clusters of endothelial cells were formed in half of these embryos (Fig. 5xiv, B, 
arrow), a response that was absent from controls.  Similar to the clustering observed 
when MMP activity was altered, the reduction in Notch signalling produced groups 
of endothelial cells that varied in size and were detected within the brain only on the 
experimental side in which the bead containing 10mM DAPT in DMSO was 
implanted.  The presence of cell clusters could result from a disruption to the 
formation of the endothelial sprouts, suggesting a crucial role for Notch signalling 
during vascular ingression into the developing brain.  No difference was found in the 
number of endothelial cells ingressing into the experimental and control sides of 
embryos exposed to 10mM DAPT in PBS (Fig. 5xiv, D, and Appendix S). 
Figure 5xiv.  Sections through the mesencephalon of G. gallus embryos following 
the implantation of beads containing DAPT.  Acrylic beads (blue) containing either 
DMSO (n=7) or PBS (n=7) are positioned in the mesoderm beneath the surface 
ectoderm of the mesencephalon in stage HH26 embryos.  A similar number of 
endothelial cells, which are detected using IHC with a CD34 antibody (brown), are 
seen ingressing into both sides of the mesencephalon at the level of the bead in control 
embryos (A, C).  A significant increase in the quantity of endothelial cells ingressing 
into the mesencephalon on the experimental side compared with the control side was 
detected in embryos implanted with beads containing 10mM DAPT in DMSO (n=5, 
B).  Clusters of endothelial cells were also observed in half of these embryos (arrow).  
No difference was found in the number of endothelial cells ingressing into the 
experimental and control sides of embryos exposed to 10mM DAPT in PBS (D, n=3).  
Scale bar = 100μm.  
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Fig. 5xv. The effect of 10mM DAPT in DMSO on endothelial cell ingression.  
The mean number of endothelial cells on the side containing the bead (n=5) is 
compared with the mean number of endothelial cells on the contra lateral control 
side (n=5) after exposure to 10mM DAPT in DMSO.  Error bars represent the 
standard error of the mean.  A statistically significant increase in the number of 
endothelial cells was identified on the experimental side (p value = 0.036, Appendix 
R). 
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The exposure of DAPT to one side of the early embryonic mesencephalon resulted in 
an increase in the number of endothelial cells ingressing into the experimental side 
compared with the control side and resulted in the formation of endothelial cell 
clusters, similar to those detected as a consequence of altering levels of MMPs.  
Since ingression into the ventral mesencephalon was previously observed at stage 
HH21, endogenous signalling at the start of brain vascularisation would enable tip 
and stalk cell selection to take place and ingression to begin as normal.  The delivery 
of DAPT at stage HH22 may therefore have enhanced ingression as the embryos 
continued to develop.  Shortly after the initiation of ingression, the formation of 
endothelial cell clusters within the mesencephalon suggests either a prevention of or 
disruption to the structural integrity of the vessel sprout brought about by the Notch 
inhibitor.  The results are among the first to suggest a crucial role for Notch 
signalling in the formation of sprouts during endothelial ingression into the 
developing brain.  Endothelial cells have been shown to dynamically shuffle and 
compete for the tip cell position, suggesting that these specialist phenotypes are 
highly transient and exchangeable.  The regular exchange of the leading tip cell 
occurs as cells interact with new neighbouring cells, and in a Notch-dependent 
system the differential regulation of VEGFR1 and VEGFR2 in individual cells 
modulates the expression of Dll4 (Jakobsson et al., 2010).  The identity of the cells 
that form the clusters as either tip or stalk cells remain unknown although alterations 
to the identities of each cell within the ingressing sprout are highly likely.  Further 
analysis should be conducted to determine whether or not these phenotypes are 
present by staining for tip and stalk cells markers such as VEGFR1 and VEGFR2 
and the cells to which they are associated could subsequently be investigated.  The 
implantation of beads could also be performed at an earlier stage to expose cells to 
the Notch inhibitor prior to tip and stalk cell selection and ingression at stage HH21.  
The lack of Notch signalling would be hypothesised to enhance sprouting into the 
mesencephalon due to an increase in the number of tip cells present and the effect 
this has on ingression can be analysed with an assay for endothelial markers.   
 
The effect on the nascent vessel morphology within the embryonic brain in addition 
to the selection of tip and stalk cells is likely to be controlled by a plethora of 
molecular pathways as well as Notch signalling, although a definitive regulatory 
network underlying brain vascularisation has not yet been established.  A primary 
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focus should be to identify the spatial and temporal expression of Notch during early 
development, which will be paramount for comparison with the effect on expression 
following loss- or gain-of-function experiments through DAPT exposure or the 
electroporation of a Notch construct in the embryonic brain, respectively.  The 
importance of Notch signalling in coordinating VEGFA-VEGFR, SEMA3E-
PlexinD1, ALK1 and endothelial Smad1/5 in the promotion or inhibition of tip cell 
formation has been researched and analysed in various model systems with a 
particular focus on the mouse retina (Gerhardt et al., 2003; Hellström et al., 2007; 
Suchting et al., 2007; Kim et al., 2011; Larrivée et al., 2012; Moya et al., 2012) and 
is in no doubt crucial in angiogenesis.  The same regulatory networks may underlie 
the formation of endothelial sprouts and ingression into the embryonic brain, 
although due to the complex function and architecture of the brain it is likely that 
this process is governed by an even more intricate system of regulation, particularly 
in orchestrating the establishment of an adequate ratio of tip and stalk cells required 
for normal sprouting patterns.  A more detailed analysis of these factors in addition 
to the functional analysis of MMPs on endothelial ingression would be worthwhile 
in providing a better understanding of the process of vascularisation in the early 
vertebrate brain.  Furthermore, the combinatory effects of MMP and VEGFA 
antagonists and agonists could later help in motivating the development of novel 
anti-angiogenic strategies that may be useful for reducing tumourigenesis and aiding 
in establishing proangiogenic treatments for the recovery of stroke. 
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APPENDICES 
 
Appendix A 
 
Endothelial cell counts from bead implantation experiments with MMP 
inhibitors and active MMP-1.  Embryos were implanted with beads containing 
pharmacological inhibitors ARP 100, SB-3CT or Batimastat, or active MMP-1, just 
beneath the surface ectoderm adjacent to the basal plate of the mesencephalon.  
Endothelial cells were detected using a CD34 antibody and counted as described in 
Figure 2ii.  Control embryos were implanted with beads containing DMSO or PBS for 
the inhibitors, or 100mM Tris-HCl pH7.5 for active MMP-1. 
 
 AVERAGE NUMBER OF ENDOTHELIAL CELLS 
CONDITION Side without Bead Side with Bead 
DMSO Control 39.00 43.00 
 55.50 50.00 
 35.00 37.00 
 65.50 69.50 
 52.00 42.00 
 23.33 27.00 
 66.00 39.00 
   
ARP 100, 8mM in DMSO 72.50 72.00 
 70.00 50.00 
 102.00 68.00 
 108.00 71.00 
 32.50 45.50 
 28.00 29.00 
   
SB-3CT, 8mM in DMSO 50.00 95.00 
 76.00 91.00 
 64.00 81.00 
   
Batimastat, 1mM in DMSO 43.00 61.00 
 81.00 46.00 
 87.00 80.00 
 87.00 49.00 
 59.00 45.50 
(continue on next page)   
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 AVERAGE NUMBER OF ENDOTHELIAL CELLS 
CONDITION Side without Bead Side with Bead 
PBS Control 59.33 39.67 
 72.67 74.33 
 32.50 38.00 
 33.00 27.00 
 27.67 25.00 
 52.00 54.00 
 27.50 27.50 
   
ARP 100, 8mM in PBS 78.00 55.00 
 69.00 247.00 
 41.00 50.00 
 55.67 39.67 
 26.00 54.00 
   
ARP 100, 1mM in PBS 49.67 68.33 
 46.67 32.67 
 14.00 33.33 
 40.33 43.33 
 60.50 91.50 
 68.00 49.50 
 63.00 59.33 
 28.67 33.00 
 49.00 46.00 
   
SB-3CT, 8mM in PBS 57.00 86.00 
 144.00 50.33 
 74.33 83.67 
 60.75 43.50 
 52.00 41.50 
 105.00 67.00 
 38.00 19.50 
(continue on next page)   
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 AVERAGE NUMBER OF ENDOTHELIAL CELLS 
CONDITION Side without Bead Side with Bead 
SB-3CT, 1mM in PBS 20.00 24.00 
 27.00 19.33 
 46.50 44.75 
 31.00 30.50 
 54.50 40.50 
 21.33 31.00 
 50.33 44.33 
 55.00 43.00 
 57.50 46.00 
 17.50 68.00 
   
100mM Tris-HCl pH7.5 Control 38.00 41.00 
 28.50 60.50 
 45.00 43.00 
 60.00 56.50 
   
Active MMP-1, 25nM in Tris 41.00 75.00 
 48.00 73.00 
 49.00 140.00 
 57.00 79.00 
 62.00 50.50 
   
Active MMP-1, 250nM in Tris 52.67 35.00 
 43.00 38.00 
 53.00 53.00 
   
Active MMP-1, 1μM in Tris 36.00 39.00 
 50.50 67.50 
 44.50 59.00 
 56.50 113.50 
 57.50 189.00 
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Appendix B 
 
Paired t-test and histogram for DMSO control bead experiments.  Embryos were 
implanted with beads containing DMSO, just beneath the surface ectoderm adjacent to 
the basal plate of the mesencephalon.  CD34-stained endothelial cells were counted on 
the control side (A) and compared with the contra lateral side containing the bead (B).  
No significant difference was found between the mean number of endothelial cells on 
the control side and on the side containing the bead. 
 
  A 
 
 
 
 
 
 
 
 
 B 
 
 
 
 
 
 
 
 
 
   N   Mean  StDev  SE Mean 
 Control      7  48.05  16.13     6.10 
 Bead         7  43.93  13.26     5.01 
 Difference   7   4.12  11.47     4.34 
 
 
 95% CI for mean difference: (-6.49, 14.73) 
 T-Test of mean difference = 0 (vs≠0): T-Value = 0.95  P-Value = 0.379 
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Appendix C 
 
Paired t-test and histogram for bead experiments with 8mM ARP 100 in DMSO.  
Embryos were implanted with beads containing 8mM ARP 100 in DMSO, just 
beneath the surface ectoderm adjacent to the basal plate of the mesencephalon.  CD34-
stained endothelial cells were counted on the control side (A) and compared with the 
contra lateral side containing the bead (B).  The mean number of endothelial cells on 
the side containing the bead was found to be lower than that of the control side, 
although the difference was not statistically significant. 
 
  A   
 
 
 
 
 
 
 
 
  B   
 
 
 
 
 
 
 
     
          N    Mean  StDev  SE Mean 
 Bead         6    55.9   17.3      7.1 
 Control      6    68.8   33.6     13.7 
 Difference   6  -12.92  20.47     8.36 
 
 95% upper bound for mean difference: 3.92 
 T-Test of mean difference = 0 (vs<0): T-Value = -1.55 P-Value = 0.091 
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Appendix D 
 
Paired t-test and histogram for bead experiments with 8mM SB-3CT in DMSO.  
Embryos were implanted with beads containing 8mM SB-3CT in DMSO, just beneath 
the surface ectoderm adjacent to the basal plate of the mesencephalon.  CD34-stained 
endothelial cells were counted on the control side (A) and compared with the contra 
lateral side containing the bead (B).  No significant difference was found between the 
mean number of endothelial cells on the control side and on the side containing the 
bead.  
 
  A   
 
 
 
 
 
 
 
 
  B   
 
 
 
 
 
 
 
 
    
   N   Mean  StDev  SE Mean 
 Bead        3  89.00   7.21     4.16 
 Control      3  63.33  13.01     7.51 
 Difference   3  25.67  16.77     9.68 
 
 95% upper bound for mean difference: 53.94 
 T-Test of mean difference = 0 (vs<0): T-Value = 2.65 P-Value = 0.941 
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Appendix E 
 
Paired t-test and histogram for bead experiments with 1mM Batimastat in 
DMSO.  Embryos were implanted with beads containing 1mM Batimastat in DMSO, 
just beneath the surface ectoderm adjacent to the basal plate of the mesencephalon.  
CD34-stained endothelial cells were counted on the control side (A) and compared 
with the contra lateral side containing the bead (B).  No significant difference was 
found between the mean number of endothelial cells on the control side and on the 
side containing the bead.  
 
  A   
 
 
 
 
 
 
 
 
  B   
 
 
 
 
 
 
 
    
   N   Mean  StDev  SE Mean 
 Bead         5  56.30  14.66     6.56 
 Control      5  71.40  19.62     8.77 
 Difference   5  -15.1   22.8     10.2 
 
 95% upper bound for mean difference: 6.7 
 T-Test of mean difference = 0 (vs<0): T-Value = -1.48  P-Value = 0.107 
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Paired t-test and histogram for PBS control bead experiments.  Embryos were 
implanted with beads containing PBS, just beneath the surface ectoderm adjacent to 
the basal plate of the mesencephalon.  CD34-stained endothelial cells were counted on 
the control side (A) and compared with the contra lateral side containing the bead (B).  
No significant difference was found between the mean number of endothelial cells on 
the control side and on the side containing the bead. 
 
  A   
 
 
 
 
 
 
 
 
  B   
 
 
 
 
 
 
 
   
   N   Mean  StDev  SE Mean 
 Control      7  43.52  17.85     6.75 
 Bead         7  40.79  17.91     6.77 
 Difference   7   2.74   8.31     3.14 
 
 
 95% CI for mean difference: (-4.95, 10.42) 
     T-Test of mean difference = 0 (vs≠0): T-Value = 0.87  P-Value = 0.417 
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Paired t-test and histogram for bead experiments with 8mM ARP 100 in PBS.  
Embryos were implanted with beads containing 8mM ARP 100 in PBS, just beneath 
the surface ectoderm adjacent to the basal plate of the mesencephalon.  CD34-stained 
endothelial cells were counted on the control side (A) and compared with the contra 
lateral side containing the bead (B).  No significant difference was found between the 
mean number of endothelial cells on the control side and on the side containing the 
bead. 
 
  A   
 
 
 
 
 
 
 
 
  B   
 
 
 
 
 
 
 
 
 
   N  Mean  StDev  SE Mean 
 Bead         5  89.1   88.5     39.6 
 Control      5  53.9   21.0      9.4 
 Difference   5  35.2   82.4     36.8 
 
 95% upper bound for mean difference: 113.7 
 T-Test of mean difference = 0 (vs<0): T-Value = 0.96  P-Value = 0.803 
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Paired t-test and histogram for bead experiments with 1mM ARP 100 in PBS.  
Embryos were implanted with beads containing 1mM ARP 100 in PBS, just beneath 
the surface ectoderm adjacent to the basal plate of the mesencephalon.  CD34-stained 
endothelial cells were counted on the control side (A) and compared with the contra 
lateral side containing the bead (B).  No significant difference was found between the 
mean number of endothelial cells on the control side and on the side containing the 
bead.  
 
  A     
 
 
 
 
 
 
 
 
  B   
 
 
 
 
 
 
 
 
    
   N   Mean  StDev  SE Mean 
 Bead         9  50.78  19.58     6.53 
 Control      9  46.65  17.17     5.72 
 Difference   9   4.13  16.27     5.42 
 
 95% upper bound for mean difference: 14.21 
 T-Test of mean difference = 0 (vs<0): T-Value = 0.76  P-Value = 0.766 
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Paired t-test and histogram for bead experiments with 8mM SB-3CT in PBS.  
Embryos were implanted with beads containing 8mM SB-3CT in PBS, just beneath 
the surface ectoderm adjacent to the basal plate of the mesencephalon.  CD34-stained 
endothelial cells were counted on the control side (A) and compared with the contra 
lateral side containing the bead (B).  No significant difference was found between the 
mean number of endothelial cells on the control side and on the side containing the 
bead. 
 
  A     
 
 
 
 
 
 
 
 
  B   
 
 
 
 
 
 
 
 
 
   N   Mean  StDev  SE Mean 
 Bead         7   55.9   24.2      9.2 
 Control      7   75.9   36.7     13.9 
 Difference   7  -19.9   39.0     14.7 
 
 95% upper bound for mean difference: 8.7 
 T-Test of mean difference = 0 (vs<0): T-Value = -1.35  P-Value = 0.112 
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Paired t-test and histogram for bead experiments with 1mM SB-3CT in PBS.  
Embryos were implanted with beads containing 1mM SB-3CT in PBS, just beneath 
the surface ectoderm adjacent to the basal plate of the mesencephalon.  CD34-stained 
endothelial cells were counted on the control side (A) and compared with the contra 
lateral side containing the bead (B).  No significant difference was found between the 
mean number of endothelial cells on the control side and on the side containing the 
bead. 
 
  A     
 
 
 
 
 
 
 
 
  B   
 
 
 
 
 
 
 
 
 
  N   Mean  StDev  SE Mean 
 Bead        10  39.14  13.81     4.37 
 Control     10  38.07  16.19     5.12 
 Difference  10   1.08  18.91     5.98 
 
95% upper bound for mean difference: 12.04 
T-Test of mean difference = 0 (vs<0): T-Value = 0.18  P-Value = 0.569 
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Paired t-test and histogram for 100mM Tris-HCl pH7.5 control bead 
experiments.  Embryos were implanted with beads containing 100mM Tris-HCl 
pH7.5, just beneath the surface ectoderm adjacent to the basal plate of the 
mesencephalon.  CD34-stained endothelial cells were counted on the control side (A) 
and compared with the contra lateral side containing the bead (B).  No significant 
difference was found between the mean number of endothelial cells on the control side 
and on the side containing the bead. 
 
  A     
 
 
 
 
 
 
 
 
  B   
 
 
 
 
 
 
 
 
   
   N   Mean  StDev  SE Mean 
 Control      4  42.88  13.27     6.63 
 Bead         4  50.25   9.70     4.85 
 Difference   4  -7.38  16.65     8.33 
 
 95% CI for mean difference: (-33.87, 19.12) 
 T-Test of mean difference = 0 (vs≠0): T-Value = -0.89  P-Value = 0.441 
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Paired t-test and histogram for bead experiments with 25nM active MMP-1 in 
Tris-HCl.  Embryos were implanted with beads containing 25nM active MMP-1 in 
Tris-HCl, just beneath the surface ectoderm adjacent to the basal plate of the 
mesencephalon.  CD34-stained endothelial cells were counted on the control side (A) 
and compared with the contra lateral side containing the bead (B).  The mean number 
of endothelial cells on the side containing the bead was higher than that of the control 
side, although the difference was not statistically significant.  
 
 A     
 
 
 
 
 
 
 
 
  B   
 
 
 
 
 
 
 
 
    
   N  Mean  StDev  SE Mean 
 Bead         5  83.5   33.5     15.0 
 Control      5  51.4    8.2      3.7 
 Difference   5  32.1   37.2     16.6 
  
 95% lower bound for mean difference: -3.3 
 T-Test of mean difference = 0 (vs>0): T-Value = 1.93  P-Value = 0.063 
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Paired t-test and histogram for bead experiments with 250nM active MMP-1 in 
Tris-HCl.  Embryos were implanted with beads containing 250nM active MMP-1 in 
Tris-HCl, just beneath the surface ectoderm adjacent to the basal plate of the 
mesencephalon.  CD34-stained endothelial cells were counted on the control side (A) 
and compared with the contra lateral side containing the bead (B).   No significant 
difference was found between the mean number of endothelial cells on the control side 
and on the side containing the bead.  
 
  A     
 
 
 
 
 
 
 
 
  B   
 
 
 
 
 
 
 
 
   
 N   Mean  StDev  SE Mean 
 Bead         3  42.00   9.64     5.57 
 Control      3  49.56   5.68     3.28 
 Difference   3  -7.56   9.11     5.26 
 
 95% lower bound for mean difference: -22.91 
 T-Test of mean difference = 0 (vs>0): T-Value = -1.44  P-Value = 0.856 
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Paired t-test and histogram for bead experiments with 1μM active MMP-1 in 
Tris-HCl.  Embryos were implanted with beads containing 1μM active MMP-1 in 
Tris-HCl, just beneath the surface ectoderm adjacent to the basal plate of the 
mesencephalon.  CD34-stained endothelial cells were counted on the control side (A) 
and compared with the contra lateral side containing the bead (B).  The mean number 
of endothelial cells on the side containing the bead was found to be higher than that of 
the control side although this increase was not statistically significant. 
 
  A     
 
 
 
 
 
 
 
 
  B   
 
 
 
 
 
 
 
    
 
           N  Mean  StDev  SE Mean 
 Bead         5  93.6   59.9     26.8 
 Control      5  49.0    8.9      4.0 
 Difference   5  44.6   52.7     23.6 
 
 95% lower bound for mean difference: -5.6 
 T-Test of mean difference = 0 (vs>0): T-Value = 1.89  P-Value = 0.066 
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Endothelial cell counts from bead implantation experiments with DAPT.  
Embryos were implanted with beads containing DAPT in either DMSO or PBS, just 
beneath the surface ectoderm adjacent to the basal plate of the mesencephalon.  
Endothelial cells were detected using a CD34 antibody and counted as described in 
Figure 2ii.  Control embryos were implanted with beads containing either DMSO or 
PBS. 
 
 AVERAGE NUMBER OF ENDOTHELIAL CELLS 
CONDITION Side without Bead Side with Bead 
DMSO Control 39.00 43.00 
 55.50 50.00 
 35.00 37.00 
 65.50 69.50 
 52.00 42.00 
 23.33 27.00 
 66.00 39.00 
   
DAPT, 10mM in DMSO 58.50 85.50 
 34.33 46.00 
 63.00 67.67 
 40.50 39.00 
 69.33 91.67 
   
PBS Control 59.33 39.67 
 72.67 74.33 
 32.50 38.00 
 33.00 27.00 
 27.67 25.00 
 52.00 54.00 
 27.50 27.50 
   
DAPT, 10mM in PBS 80.00 37.00 
 41.00 30.00 
 37.00 31.67 
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Paired t-test and histogram for DMSO control bead experiments.  Embryos were 
implanted with beads containing DMSO, just beneath the surface ectoderm adjacent to 
the basal plate of the mesencephalon.  CD34-stained endothelial cells were counted on 
the control side (A) and compared with the contra lateral side containing the bead (B).  
No significant difference was found between the mean number of endothelial cells on 
the control side and on the side containing the bead. 
 
  A 
 
 
 
 
 
 
 
 
  B 
 
 
 
 
 
 
 
   
   N   Mean  StDev  SE Mean 
 Control      7  48.05  16.13     6.10 
 Bead         7  43.93  13.26     5.01 
 Difference   7   4.12  11.47     4.34 
 
 95% CI for mean difference: (-6.49, 14.73) 
 T-Test of mean difference = 0 (vs≠0): T-Value = 0.95 P-Value = 0.379 
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Paired t-test and histogram for PBS control bead experiments.  Embryos were 
implanted with beads containing PBS, just beneath the surface ectoderm adjacent to 
the basal plate of the mesencephalon.  CD34-stained endothelial cells were counted on 
the control side (A) and compared with the contra lateral side containing the bead (B).  
No significant difference was found between the mean number of endothelial cells on 
the control side and on the side containing the bead. 
 
  A   
 
 
 
 
 
 
 
 
  B   
 
 
 
 
 
 
 
 
  
      N   Mean  StDev  SE Mean 
 Control      7  43.52  17.85     6.75 
 Bead         7  40.79  17.91     6.77 
 Difference   7   2.74   8.31     3.14 
 
95% CI for mean difference: (-4.95, 10.42) 
T-Test of mean difference = 0 (vs≠0): T-Value = 0.87  P-Value = 0.417 
249 
 
80706050403020
2.0
1.5
1.0
0.5
0.0
Mean 53.12
StDev 15.02
N 5
Number of Endothelial Cells
F
re
q
u
e
n
c
y
Control
12010080604020
2.0
1.5
1.0
0.5
0.0
Mean 65.98
StDev 23.31
N 5
Number of Endothelial Cells
F
re
q
u
e
n
c
y
Side Containing Bead
Appendix R 
 
Paired t-test and histogram for bead experiments with 10mM DAPT in DMSO.  
Embryos were implanted with beads containing 10mM DAPT in DMSO, just beneath 
the surface ectoderm adjacent to the basal plate of the mesencephalon.  CD34-stained 
endothelial cells were counted on the control side (A) and compared with the contra 
lateral side containing the bead (B).  The mean number of endothelial cells on the side 
containing the bead was found to be significantly higher than that of the control side. 
 
  A   
 
 
 
 
 
 
 
 
  B   
 
 
 
 
 
 
 
 
    
   N   Mean  StDev  SE Mean 
 Bead         5   66.0   23.3     10.4 
 Control      5   53.1   15.0      6.7 
 Difference   5  12.86  11.89     5.32 
 
 95% lower bound for mean difference: 1.53 
 T-Test of mean difference = 0 (vs>0): T-Value = 2.42  P-Value = 0.036 
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Paired t-test and histogram for bead experiments with 10mM DAPT in PBS.  
Embryos were implanted with beads containing 10mM DAPT in PBS, just beneath the 
surface ectoderm adjacent to the basal plate of the mesencephalon.  CD34-stained 
endothelial cells were counted on the control side (A) and compared with the contra 
lateral side containing the bead (B).  No significant difference was found between the 
mean number of endothelial cells on the control side and on the side containing the 
bead. 
 
  A   
 
 
 
 
 
 
 
 
  B   
 
 
 
 
 
 
 
 
  
   N   Mean  StDev  SE Mean 
 Bead         3   32.9    3.7      2.1 
 Control      3   52.7   23.8     13.7 
 Difference   3  -19.8   20.3     11.7 
 
 95% lower bound for mean difference: -54.0 
 T-Test of mean difference = 0 (vs>0): T-Value = -1.69  P-Value = 0.883 
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